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Insights into the regulation of the DEAH-box helicase Prp43p through 
its interactions with three G-patch proteins 
 
Jennifer Ann Hennigan, Ph.D. 
The University of Texas at Austin, 2013 
 
Supervisor: Scott Stevens 
 
The RNA helicase Prp43p is one of the few members of the DEAH-box helicase 
family that is known to operate in more than one cellular process in Saccharomyces 
cerevisiae. With roles in ribosome biogenesis and pre-mRNA splicing, Prp43p may be 
important in maintaining a communication conduit between these two pathways. Our 
studies provide insights into how Prp43p function is regulated through the use of three 
cofactors, Ntr1p, Pfa1p, and Gno1p, all of which interact with Prp43p at different steps of 
pre-mRNA splicing or ribosome biogenesis. Each cofactor contains a unique G-patch 
domain and our data show that they associate with Prp43p in a mutually exclusive 
manner. A strong growth defect and RNA processing phenotypes are seen upon 
overexpression of Pfa1p due to the dominance of Pfa1p interaction with Prp43p. 
Moreover, excess Pfa1p precludes Prp43p from interacting with either 35S pre-rRNA or 
U6 snRNA, indicating this one cofactor can negatively regulate Prp43p recruitment into 
ribosome biogenesis and pre-mRNA splicing pathways, respectively. We have 
determined that Ntr1p and Gno1p are able to compete with one anther for Prp43p 
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occupancy. Similar to Ntr1p, we show that the G-patch domain of Gno1p contributes to 
its association with Prp43p. 
To further understand pathway specificity of Prp43p, we characterized conditional 
prp43 alleles with mutations C-terminal to the conserved RecA domains of Prp43p. 
These novel alleles affect pre-mRNA splicing and ribosome biogenesis, though none are 
mutually exclusive. Multiple prp43 alleles are deficient in tri-snRNP formation, a 
previously uncharacterized phenotype in prp43 mutants. The majority of our prp43 
mutants display varying rRNA defects, with some alleles impacting ribosome biogenesis 
more severely or moderately than known prp43 ATPase mutants. To correlate the 
processing defects seen in each allele, we have determined the extent of association of the 
mutants with each G-patch protein. Altogether, our data support a working model for 
Prp43p in which its substrate specificity, activation, and cellular distribution is 
coordinated through the efforts of the three G-patch proteins in yeast and sheds light on 
potential mechanisms of general DExH/D helicase function and regulation.  
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Chapter 1: Introduction 
1.1 EUKARYOTIC GENE EXPRESSION  
In eukaryotes, efficient gene expression is dependent upon RNA and proteins 
complexed together in several ribonucleoprotein (RNP) machineries. From the moment 
transcription by RNA Polymerase II (RNA Pol II) begins in the nucleus, a pre-mRNA is 
bound by heterologous nuclear RNP (hnRNP) proteins and serine/arginine-rich (SR) 
proteins (rev. in Wahl et al. 2009). While in the nucleus, intervening sequences in pre-
mRNAs called introns are removed through the action of the spliceosome, a multiple 
mega-dalton complex composed of five small nuclear RNPs (snRNPs) and dozens of 
trans-acting factors. Each snRNP is comprised of a small nuclear RNA (snRNA), either 
U1, U2, U4, U5 or U6, and both common and specific proteins (rev in Hoskins and 
Moore 2012). Mature mRNAs are exported through the nuclear pore complex (NPC) to 
the cytoplasm and are translated by another large RNP machine, the ribosome (rev. in 
Mor and Shav-Tal 2010). The ribosomal RNAs (rRNA) that compose the ribosome often 
have modifications that are directed by small nucleolar RNAs (snoRNA) complexed with 
proteins as small nucelolar RNPs (snoRNP) (rev. in Watkins and Bohnsack 2012). Cells 
also use other non-coding RNAs (ncRNA) like microRNAs (miRNAs) to provide more 
subtle regulation over gene expression. miRNAs can affect the stability or translation of a 
target mRNA through perfect or imperfect basepairing with the target, respectively. 
Through differential expression, miRNAs can regulate gene expression in a tissue- or 
developmental-stage-specific manner. Overall, all of these ncRNAs are essential in the 
infrastructure and the regulation of a eukaryotic cell (rev. in Mattick and Makunin 2006). 
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1.2 PRE-MRNA SPLICING 
The spliceosome works to remove non-coding sequences, termed introns, from 
pre-mRNAs. In the process, the coding sequences, termed exons, are ligated to form a 
mature substrate for translation. The snRNP complexes that make up the major 
spliceosome contain the U1, U2, U4, U5 and U6 snRNAs, as well as both common and 
unique proteins. Most pre-mRNAs are addressed by the major spliceosome, while in 
higher eukaryotes, a smaller number of transcripts are processed via the minor 
spliceosome. This complex also contains the U5 snRNP, but the U1, U2, U4, and U6 
snRNPs are substituted by the U11, U12, U4atac, and U6atac snRNPs, respectively. 
Since the minor spliceosome is only present in higher eukaryotes and is thought to 
generally act in a similar manner to the major, it will not be extensively covered here 
(rev. in Patel and Bellini 2008). My work presented here was conducted in 
Saccharomyces cerevisiae, but since 85% of yeast pre-mRNA splicing factors have clear 
orthologs in humans, the yeast spliceosome is believed to represent the core of the human 
spliceosome (Fabrizio et al. 2009).  
1.2.1 Functional importance of introns 
The prevalence and length of introns appears to vary between species. In yeast, 
only 5% of genes contain introns within some 283 genes (Spingola et al. 1999; Juneau et 
al. 2007; Parenteau et al. 2008). Only a handful of these genes contain more than one 
intron, and most introns are relatively short (~100-400 bp) compared to human introns, 
which number on average seven per transcript and range to greater than 490,000 bp 
(Spingola et al. 1999; Sakharkar et al. 2004). Additionally, since human genes generally 
 3 
contain multiple introns, different transcripts are commonly produced through alternative 
pre-mRNA splicing to include or exclude exons in the mRNA in a regulated manner 
(Nagasaki et al. 2005).  
The introns of human genes also contain non-coding elements like snoRNAs and 
miRNAs (Rearick et al. 2011). For example, the mammalian U22 snoRNA gene contains 
ten introns, and seven other snoRNAs (U25-U31) encoded in its introns (Tycowski et al. 
1996). In humans, snoRNAs are predominantly processed in a splicing-dependent 
manner. Generally, it is only after intron removal by the spliceosome and debranching of 
the intron lariat that the mature snoRNA is released. Human miRNAs can either be 
processed in a similar manner from the excised intron lariat, from the unspliced pre-
mRNA, or concurrently with splicing. Such different pathways are hypothesized to 
provide competition between pre-mRNA splicing and miRNA biogenesis, which might 
regulate gene expression (Brown et al. 2008). In yeast, only six snoRNAs are known to 
be located in introns: U24, snR38, U18, snR44, snR59 and snR39 in ASC1, TEF4, EBF1, 
RPS22B, RPL7B, RPL7A, respectively. As in humans, these snoRNAs are dependent on 
Dbr1p to debranch the intron lariat for their release and proper maturation (Ooi et al. 
1998). However, the loss of any of these snoRNAs does not affect cell growth in rich 
media (Parenteau et al. 2008, 2011). Only three genes in yeast contain introns that are 
important for cell growth under normal conditions (MTR2, YRA1, and TAD3), but the 
essentiality of these introns is dependent upon the promoter of the gene, indicating the 
introns are utilized for transcriptional control of the genes. However, the loss of some 
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introns can affect growth under stress such as hypo- or hyperosmotic conditions 
(Parenteau et al. 2008)  
In yeast, 50% of RNA transcripts produced by RNA Pol II encode structural 
ribosomal proteins (r-proteins) (Ares et al. 1999; Warner 1999), and these transcripts 
comprise 90% of the intron-containing pre-mRNAs, making them the largest class of 
proteins transcribed by RNA Pol II and addressed by the spliceosome (Ares et al. 1999). 
A link between rRNA and mRNA processing has been hypothesized which may serve to 
maximize the regulation of ribosome production (Ares et al. 1999). Indeed, introns in r-
protein genes appear to be involved in the regulation of ribosome biogenesis. If the 
introns of certain r-protein genes are removed, the expressions of the genes are affected. 
Additionally, within duplicated r-protein pairs, the majority of introns exert some 
intergenic regulation. For example, the removal of an intron in one r-protein paralog can 
reduce the expression of the other paralog. Therefore, some r-protein paralog pairs are 
expressed in an intron-dependent manner (Parenteau et al. 2011). The presence of introns 
in 15% of r-protein genes contributes to proper rRNA processing. Removal of these 
introns results in increased or decreased abundance in the 35S pre-rRNA levels. 
Increased 35S pre-rRNA levels, signifying a delay in processing, are specifically linked 
to introns of large subunit r-protein genes, several of which also affect A1 and D site 
cleavages (see Chapter 1.3.2 for details on cleavages) (Parenteau et al. 2011).  
As additional evidence for coordination, the pre-mRNA and mRNA levels of r-
proteins change in response to various environmental stresses (Pleiss et al. 2007; 
Bergkessel et al. 2011). For example, yeast respond to amino acid starvation by 
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decreasing the splicing efficiency of r-protein encoding pre-mRNAs in a transcript-
specific manner, which results in pre-mRNA accumulation (Pleiss et al. 2007; Bergkessel 
et al. 2011). In contrast, stresses that lead to TORC1 inactivation, like heat shock and 
hyperosmotic stress, result in a rapid loss of r-protein pre-mRNAs rather than their 
accumulation. Therefore, pre-mRNA processing is a means by which the cell can 
modulate ribosome production appropriately in response to environmental conditions 
(Parenteau et al. 2011).  
1.2.2 Pre-mRNA splicing mechanism  
Pre-mRNAs are spliced within a 40S spliceosome in a series of ATP-dependent 
steps (Brody and Abelson 1985; Lin et al. 1987; Schwer and Gross 1998; Martin et al. 
2002). First, the spliceosome must assemble on the pre-mRNA substrate, then it directs 
two transesterification reactions to join the exons. Finally, in a third step, the pre-mRNA 
and lariat intron are released (Lin et al. 1987). Two SN2 transesterification reactions occur 
during splicing of a pre-mRNA (Illustration 1.1) (Domdey et al. 1984; Grabowski et al. 
1984; Padgett et al. 1984; Rodriguez et al. 1984; Lin et al. 1987). First, the 
phosphodiester bond of the 5' splice site (5’ SS) is nucleophilically attacked by the 2'-OH 
of a conserved adenosine in the branch point sequence within the intron (UACUAAC). 
This reaction yields the free 5' exon and the 3' exon attached to a circularized intron, 
called the lariat intermediate. The branchpoint adenosine is linked by a 2'-5'-
phosphodiester bond to the guanosine from the conserved GU in the 5' SS (Breathnach et 
al. 1978), as well as the downstream cytosine by a typical 3'-5' phosphodiester bond 
(Domdey et al. 1984). In the second reaction, the 3'-OH of the 5' exon attacks the 
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phosphate following the conserved AG in the 3' splice site (3’ SS) (Breathnach et al. 
1978), joining the 3' and 5' exons. Unlike the self-splicing group II introns, pre-mRNAs 
cannot catalyze these two reactions alone, but depend on the trans-acting factors that 
comprise the spliceosome to fold and rearrange the pre-mRNA for catalysis. 
Additionally, none of the snRNAs of the spliceosome contain a pre-formed catalytic site. 
In fact, the RNA-RNA interactions within the spliceosome are generally weak and are 
dependent upon the protein factors for stability, scaffolding, and remodeling during the 
catalytic cycle (rev. in Wahl et al. 2009).  
1.2.3 snRNP biogenesis 
The U1-U5 snRNAs are transcribed by RNA Pol II and are capped co-
transcriptionally with a 5'-7-methylguanosine cap (m7G) like other RNA Pol II transcripts 
(rev. in Patel and Bellini 2008). In S. cerevisiae, snRNP biogenesis is completed within 
the nucleus, but in higher eukaryotes pre-snRNAs undergo a cytoplasmic maturation 
phase (Verheggen and Bertrand 2012). In both cases, a heteroheptameric ring of Sm 
proteins bind around a conserved sequence motif called the Sm site (PuAU4-6GPU) 
(Raker et al. 1999). The methyltransferase Tgs1p recognizes the assembled Sm core and 
adds two methyl groups to the 5' cap to create a distinct hyper-methylated 2,2,7-
trimethylguanosine cap (Verheggen and Bertrand 2012). In yeast, Tgs1p localizes to the 
nucleoli, indicating that pre-snRNPs transit through the nucleoli during maturation 
(Mouaikel et al. 2002). In humans, the pre-snRNAs are transported into the cytoplasm 
prior to Sm assembly in a CRM1-dependent manner through association with the 
Phosphorylated Adaptor for RNA export (PHAX). The formation of the Sm ring is   
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Illustration 1.1 Chemical reactions of pre-mRNA splicing.  
Pre-mRNA splicing occurs through two transesterification reactions. First, the 
2’OH of the branchpoint adenosine attacks the 5’ SS to produce a free 5’ exon and a 
lariat intermediate. The reactive adenosine in the concensus sequence is underlined. In 
the second reaction, the 5’ SS attacks the conserved guanosine in 3’SS. The two exons 
are now ligated to create a mature mRNA and the intron is released as a branched 2’-5’ 
phosphodiester lariat that is degraded.  
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facilitated by a multisubunit enzyme called the survival of motor neuron protein (SMN) 
complex. hTgs1p is a component of the SMN complex in the cytoplasm, and, following 
its activity, the trimethylated cap and the Sm core act as nuclear localization signals 
(NLS) (rev. in Patel and Bellini 2008). In metazoans, the adaptor protein Snurportin 
recognizes the trimethylated caps and enchances the trafficking of the nascent snRNPs 
into the nucleus for final maturation (Huber et al. 1998). In the nucleus, the snRNAs are 
modified with 2'-O-methylations and psueduridylations that are directed by small Cajal 
body-specific RNAs (scaRNAs) (Jády et al. 2003) and assembly with the remaining 
snRNP-specific proteins is completed therein. 
In contrast to the other snRNAs, the U6 snRNA is transcribed by RNA Pol III. 
After transcription, the La protein binds both its 5'-triphosphate cap and a 3' U-rich motif, 
and protects the pre-snRNA from degradation (rev. in Patel and Bellini 2008). The 5' end 
of the U6 pre-snRNA is uniquely capped by a specific methyl transferase to produce a !-
monomethyl cap (Shimba and Reddy 1994). Additionally, the 3' end of the pre-snRNA is 
trimmed by a specific exonuclease and an unidentified enzyme produces a 2', 3' cyclic 
phosphate tail. Together, these two unique modifications preclude the continued binding 
of the La protein (rev. in Patel and Bellini 2008). Unlike other snRNPs, the U6 snRNP 
lacks the Sm site and proteins, but contains Sm-like proteins (Lsm 2-8). After removal of 
the La protein, the Lsm proteins bind to the same 3' U-rich motif as a heteroheptameric 
complex (Achsel et al. 1999). The Lsm proteins are necessary for retention of the U6 in 
the nucleus; therefore, the U6 pre-snRNP does not have a cytoplasmic maturation phase 
like other snRNPs in metazoa (Spiller et al. 2007). At some point during its maturation, 
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the U6 snRNA cycles through the nucleolus and snoRNAs direct 2'-O-ribose 
methylations and pseudouridylations (Ganot et al. 1999). After transitioning through the 
nucleolus, the U6 snRNA accumulates in Cajal bodies like the other snRNAs (Lange and 
Gerbi 2000). The mature U6 snRNP also contains the unique component Prp24p (SART3 
in human) in addition to the Lsm core (Shannon and Guthrie 1991).  
1.2.3.1 Di-snRNP biogenesis 
The di-snRNP particle contains the U4 and U6 snRNAs extensively paired in two 
intermolecular stems (Brow and Guthrie 1988). This annealing is facilitated by the U6 
RNA binding factor, Prp24p (Raghunathan and Guthrie 1998a). An intramolecular stem 
loop (ISL) in the 3' end of U6 must be disrupted for proper annealing of the U4 snRNA 
(Fortner et al. 1994). Four RNA recognition motifs (RRMs) in Prp24p bind the U6 
snRNA surrounding the ISL (Martin-Tumasz et al. 2010, 2011). RRM1 and RRM2 bind 
along the stem of the ISL (Martin-Tumasz et al. 2010), while RRM3 binds closer to the 
loop (Martin-Tumasz et al. 2011). An occluded RRM, oRRM4, at the base of the helix is 
thought to be able to disrupt base pairing in the ISL. Prp24p is then thought to be released 
due to the more highly favorable free energy of the newly formed U4/U6 duplex. The 
intramolecular U4/U6 stem eliminates the binding site of Prp24p within the U6 snRNA 
(Martin-Tumasz et al. 2011). Due to the energetically favorable binding of U4/U6, little 
free U4 can be detected in wildtype conditions (Anthony et al. 1997; Martin-Tumasz et 
al. 2011). Consequently, the levels of free U6 snRNP is approximately five times greater 
than the levels of free U4 snRNP (Li and Brow 1993)  
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Due to the low abundance of free U4 snRNP, it has been difficult to determine the 
order of proteins that join the U4/U6 di-snRNP. However, in yeast, these di-snRNP 
proteins include Prp3p (Anthony et al. 1997), Prp4p (Banroques and Abelson 1989), and 
Prp31p (Weidenhammer et al. 1997). All of these have also been characterized as tri-
snRNP components (Stevens and Abelson 1999) and are present in spliceosomes 
(Fabrizio et al. 2009). However, di-snRNP components are not found in activated 
spliceosomes, which indicates that they may leave coincident with U4 snRNA release 
(Fabrizio et al. 2009). 
1.2.3.2 Tri-snRNP formation 
The U4/U6 di-snRNP joins the 16S U5 snRNP containing Brr2p to form a 25S tri-
snRNP species, U4/U6•U5. A complement of 24 proteins sediment with U4/U6•U5 
(Stevens and Abelson 1999). Interactions between the U4/U6 and U5 snRNPs are 
mediated by proteins and not by RNA base pairing. Tri-snRNP is structured so that the 
U4/U6 snRNP extends from a centralized middle as an arm (Häcker et al. 2008). In yeast, 
Prp6p is essential for the formation of tri-snRNP (Galisson and Legrain 1993) and has 
been mapped in the linker region between the snRNPs. This linker also contains Prp31p, 
which lies adjacent to Prp6p. The heterodimer Prp3p/Prp4p is positioned further up the 
arm (Häcker et al. 2008). Prp3p also is necessary for tri-snRNP formation; its loss results 
in a reduced amount of tri-snRNP, most likely due to decreased stability of the U4/U6 di-
snRNP in vivo (Anthony et al. 1997).  
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1.2.3.3 Penta-snRNP model  
Data exists that supports two methods of spliceosome assembly, either a stepwise 
model or a pre-formed model. Under the low salt conditions required for in vitro pre-
mRNA splicing, a 45S penta-snRNP can be isolated which contains all five snRNPs. This 
model postulates that the penta-snRNP binds the pre-mRNA substrates as a pre-formed 
complex, rather than individual steps of U1, U2, then tri-snRNP joining. Conspicuously, 
all the DEAH and DEAD-box helicases involved in pre-mRNA splicing are absent from 
the penta-snRNP (Stevens et al. 2002). Moreover, corresponding data has been found in 
HeLa and chicken cells with the discovery of the supraspliceosome (Chen et al. 2007). 
The supraspliceosome is a macromolecular complex consisting of four intact 
spliceosomes containing all five snRNPs. These four complexes are threaded with the 
pre-mRNA so that splice sites can be aligned and unprocessed regions of the pre-mRNA 
can be protected (Azubel et al. 2006). For the purpose of relating the regulation of pre-
mRNA splicing, the details of the step-wise model will be outlined further and referenced 
throughout. 
1.2.4 Spliceosome assembly and dynamics 
In the step-wise model for yeast spliceosome assembly (Illustration 1.2) (rev. in 
Wahl et al. 2009; Hoskins and Moore 2012), the U1 snRNP recognizes the 5' SS and 
basepairs with it in an ATP-independent manner (Legrain et al. 1988; Séraphin et al. 
1988). Additionally, the branchpoint binding protein (Msl5p/hBBP) and Mud2p bind to 
the branchpoint and a polypyrimidine tract that lies directly downstream of it. The pre- 
mRNA bound by the U1 snRNP and these proteins create the early complex (E complex) 
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or commitment complex (Hoskins and Moore 2012; Seraphin and Rosbash 1989). Past 
investigations indicated that the association of the U1 snRNP commits the pre-mRNA to 
complete splicing (Legrain et al. 1988), but more recent investigations have shown that 
pre-mRNAs can be released after U1 snRNP binding. Instead of a single event 
committing a pre-mRNA to splicing irreversibly, as the pre-mRNA passes quality control 
checks along the pathway, commitment to the splicing pathway increases (Hoskins et al. 
2011; rev. in Cordin et al. 2012). Therefore, the term 'commitment complex' is 
misleading.  
In an ATP-dependent reaction, Mud2p and Msl5p are replaced by U2 snRNP 
binding and basepairing to the branchpoint (rev. in Hoskins and Moore, 2012). The 
DEAD-box helicase Sub2p (hUAP56) is necessary for the removal of Mud2p, and 
possibly Msl5p; interestingly, the function of Sub2p can be bypassed by the deletion of 
Mud2p (Kistler and Guthrie 2001). Concurrently, Prp5p acts on the U2 snRNP in an 
ATP-dependent manner to remodel it so that its branchpoint binding region is accessible 
(Wiest et al. 1996). The addition of the U2 snRNP leads to the formation of the A 
complex. The SF3a and SF3b subcomplexes that are a part of the U2 snRNP help to 
stabilize the basepairing between the U2 snRNA and the intron (Gozani et al. 1996).  
Next, the U4/U6•U5 tri-snRNP joins to make the B complex (or the pre-
spliceosome in yeast), which is still catalytically inactive (rev. in Hoskins and Moore, 
2012). Additionally, a large heteromeric complex of non-snRNP associated proteins 
called the Nineteen complex (NTC) associates at this time (Tarn et al. 1993). The B 
complex is activated through a series of RNA and protein rearrangements to create a  
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Illustration 1.2 Step-wise splicing cycle. 
Pre-mRNAs can be addressed by the spliceosome in a step-wise manner (see 
Chapter 1.2.4 for details). The U1 snRNP first joins the pre-mRNA in a commitment 
complex, then the U2 snRNP basepairs with the brachpoint. Tri-snRNP joins and the 
spliceosome is activated through the removal of the U1 and U4 snRNPs. The two 
transesterification reactions are depicted by the red arrows. After splicing, the mature 
mRNA and lariat intron are released. SnRNPs that need to be recycled are depicted in 
dark orange. Di-snRNP is recycled from released U4 and U6 snRNPs (see Chapter 
1.2.3.1) and U5 snRNP undergoes nuclear export and reentry for recycling (see Chapter 
1.2.5.1).   
 14 
catalytically active Bact complex (rev. in Hoskins and Moore, 2012). The U1 snRNP is 
released through the ATP-dependent action of Prp28p, which unwinds the U1:5' SS 
duplex (Staley and Guthrie 1999). Brr2p also acts in an ATP-dependent manner to 
unwind U4 from U6 (Raghunathan and Guthrie 1998b), which then allows U6 to 
substitute for U1 and allow baseparing between a conserved sequence (ACAGAG) and 
and the 5' SS (Lesser and Guthrie 1993). The U5 snRNP interacts with the 5' exon, and 
the NTC helps stabilize the interactions within the Bact complex. Without the NTC, the 
U6:5' SS interaction is not correctly positioned for spliceosome activation (Chan and 
Cheng 2005). 
The Prp2p RNA helicase acts in an ATP-independent manner when it joins the 
spliceosome to induce a conformational change of the Bact complex. Then through an 
ATP-dependent action, Prp2p removes the SF3 subcomplexes, which has been proposed 
to expose the brachpoint adenosine (Lardelli et al. 2010). Now in the correct structural 
context, the B* spliceosome is formed and the first transesterification reaction proceeds 
(Lardelli et al. 2010). The C1 complex contains the free 5' exon and the lariat 
intermediate. To promote the next transesterification, the helicase Prp16p remodels the 
C1 complex into the C2 complex in an ATP-dependent manner (Schwer and Guthrie 
1991). In the transition, the U6:5' SS basepairing must be destabilized to allow for the 
conformational change in the spliceosome that promotes the second step reaction. The 
3'SS of the lariat-exon intermediate competes with the branched lariat intron for the 
active site. This competition between the first step products and the second step 
substrates can drive the reaction either forward or backward (Konarska et al. 2006; Tseng 
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and Cheng 2008). Two second step factors, Slu7p and Prp18p, help position the 3’ SS 
correctly in the active site (James et al. 2002). Also, the DEAH-box helicase Prp22p joins 
the spliceosome before the second reaction and plays an ATP-independent role (Schwer 
and Gross 1998). Once in position in the C2 complex, the second transesterification 
reaction proceeds and the pre-mRNA splicing reaction is complete.  
1.2.5 Spliceosome disassembly and recycling  
After the splicing reaction, the post-catalytic spliceosome contains the U2/U6•U5 
snRNPs still associated with the spliced mRNA and the lariat intron. Prp22p unwinds the 
duplex formed by loop 1 of the U5 snRNA and mRNA in an ATP-dependent manner to 
release the mature mRNA from the spliceosome (Schwer and Gross 1998; Schwer 2008). 
At the point of Prp22p action, the second step factors Slu7p and Prp18p are also removed 
(Schwer 2008). Slu7p and Prp18p have been proposed to be necessary for Prp22p to join 
the spliceosome (James et al. 2002); however, recent in vitro data indicate that these 
factors are not strictly required for Prp22p recruitment or function (Fourmann et al. 
2013). Therefore, the removal of Slu7p and Prp18p is not the action that destabilizes the 
mRNA, but rather the helicase activity of Prp22p. In addition to the removal of Slu7p and 
Prp18p, Prp22p displaces the RES (Retention in splicing) complex as well as Cwc22p 
and Cwc21p (Fourmann et al. 2013). The RES complex functions to retain pre-mRNAs 
in the nucleus until splicing has been completed (Dziembowski et al. 2004), and its 
removal by Prp22p is thought to allow mRNAs to be exported from the nucleus 
(Fourmann et al. 2013). The significance of the removal of Cwc22 or Cwc21 is not yet 
known, but they are speculated to lie at the interface between U5 and the mRNA. The 
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intron-lariat spliceosome that remains after Prp22p action contains the U2, U5, and U6 
snRNPs still complexed with with the lariat intron (Fourmann et al. 2013).  
The intron lariat is removed from the snRNPs through the ATP-dependent action 
of another RNA helicase, Prp43p, which is recruited to the spliceosome as a component 
of the trimeric NTR complex with Ntr1p and Ntr2p (Martin et al. 2002). Previous data 
suggested that Brr2p works to unwind the U2/U6 basepairing similar to its role in 
activating the spliceosome (Small et al. 2006). However, recent in vitro data 
demonstrates that the Prp43p alone can completely separate the U2, U5, and U6 snRNPs 
without the assistance of Brr2p. A 20-25S U2 snRNP and an ~18S U5 snRNP were 
purified from in vitro splicing assays conducted with reconstituted spliceosomes after the 
action of Prp43p. U6 is released as a protein-free snRNA. There are no significant 
changes in the protein composition of the U2 or U5 snRNPs purified after Prp43p action 
compared to their compositions in the post-catalytic spliceosome. These data indicate that 
the U2 snRNP is not significantly remodeled during the splicing cycle (Fourmann et al. 
2013), which stands in opposition to previous reports that U2 proteins are lost during 
catalysis (Lardelli et al. 2010) or after disassociation (Tsai et al. 2005), although it should 
be noted that those experiments were performed in vivo (Lardelli et al. 2010) vs. in vitro 
(Fourmann et al. 2013).  
Following their removal from the spliceosome or disassembly, snRNPs are 
recycled for further rounds of splicing. As mentioned above, Prp24p plays an essential 
role in the recycling of the U4 and U6 snRNPs into di-snRNP (Raghunathan and Guthrie 
1998a). The necessity to recycle the U2/U6!U5 post-catalytic snRNP in vivo is suggested 
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by the genetic interactions between the disassembly factor Prp43p and the tri-snRNP 
assembly factor Prp38p. Additionally, mutations in Ntr1p and the U5 recycling factor 
Aar2p can also suppress prp38-1 mutants (Pandit et al. 2006). Though the U2 snRNP 
appears to be released intact, it is speculated that the U2 snRNA requires conformational 
changes induced by the DEAD-box RNA helicases Sub2p and Prp5p for its recycling. 
Additionally, the U5 snRNP that is released was only characterized as containing Brr2p, 
Snu114p, and Prp8 and must be recycled properly via Aar2p (see Chapter 1.2.51) 
(Fourmann et al. 2013).  
Once the lariat intron in released, the debranching enzyme Dbr1p hydrolyzes the 
2'-5' phosphodiester bond (Chapman and Boeke 1991). While Dbr1p is non-essential in S. 
cerevisiae and its deletion confers no growth defect, the loss of its homolog in S. pombe 
renders the cells slow growing and morphologically deformed (Chapman and Boeke 
1991; Kim et al. 2000). These defects are thought to occur in S. pombe rather than S. 
cerevisiae due to the increased number of introns in the S. pombe genome. Likewise, it is 
hypothesized that the role of Dbr1p in higher eukaryotes is essential to clear lariats and 
release any ncRNAs that may be encoded within (Kim et al. 2000). 
Additionally, stalled, aberrantly-formed splicing intermediates can also be 
disassembled through the action of Prp43p as a part of the NTR complex (Koodathingal 
et al. 2010; Chen et al. 2013). The interaction between the NTR complex and the 
spliceosome is mediated via Ntr2p and the C-terminal region of Brr2p comprising its 
second helicase domain and the C-terminus (aa 1209-2163). Since Brr2p is a stable 
component of the U5 snRNP, Ntr2p binding must be inhibited throughout the splicing 
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cycle to prevent premature disassembly. While Ntr2p can join a stalled splicesome at 
specific stages, its greatest affinity is for its natural substrate, the post-splicing lariat RNP 
(U2/U6!U5 plus lariat intron). The NTR complex can catalyze disassembly after the 
action of Prp2p or Prp16p, but not before or while these helicases are bound to the 
spliceosome. In fact, Prp16p can outcompete Ntr2p for binding to spliceosomes stalled at 
the Prp16-dependent step. Additionally, spliceosomal factors Cwc25p and Slu7p, 
involved at the first and second step, respectively, also prevent spliceosomes from being 
susceptible to disassembly. Altogether, the model suggests that aberrant pre-mRNAs, 
which are identified via kinetic proofreading, are substrates for disassembly after the 
ATP-dependent function of Prp2p, Prp16p and Prp22p (Chen et al. 2013).  
1.2.5.1 U5 Recycling  
 In yeast, the U5 snRNP is released from the post-splicing lariat RNP as an 18S 
complex (Fourmann et al. 2013) which must be recycled into the 16S species which is 
incorporated into tri-snRNP (Gottschalk et al. 2001; Stevens et al. 2001; Tsai et al. 
2007). In humans, the post-splicing U5 snRNP has been purified as a 35S particle and 
contains the NTC, which joins the U5 snRNP at spliceosome activation (Makarov et al. 
2002). In yeast, only a small portion of released U5 snRNP contains the NTC, and a 
corresponding 35S species could not be recovered from in vitro resconstitution and 
disassembly assays (Fourmann et al. 2013) While the details are not completely 
understood regarding U5 snRNP recycling in yeast, the process appears to be essential in 
vivo (Gottschalk et al. 2001). One crucial step in this process involves the use and 
removal of recycling factor Aar2p (Weber et al. 2011).  
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The 16S U5 snRNP exists as two species, either with or without Aar2p 
(Gottschalk et al. 2001; Stevens et al. 2001). The Aar2p-U5 species is cytoplasmic and is 
not present in tri-snRNP (Gottschalk et al. 2001; Boon et al. 2007). Depletion of Aar2p 
does not affect pre-mRNA splicing in vitro, but is lethal in vivo, indicating that its loss 
prevents further rounds of splicing without inhibiting the splicing reaction itself. This 
species is composed of the U5 snRNA, Aar2p, Prp8p, Snu114p, and the Sm proteins. Its 
electron microscopic structure is remarkably similar to the 16S counterpart in humans, 
the 20S U5 snRNP (Kastner et al. 1990; Gottschalk et al. 2001). This cytoplasmic 16S 
U5 snRNP translocates to the nucleus via an NLS in Prp8p. Once in the nucleus, Brr2p 
replaces Aar2p (Boon et al. 2007). Aar2p binds the RNase H domain in the C terminus of 
Prp8p and sequesters the Jab1/MPN domain of Prp8p to which Brr2p binds. Some 
unknown nuclear kinase phosphorylates Aar2p to induce a structural change. After 
phosphorylation, Aar2p releases Prp8p so that Brr2p now has access to the Jab1/MPN 
domain. The presence of Aar2p is hypothesized regulate tri-snRNP formation by 
preventing the incorporation of Brr2p into the U5 snRNP (Weber et al. 2011). 
Presumably at the same time as Brr2p, other U5 proteins (Prp28p, Snu40p, and Dib1p) 
join to produce the other 16S U5 snRNP species lacking Aar2p (Stevens et al. 2001). In 
the reverse manner, it is hypothesized that Aar2p might replace Brr2p in the post-splicing 
snRNP (Weber et al. 2011).  
1.2.7 Diseases related to pre-mRNA splicing 
Due to the large number of introns in human genes and the crucial role of pre-
mRNA splicing in gene expression, dysregulation of splicing can often lead to disease. In 
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fact, about 50% of disease-related mutations cause disruption in splicing (López-Bigas et 
al. 2005). Mutations in either the pre-mRNA or spliceosome machinery can be the 
underlying cause of the phenotypes (Cooper et al. 2009). Cis mutations in consensus 
splice site sequences are predicted to cause approximately 15% of genetic disorders 
(Krawczak et al. 1992). However, it is evident that point mutations outside of these 
consensus sequences affect splicing, perhaps due to changes in splicing enhancer or 
silencer elements (Cooper et al. 2009). In support of this prediction, investigations using 
the (cystic fibrosis transmembrane conductance regulator) CFTR gene have shown that 
up to 25% of silent mutations in exons still result in splicing disruptions caused by exon 
skipping (Pagani et al. 2005).  
Mutations in the proteins or snRNAs that compose the spliceosome can also 
contribute to disease. The only known case of a spliceosomal RNA that causes disease is 
the mutation of U4atac in Taybi-Linder Syndrome. Three mutations found in patients are 
located in the 5' stem loop of U4atac and fourth in the 3' stem loop. These mutations 
render splicing by the minor spliceosome null, and splicing can be rescued by a 
compensatory mutation. This example indicates the importance of the snRNA secondary 
structure in function (Edery et al. 2011; He et al. 2011). 
Very few mutations in the protein machinery of the spliceosome have been 
identified in patients, which could indicate that such perturbations in the spliceosome are 
generally not tolerated. One case in which the basal splicing level is affected but not 
lethal occurs in retinitis pigmentosa (Cooper et al. 2009). Mutations in the tri-snRNP 
components, hPrp31p, hPrp8p, and hPrp3p have all been found in retinitis pigmentosa 
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patients (McKie et al. 2001; Chakarova et al. 2002; Vithana et al. 2001). In these 
patients, the mutations in Prp8p cluster in its C-terminus (McKie et al. 2001) and 
interfere with its interaction with Brr2p so the levels of functional U5 snRNP, and 
consequently tri-snRNP, are reduced in the cell (Boon et al. 2007). The pronounced 
effect seen in the retina is thought to be due to the daily turnover of the photoreceptor 
components resulting in unusually high gene expression. These prp8 mutants are 
hypothesized to lower the splicing capacity of cells so that a cumulative effect of reduced 
splicing is evident. Another possible hypothesis is that the Aar2p-U5 immature snRNP is 
being incorporated into spliceosomes, causing the dominant effect seen in retinitis 
pigmentosa (Boon et al. 2007).  
Interestingly, the debranching enzyme Dbr1p has been linked to a nucleic acid 
binding protein, TDP-43, which has been found to be mutated in some neurodegenerative 
diseases and forms aggregates in amyotrophic lateral sclerosis (ALS), Alzheimer’s and 
Parkinson’s diseases (Hasegawa et al. 2007; Lagier-Tourenne et al. 2010; Uryu et al. 
2008; Armakola et al. 2012). Recent evidence shows that the inhibition of Dbr1p 
function can suppress the toxicity of TDP-43. The increase in the abundance of lariat 
introns competes with normal RNAs for TDP-43 binding, thereby protecting cells from 
the negative impact of TDP-43 aggregates (Armakola et al. 2012). It will be intersesting 
to see if inhibition of hDbr1p function becomes a viable treatment for neurodegenerative 
diseases in general. 
Additionally, HIV-1 is thought to be dependent on Dbr1p for its replication cycle. 
The mechanism of HIV-1 replication is similar to that of the Ty1 retrotransposon in 
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yeast, which has been proposed to use yDbr1p to debranch a genomic lariat RNA in the 
course of reverse transcription (Cheng and Menees 2004; Ye et al. 2005). HIV-1 
replication was reduced when the levels of hDbr1p were depleted via siRNA treatments 
(Ye et al. 2005). Perhaps Dbr1p function could be targeted as a retroviral treatment as 
well.  
Splicing dysregultion also commonly occurs in cancers. Abnormal levels of 
splicing regulators can have a very different influence on splicing depending on cell type 
(Venables et al. 2008). In a well understood case, overexpression of the splicing factor 
SF2/ASF can induce the splicing of an oncogenic form of the ribosomal protein S6K1, 
which regulates translation (Karni et al. 2007). In general, overexpression or 
downregulation of helicases involved in splicing have also been correlated with cancers 
(Abdelhaleem 2004). 
1.3. RIBOSOMAL RNA PROCESSING  
Saccharromyces cerevisiae produces an average of 33 ribosomes per second 
(Warner 1999). RNA pol I transcribes a 35S/47S transcript (yeast and human, 
respectively) from rDNA loci, which is rapidly organized into the 90S small subunit 
(SSU) processome (rev. in Henras et al. 2008). From this primary transcript the mature 
rRNAs 25/28S, 18S, and 5.8S are released through endonucleolytic and exonucleolytic 
cleavages. A fourth rRNA, 5S, is transcribed in a separate message by RNA Pol III (rev. 
in Venema and Tollervey, 1999).  
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1.3.1 Organization and transcription of rDNA  
Ribosomal DNA (rDNA) is organized in a cluster of 140 tandem repeats on 
chromosome XII in S. cerevisiae (Barrell et al. 1996). The organization of these rDNA 
units is conserved throughout eukaryotes, though the processing events can differ 
(Illustration 1.3). In yeast, the rDNA transcription units are separated by external 
nontranscribed spacers (ETS), which flank the 5S rRNA gene. Transcription begins at the 
5' external transcribed spacer and continues through to the 3' ETS downstream of the 25S 
rRNA. The 18S and 25S rRNAs are separated from the 5.8S rRNA by two internal 
transcribed spacers (ITS1 and ITS2), which are removed through endonucleolytic and 
exonucleolytic cleavages (rev. in Venema and Tollervey, 1999). Co-transcriptional 
cleavage in the 3' ETS by Rnt1p releases the full length 35S transcript (Kufel et al. 1999). 
As Pol I transcribes the rDNA, the transcripts extending out from the rDNA begin folding 
elaborately and can be visualized as 'Christmas trees' by electron microscopy (Mougey et 
al. 1993). After Rnt1p cleavage in the 3' ETS, a 90S particle containing the 35S pre-
rRNA transcript, the t-UTP (U Three Protein) complex, the U3 snoRNP, the UTP-B or -C 
complexes, and the Mpp10p complex is released (Kufel et al. 1999; Gallagher et al. 
2004; Pérez-Fernández et al. 2007; rev. in Henras et al. 2008).  
1.3.2 Ribosomal RNA processing pathway  
The U3 snoRNP is essential for the first three cleavage events in a manner that is 
currently poorly understood. Without the U3 snoRNA, cleavages at the A0, A1, and A2 sites 
are inhibited (Hughes and Ares 1991). No evidence exists that the U3 snoRNA itself   
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A.  
B. 
Illustration 1.3 S. cerevisiae and human rRNA processing pathways.  
rRNA processing pathways are highly conserved from yeast (A) to humans (B) 
(see Chapter 1.3.2 for details). RNA Pol I initiates transcription of the rDNA at the 5’ 
end, as indicated by the left facing arrow. Cleavage sites are indicted by the vertical lines 
and their associated names on the rDNA, while orange triangles indicate the cleavage 
events that occur at each step. The black boxes indicate mature rRNAs, while the grey 
boxes depict either external or internal transcribed spacers that are removed. Pacman 
symbols indicate exonucleolytic steps.  
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catalyzes the endonucleolytic reactions, and most likely the U3 snoRNP chaperones the 
rRNA through direct base pairing so that the 18S rRNA is properly folded (rev. in Henras 
et al. 2008). The 35S pre-RNA is first cleaved at the A0 site in the 5' ETS, 90 nucleotides 
upstream of the 18S. The 33S pre-rRNA produced by cleavage at A0 then is rapidly 
cleaved at the A1 site, which immediately precedes the 18S rRNA, resulting in a rapidly 
processed intermediate, the 32S pre-rRNA (rev. in Venema and Tollervey, 1999). The 
cleavage at A0 is not essential for cell viability and its absence does not affect A1 
cleavage; however, inhibition of cleavage at A1 results in the loss of A0 cleavage (Venema 
et al. 1995; rev. in Venema and Tollervey, 1999). In contrast, the A1 and A2 cleavages are 
coupled so that if A1 cleavage is inhibited, A2 cleavage in ITS1 does not occur. Mutants 
defective in A1 cleavage produce an aberrant 22S RNA molecule that extends from A0 to 
A3, indicating that A3 cleavage is not coupled to the previous two (Venema et al. 1995; 
rev. in Venema and Tollervey, 1999). Alternatively, an aberrant 23S product can be 
produced due to cleavage at A3 prior to A1 and A2. The 23S RNA is not processed further, 
but discarded through the exosome (Zanchin and Goldfarb 1999). Rcl1p cleaves at A2 in 
ITS1, splitting the 32S pre-rRNA into the 20S and 27SA2 pre-rRNAs (Horn et al. 2011). 
The 20S pre-rRNA is exported to the cytoplasm for further processing, while the 27SA2 
pre-rRNA can be processed by two different pathways in the nucleus in yeast.  
In the major 27S processing pathway, RNase MRP, composed of an RNA 
molecule and nine proteins (Chamberlain et al. 1998), cleaves at A3, which is 90 
nucleotides downstream of A2, to yield 27SA3. Exonucleases Rat1p and/or Xrn1p digest 
the 5' end to the B1S site, upstream of the 5' end of 5.8S, to generate 27SBS (Henry et al. 
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1994; rev. in Venema and Tollervey, 1999). A second minor pathway processes 27SA2 
by an endonucleolytic cleavage by an unknown factor directly at B1L, at the 5' start of 
5.8S. This pathway produces the 27SBL precursor, which is only heterologous to 27SBS at 
its 5' end (Henry et al. 1994). Concurrently with 5' end processing, the 3' end of 27SBL 
and 27SBS precursors are removed by an unknown mechanism up to B2 at the end of the 
mature 25S rRNA. Processing at the C1 and C2 sites in ITS2 separates the 7S pre-rRNAs 
from the mature 25S rRNA (rev. in Venema and Tollervey, 1999). These reactions result 
in either 7SBL or 7SBS, which are processed by 3' to 5' exonucleases to produce the 5.8SL 
or 5.8SS, and both forms are efficiently incorporated into mature, functional ribosomes 
(rev. in Henras et al. 2008).  
In the nucleus, a few ribosome biogenesis factors, such as Ltv1p, Pfa1p, Rio1p 
and Rio2p, join the pre-40S after A2 cleavage (rev. in Henras et al. 2008). In the 
cytoplasm, the 20S pre-rRNA is methylated at two adjacent adenines, A1779 and A1780. 
The methylase Dim1p catalyzes both modifications, though its essential role is most 
likely its presence rather than its methylase activity since methylase deficient mutants 
support normal pre-rRNA processing (Brand et al. 1977; Lafontaine et al. 1998). For 
final 18S maturation, the endonuclease Nob1p cleaves at the D-site, the junction of 18S 
rRNA and ITS1 (Pertschy et al. 2009). This action is thought to occur in a translation-like 
cycle, in which the pre-40S subunit joins the 60S subunit through Fun12p (eIF5b) and 
ITS1 lies in the mRNA channel formed between the two subunits. Fun12p functions as a 
GTPase and is predicted to rotate the 40S so that ITS1 is displaced from the cleft. This 
rotation brings Nob1p in context of the D site, which is now accessible for cleavage 
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(Lebaron et al. 2012). Once D site cleavage has occurred, Rli1p and Dom34p are 
necessary to dissociate the now mature 40S subunit from the 60S (Strunk et al. 2011). It 
will be interesting to see if 60S undergoes a similar quality control check in the presence 
of pre-40S or 40S.  
1.3.3 Cytoplasmic maturation of ribosomal subunits  
Quality control mechanisms check the ribosomal subunits as they assemble to 
ensure the proper steps are completed before the subunits are released into the translating 
pool. Ribosomes are exported from the nucleus in a immature state, and maturation is 
completed in the cytoplasm by a host of trans-acting factors. Often these ribosome 
biogenesis factors are recruited or released as steps along the subunit’s cytoplasmic 
maturation pathway (rev. in Panse and Johnson, 2010). For example, in pre-60S subunits 
Jjj1 and Ssa1 work together to release a factor from the exit of the polypeptide tunnel (Lo 
et al. 2010). Additionally, factors in pre-60S subunits may act as placeholders, such as 
Efl1p. Efl1p has homology to elongation factor-2 (EF2), and works with the assembly 
factor Sdo1p to authenticate a functional P site in the maturing ribosome (Bussiere et al. 
2012).  
Similarly, in late pre-40S subunits, trans-acting factors mask the binding sites for 
translation initiation factors and the entrance of the mRNA channel. For example, the 
binding site for Rps10 overlaps with the export adaptor Ltv1p, and Rps26 and Pno1p, the 
regulator of Nob1p, also share a binding site. The presence of pre-40S assembly factors 
prevents premature translation initiation (Strunk et al. 2011). Recent work indicates that a 
translation-like cycle may check the functionality of both large and small subunits in an 
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80S-like pre-ribosomal particle during a final step in their maturation (Lebaron et al. 
2012; Strunk et al. 2012). The removal or remodeling of assembly factors by DExD/H-
box helicases is likely to be vital for the production of mature ribosomes.  
1.3.4 Modifications of rRNA directed by snoRNAs 
Pseudouridylation and 2'-O ribose methylation modifications in rRNA are 
catalyzed by enzymes that are directed to the site by base-pairing of either box H/ACA or 
box C/D small nucleolar RNAs (snoRNAs), respectively (Colau et al. 2004; Kiss et al. 
2006). Some bases are directly methylated by methyltransferases like Dim1p and Bud23p 
(Lafontaine et al. 1998; White et al. 2008). However, such modifications, though they 
often cluster in functional regions of the mature ribosome, often prove to not be strictly 
necessary for vegetative growth (King et al. 2003; Liang et al. 2007).  
Additionally, the U3, U14, snR30 and snR10 snoRNAs are essential for proper 
folding and the rRNA cleavages A0, A1, and A2 (Henras et al. 2008). The U3 snoRNA is 
the best studied of these and makes numerous regions of basepairing with the 35S pre-
rRNA transcript. The secondary structure of the U3 snoRNA can be divided into three 
domains: a 5' domain that basepairs to the pre-rRNA, a hinge, and the 3' C/D box motifs. 
The 5' domain makes contacts with the 5' ETS of the pre-rRNA and within the 18S rRNA 
via conserved sequences Box A, Box A' and GAC box. Additionally the 5' part of the 
hinge region also contacts the 5' ETS. As mentioned above, the U3 snoRNA itself does 
not have any known catalytic function, but rather appears to act as a chaperone. The 
U3:rRNA interactions have also been proposed to prevent the premature folding of the 5' 
end of the 18S rRNA into the conserved pseudoknot structure in the mature small subunit 
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(rev. in Phipps et al. 2011). The depletion of U3 in yeast results in the cleavage at A3 
without A0-A2 producing an aberrant, non-functional 23S product which is then 
degraded (Hughes and Ares 1991; Morrissey and Tollervey 1993). 
The U14 box C/D snoRNA base pairs in two areas near a loop in the 5' end of the 
18S rRNA (Liang and Fournier 1995). The basepairing site near the D box of U14 directs 
the methylation of C414. On the opposite side of the loop, the other snoRNA:rRNA 
duplex is required for rRNA processing events (Dunbar and Baserga 1998; Liang and 
Fournier 2006). In the absence of U14, A0 to A2 cleavages do not occur, which results in 
rapid turnover of 20S pre-rRNA, and therefore no further 18S rRNA production (Li et al. 
1990). The removal of U14 from pre-ribosomal particles appears to be dependent 
multiple RNA remodeling steps since both DEAD helicases Dbp4p, Has1p, and the 
DEAH-box helicase Prp43p have been shown to necessary for this action (Kos and 
Tollervey 2005; Liang and Fournier 2006; Bohnsack et al. 2009).  
snR30 is an essential H/ACA box snoRNA that also affects 18S rRNA processing 
but has no affect on 27S pre-rRNA processing. Similar to U3 and U14 defects, loss of 
snR30 produces the 23S aberrant pre-rRNA product (Morrissey and Tollervey 1993). 
Though snR30 does not appear to direct pseudouridinylation, it still basepars with the 
rRNA through two essential conserved motifs in the loop that normally targets the correct 
uridine for pseudouridinylation. The bottom of this pseudouridine loop rather than the top 
binds on either side of the base of an 18S rRNA hairpin (bp 799-841), making a unique 
snoRNA:rRNA duplex (Fayet-Lebaron et al. 2009). The structure of the snR30:rRNA 
duplex is proposed to form for loading for 18S factors (Watkins and Bohnsack 2012). 
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1.3.5 Diseases related to ribosome biogenesis 
Despite the fact that most ribosome biogenesis factors are essential, defects in 
some lead to human diseases rather than embryonic lethality. Interestingly, although a 
ribosomal defect would be thought to have a global affect, most diseases are tissue 
specific. For example, defects in two different proteins involved in early 90S processing 
and 18S maturation have wide effects. Defects in UTP14c/UTP14 causes male infertility 
due to a failure in spermatogenesis, while EMG1/EMG1mutations cause Bowen-Conradi 
syndrome with growth retardation and psychomotor delay (Freed et al. 2010). In 
particular, many ribosomal mutations are associated with disorders that result in 
hematopoietic conditions, like Diamond-Blackfan anemia, 5q-syndrome and cartilage 
hair hypoplasia, which manifest anemias, or Shwachman-Diamond syndrome, which 
causes neutropenia. Mutations in the both large and small subunit proteins have been 
linked to Diamond-Blackman anemia, in which the bone marrow fails to produce red 
blood cells (Narla and Ebert 2010). Patients have been found to carry mutations in 
Rps19p (Draptchinskaia et al. 1999), which is essential for cleavage of the ITS1 in 20S 
pre-RNA processing and small subunit assembly (Idol et al. 2007). Likewise, Rps24p 
mutants in Diamond-Blackman syndrome patients have been shown to be deficient for 
small subunit assembly and the cleavage of the 5' ETS (Choesmel et al. 2008). With a 
growing number of ribosomal mutations linked to pathologies, it is likely that the 
ribosomal dysfunction may be the cause (Narla and Ebert 2010). Alternatively, rare 
mutants can modify diseases caused by a non-ribosomal protein and intensify its 
manifestation (Freed et al. 2010).  
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In cancer, rRNA transcription rates are increased, as well as protein synthesis, 
which might be due to the loss of key checkpoints in cell cycle progression. The tumor 
suppressor p53 can repress Pol I transcription, and the loss of p53 in many cancers could 
be the cause of the upregulation of rRNA production observed in those cells (Ruggero 
and Pandolfi 2003). Haploinsufficiency of some r-proteins may also cause dysregulation 
of p53 levels. In response to nucleolar stress, r-proteins Rpl5p, Rpl11p, and Rpl23p bind 
the E3 ubiquitin ligase Mdm2p that targets p53 for degradation. Once bound, these r-
proteins normally sequester Mdm2p to allow for p53 activation, which triggers cell death. 
However, in cancers, reduced levels in r-proteins result in the failure to sequester Mdm2p 
and p53 levels are not stabilized. Thus, haploinsufficiency of the r-proteins effectively 
results in the loss of the tumor suppressor p53 (Zhang and Lu 2009). Additionally, the 
p53 mRNA can be targeted for translation via the binding of RPL26 to its 5' or 3' UTR 
(Freed et al. 2010). Therefore, loss of function for these proteins could result in 
downregulation of p53. Alternatively, r-proteins are often overexpressed in cancers, 
which might affect translation (Zhang and Lu 2009). Altogether, ribosome biogenesis is 
often dysregulated in cancers and diseases and understanding the molecular mechanisms 
in each of these cases is essential to design treatments.  
1.4 RNA HELICASES IN GENE EXPRESSION 
RNA helicases are ubiquitous enzymes involved in almost all gene expression 
processes in cells (Jankowsky 2011). Two major superfamilies (SFs) of RNA helicases 
are SF1 and SF2, which descended from a common ancestral helicase. The families are 
present in all kingdoms of life, though the SF2 members are more prominent in gene 
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expression in eukaryotes. Helicases in the SF1 and SF2 families have a structurally 
conserved helicase core with an N-terminal P-loop ATPase domain followed by a C-
terminal divergent P-loop domain (Anantharaman et al. 2002). These two RecA-like 
domains can contain at least twelve motifs that make up the core, and they are highly 
conserved within the SF, but only partially conserved between SFs. The first RecA-like 
domain encompasses motifs I-III, and the second RecA-like domain with motifs IV-VI is 
folded back on the first domain to create the active site. Each of these core elements 
serves to bind a nucleotide, generally ATP, or the substrate (Illustration 1.4). The N- and 
C-terminal domains flanking the helicase core are specific to each protein and are thought 
to provide specificity or regulation for the particular function of each protein (Jankowsky 
2011).  
Classically, these enzymes have been characterized as ATP-dependent helicases, but their 
unwinding activity may not be their primary physiological function. In fact, many of 
these enzymes have been shown to disrupt RNA duplexes poorly (Fairman-Williams et 
al. 2010). Perhaps a more important physiological role of RNA helicases is the ATP-
dependent remodeling of RNPs. RNA helicases can displace proteins from RNA 
concurrent with RNA unwinding or independent of it, which indicates they may not 
always translocate along a duplex (Jankowsky 2011). Of the SF2 family, the largest 
subfamily is the DEAD box helicases. Another SF2 subfamily, DEAH-box helicases, 
shares a related motif II sequence to DEAD helicases; however, there are some important 
structural, mechanistic, and physiological differences between the two subfamilies 
(Fairman-Williams et al. 2010).  
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Illustration 1.4 RNA helicase core.  
The core helicase motifs of the SF2 superfamily are conserved in DEAH and 
DEAD-box family members. Motifs I, II, and VI are involved in ATP binding and 
hydrolysis, while motifs Ia, Ib, IV and V all bind RNA substrates. Additionally, motifs I 
and II coordinate the magnesium needed for activity. The conserved sequences for the 
DEAD and DEAH-box families are listed beneath each motif. The characteristic name 
for each family is derived from the sequence of motif II.  
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1.4.1 DEAD-box helicases 
In addition to the canonical SF2 motifs described above, the DEAD-box helicases 
contain the Q motif. The conserved glutamine of the Q motif specifically recognizes ATP 
by making direct interactions with the N6 and N7 positions of the adenosine. Therefore, 
DEAD-box helicases can only hydrolyze ATP (Kim et al. 1992; Tanner et al. 2003). The 
binding of RNA by a DEAD-box helicase is controlled by an interaction between an "-
helix at the end of motif II and an arginine in motif V, which occurs only in the ATP 
bound state (Schütz et al. 2010). Interestingly, the helicase core only makes contacts 
along the sugar-phosphate backbone of the RNA, accounting for its lack of sequence 
specificity. Instead, substrate specificity is dictated by the recognition of the geometry of 
A form nucleic acid (Mallam et al. 2012) . 
The DEAD-box helicases are non-processive, meaning they can locally separate 
duplexes. This function of DEAD-box helicases allows RNA:RNA and RNA:protein 
complexes to be remodeled without globally destroying the RNA structure (Cordin et al. 
2012). DEAD-box helicases bind RNA and ATP in a cooperative manner. The N-
terminal and C-terminal RecA domains function independently to bind ATP and RNA, 
respectively, while the helicase is in an open conformation. The interactions of each 
substrate binding to the opposing domains result in cooperative ATP/RNA binding, and 
the enzyme transitions to a closed state. Only one strand of the RNA is stably bound to 
domain 2, and upon closing, it is thought that domain 1 actively displaces the 
complimentary RNA strand. It is hypothesized that two bends are induced in the RNA by 
the helicase, which prevent reannealing of the strands. Also concurrent with closing, a 
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loop downstream of motif V moves to form the ATPase active site and possibly triggers 
ATP hydrolysis. With ATP hydrolysis, the dissociation of Pi and ADP allows the helicase 
to transition back to an open state. Thus, the enzyme is recycled (Mallam et al. 2012). 
1.4.2 DEAH-box helicases 
DEAH-box helicases contain the canonical SF2 motifs described above, as well as 
some distinct structural characteristics as defined by the only solved structure of a 
DEAH-box helicase (He et al. 2010; Walbott et al. 2010). Similar to DEAD helicases, the 
canonical helicase core is composed of two RecA domains with the NTP binding site 
between them (Fig. 4.1A). However, the nucleotide of the NTP is twisted by 150° in the 
DEAH-box active site, so that it is wedged non-specifically between the two RecA 
domains. No direct contacts are made with the nucleotide base, which accounts for the 
enzyme’s lack of NTP specificity (He et al. 2010; Walbott et al. 2010). Therefore, 
DEAH-box helicases can work as NTPases, not specifically as ATPases (Schwer and 
Guthrie 1992). Specific insertions in the RecA domains may be a mechanism of 
regulation, as predicted with the human DEAH-box helicase DHX29. Structural 
modeling of DHX29 using Prp43p indicates a unique loop in its RecA-2 domain lies 
close to the putative RNA-binding tunnel. Mutational analysis proved the region to 
negatively regulate the basal ATPase activity of DHX29 (Dhote et al. 2012).  
DEAH-box helicases also possess a long #-hairpin (5' HP) between motifs V and 
VI of the C-terminal RecA domain. In the functional model, the 5' HP moves to allow 
RNA binding to the active site in an ATP-dependent manner (He et al. 2010; Walbott et 
al. 2010). In fact, ADP binding inhibits RNA binding by the enzyme (He et al. 2010). 
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Therefore, it is thought that DEAH-box helicases can bind ATP independent of RNA 
binding (Cordin et al. 2012). This 5' HP structure is similar to the related Ski2-like 
helicases which possess a shorter 6-8 amino acid 5' HP; however, it appears they regulate 
RNA binding differently. The Ski2-like helicase Mtr4p was co-crystallized with ssRNA 
and ADP, indicating that ADP may not inhibit RNA binding (Weir et al. 2010). The 5' 
HP structure in both DEAH-box and Ski2-like helicases is thought to invade dsRNA to 
displace the duplex strands (He et al. 2010; Walbott et al. 2010; Weir et al. 2010). 
Indeed, mutations at the tip of the putative 5' HP in DHX29 abolishes its NTPase activity 
and renders it functionally inactive (Dhote et al. 2012). Also, similar to Ski2-like 
helicases, DEAH-box helicases contain a long "-helix known as the ratchet domain, 
which is proposed to pull the helicase along the RNA duplex (Büttner et al. 2007; He et 
al. 2010; Walbott et al. 2010). Unlike the non-processive DEAD-box helicases, DEAH-
box helicases can use ATP hydrolysis to "ratchet" along the RNA in a reasonably 
processive manner (Cordin et al. 2012). 
The DEAH-box helicases are thought to be in an open conformation when bound 
to ADP, and RNA binding is blocked by the 5' HP. When ATP is bound, the enzymes 
adopt a closed conformation, and the 5' HP is physically moved so that RNA can contact 
the helicase core and the ratchet domain. Upon ATP hydrolysis the enzyme is ratcheted 
along the duplex, and the 5' HP actively separates the two strands (He et al. 2010). N- or 
C-terminal regions may limit the movement of the two RecA domains when binding a 
substrate, which possibly provides some regulation of the helicase activity (He et al. 
2010; Walbott et al. 2010; Weir et al. 2010). 
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1.4.3 RNA helicases in splicing  
RNA helicases from the DExH/D-box family, including Ski2-like, DEAD- and 
DEAH-box helicases, are necessary for the proper timing and progression of the splicing 
cycle. DEAD helicases are needed for spliceosome assembly (Sub2p, Prp5p, and 
Prp28p), while the DEAH helicases (Prp2p, Prp16p, Prp22p, Prp43p) and a Ski2-like 
helicase (Brr2p) are required for the catalytic cycle and disassembly (King and Beggs 
1990; Schwer and Guthrie 1991; Ruby et al. 1993; Raghunathan and Guthrie 1998b; 
Schwer and Gross 1998; Staley and Guthrie 1999; Kistler and Guthrie 2001; Martin et al. 
2002; Small et al. 2006). While the ATPase/ helicase activity of all of these enzymes is 
necessary in canonical splicing, null mutants of some helicases can be bypassed by 
mutations in the splice site or branchpoint sequences, or by the deletion of non-essential 
genes with which they operate. For example, Prp5p remodels the U2 snRNA so that it 
can access the branchpoint region of the pre-mRNA (Wiest et al. 1996). However, 
ATPase mutants of Prp5p can be suppressed by point mutations in the branchpoint region 
of the intron that hyperstabilize its interaction with U2 (Xu and Query 2007). Similar 
results have been found for Prp16p, mutants of which can be suppressed by branchpoint 
mutations, and mutants of Prp22p, which can be suppressed by 3' SS mutations (Villa and 
Guthrie 2005; Mayas et al. 2006). Altogether, it is thought that the progression of the 
splicing reaction is regulated by the helicases through kinetic proofreading.  
The kinetic proofreading model postulates that the spliceosomal helicases provide fidelity 
through the rate of their ATPase activity. At each step they determine whether the 
substrates continue through the cycle or are discarded depending on whether the ATPase 
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rate is normal or abnormal, respectively (Burgess and Guthrie, 1993; Illustration 1.5). 
During spliceosome assembly, Prp5p proofreads the U2/intron branch-site duplex (Xu 
and Query 2007) and Prp28p proofreads the 5’ SS:U6 duplex (Yang et al. 2013). During 
catalysis, Prp16p proofreads the branch site and 5' SS before the first step (Koodathingal 
et al. 2010; Schwer and Guthrie 1992), and Prp22p proofreads the exon ligation before 
the second step (Mayas et al. 2006). Prp43p can discard stalled complexes at either the 
first or second steps; therefore, it is a general disassembly factor and deregulation of its 
helicase activity could result in inappropriate pre-mRNA discard (Koodathingal et al. 
2010).  
Additionally, these helicases can remove spliceosomal factors in a temporal 
fashion to contribute to fidelity. For example, the ATPase activity of Prp5p removes 
Cus2p in the association of U2 with the branchpoint during spliceosome assembly. In 
strains lacking Cus2p, this step is now ATP-independent and decoupled from Prp5p 
activity (Perriman et al. 2003). Similarly the deletion or mutation of other spliceosomal 
proteins can suppress DEAD-box helicase mutants, as with the case with Mud2p and 
helicase Sub2p, (Kistler and Guthrie 2001) or Yhc1p and helicase Prp28p (Chen et al. 
2001). In the spliceosome, the substrates of DEAD-box helicases appear to the inherently 
unstable. These substrates are temporarily stabilized by other proteins, which are then 
displaced due to helicase activity. Without these stabilizing proteins, the ATP-dependent 
function of the DEAD-box helicases can be surpassed. Such data indicate that the ATP-
dependent function of these helicases is truly the timing of the rearrangement reactions 
rather than forcing these rearrangements (Cordin et al. 2012).  
 39 
 
 
Illustration 1.5 Kinetic proofreading of pre-mRNA splicing.  
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(Illustration 1.5 contd.)  
The splicing reaction is regulated by the ATPase activities of DEAD and DEAH-box 
helicases. DEAD- and DEAH-box helicases are highlighted in green and red, 
respectively. Brr2p, the Ski2-like helicase, is boxed in purple. The snRNPs (orange) join 
the pre-mRNA for the splicing reaction and are released to be recycled (dark orange). 
The steps at which the helicases can trigger the discard of aberrant spliceosomes are 
indicated by the dashed red arrows. The kinetic proofreading capability of Prp16p and 
Prp22p triggers the discard either before the first or second catalytic step. Prp43p is able 
fully discard the stalled spliceosome intermediates. Adapted from Cordin et al. 2012.  
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The RNA helicases may also facilitate optimal splicing by acting as cofactors to 
one another. As one helicase joins the spliceosome, it acts and undergoes a 
conformational change. This change then allows this helicase to function as an effector to 
a downstream helicase to stimulate its activity. Such a coordinated scheme would allow 
helicases to provide directionality to the splicing reaction (Van Nues and Beggs, 2001; 
rev. in Cordin et al. 2012).  
1.4.4 RNA helicases in ribosome biogenesis  
In ribosome biogenesis, RNA helicases are proposed to act in one or more of the 
following ways: 1) remodel RNPs locally and disrupt RNA:RNA, RNA:protein or 
protein:protein interactions, 2) expose pre-rRNA for nucleases or mask pre-rRNA from 
them, and/or 3) unwind snoRNA:pre-rRNA duplexes to release snoRNP complexes. 
Through these functions, the helicases are hypothesized to provide directionality to the 
assembly process in a similar manner to the kinetic proofreading seen for pre-mRNA 
splicing (Staley and Woolford 2009; Kressler et al. 2010). Seven DExH/D helicases have 
been shown to be necessary for 40S biogenesis (Dbp4p, Dbp8p, Dhr1p, Dhr2p, Fal2p, 
Rok1p, and Rrp3p), and ten are required for 60S biogenesis (Dbp2p, Dbp3p, Dbp6p, 
Dbp7p, Dbp9p, Dbp10p, Drs1p, Mak5p, Mtr4p, and Spb4p). Only two helicases, Has1p 
and Prp43p, have been determined to impact both large and small subunit biogenesis 
(rev. in Kressler et al. 2010). While mutations in these helicases often result in varying 
ribosome biogenesis defects (Bernstein et al. 2006; Granneman et al. 2006), the exact 
function of most of these enzymes remains elusive.  
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Similar to Prp43p, Has1p is necessary for cleavages at A0, A1, and A2 (Emery et al. 
2004; Combs et al. 2006). Loss of its function results in an increase in the 35S pre-rRNA 
transcript, with a stark reduction in 18S and a delay in 25S production. Depletion of 
Has1p results in increased amounts of snoRNAs stably associating with pre-ribosomal 
complexes. It should be noted that these snoRNAs bind in drastically different locations 
on the pre-rRNA and are of different snoRNA classes. For example, U3, U14, snR30 and 
snR10 are affected and are all involved in the processing of the rRNA, while snR63, 
snR70 and snR77 are all C/D snoRNAs. U14 and snR70 bind to the 18S rRNA, but 
snR63, snR77 and snR10 bind to the 25S rRNA (Emery et al. 2004; Liang and Fournier 
2006). Interestingly, two other DEAD-box helicases have been reported to affect the 
association of diverse snoRNAs, Dbp4p and Rok1p (Kos and Tollervey 2005; Bohnsack 
et al. 2008). Dbp4p is also involved in the release of U14, and loss of its ATPase activity 
traps the snoRNA on pre-ribosomal particles (Kos and Tollervey 2005).  
1.4.5 Cofactors and RNA helicases  
The activity of some DExD/H-box helicases has been shown to be modulated by 
interacting proteins (Lebaron et al. 2009; Maeder et al. 2009; Pertschy et al. 2009; 
Montpetit et al. 2011; Noble et al. 2011). For example, the C-terminal portion (CTD) of 
the core spliceosomal factor Prp8p inhibits the ATPase activity of the Ski2-like helicase 
Brr2p, but also stimulates the helicase activity of Brr2p. This interaction between Brr2p 
and the CTD of Prp8p is hypothesized to account for the correct timing of U4/U6 
unwinding by Brr2p in spliceosome activation (Maeder et al. 2009). Alternatively, some 
helicases can act as effector proteins for other helicases along a gene expression pathway. 
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Conformational changes induced by one helicase can create the substrate for the next 
helicase in sequence thereby providing directionality to the splicing reaction and correct 
temporal control (Cordin et al. 2012).  
Regulation may be provided in DEAH-box and Ski2-like helicases through their 
C-terminal domains, which are involved in RNA binding and interact with the RecA 
domains. These domains show sequence and structural conservation and may be 
important in regulating the activity of the RNA helicases. Effector proteins that bind to 
C-terminal domains might cause the active site to be restructured so that ATP hydrolysis 
or helicases activity is activated or inhibited, as required. In contrast, the C-terminal 
domains of DEAD-box helicases are diverse. Each protein contains different features, 
like RRMs or dimerization motifs, that may provide specific regulation (Cordin et al. 
2012). Additionally, DEAD-box helicases have a conserved surface of their RecA-2 
domains which can bind effectors (Montpetit et al. 2011). Interestingly, there are three 
known DEAD-box box and SF1 regulators which all show structural homology. Gle1p 
and eIF4G have been shown to regulate Dbp5p in mRNA export and eIF4A in translation 
initiation, respectively (Oberer et al. 2005; Schütz et al. 2008; Montpetit et al. 2011). 
This homology suggests there may be a common activation mechanism utilized by these 
Gle1p- and eiF4G-like cofactors. The activators stably interact with the C-terminal RecA 
domain and transiently interact with the N-terminal RecA domain. In the case of Dbp5p, 
when it binds RNA, a closed conformation is formed. In this closed state, ATP is bound 
and hydrolyzed. Subsequently, Gle1p-Inositol-6-phosphate (Gle1p-IP6) binds and 
restructures the active site so that the RNA substrate is released. Another releasing factor, 
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Nup159, then binds Dbp5p to promote an open conformation, releasing ADP and Gle1p-
IP6. Both of the factors are hypothesized to influence the position of the N terminal RecA 
domain of Dbp5p relative to its C terminal one (Montpetit et al. 2011).  
Cofactors may also provide regulation by acting as recruitment factors (Cordin et 
al. 2012). One class of RNA binding proteins that have been implicated in providing 
regulation for helicases are G-patch proteins, which contain a glycine rich domain from 
which their name is derived. The G-patch sequence contains six glycines that follow two 
bulky hydrophobic residues and are separated by an aromatic residue or any amino acid 
(hhx(3)Gax(2)GxGhGx(4)Gx(13-20)G; h=bulky hydrophobic, a=aromatic, x=any residue 
for the number of positions indicated). The secondary structure of this sequence is 
predicted to be two "-helices connected a loop in which most of the glycines lie, and the 
position of the final conserved glycine is specific to each protein. Interestingly, G-patch 
proteins only contain one G-patch motif, and they commonly also contain other RNA 
binding motifs (Aravind and Koonin 1999).  
There are five G-patch proteins annotated in S. cerevisiae: Spp2p, Ntr1p, Gno1p, 
Pfa1p, and YLR217W (Aravind and Koonin 1999; Silverman et al. 2004). Two G-patch 
proteins are known to recruit two spliceosomal DEAH-box helicases in yeast. Prp2p joins 
the spliceosome through an interaction between its C-terminus and the G-patch domain of 
Spp2p. An eleven amino acid sequence in Prp2p is required for Spp2p interaction, and 
therefore, splicing activity (Silverman et al. 2004). However, it is still unknown whether 
Spp2p can stimulate the activity of Prp2p as well as recruit it. Prp43p is also recruited by 
the G-patch protein Ntr1p (see Chapter 3.1 for details) (Tsai et al. 2007). There are no 
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obvious G-patch proteins known to recruit or activate Prp16p or Prp22p in yeast; 
however, recent data identifies GPKOW as a G-patch protein that might regulate these 
helicases in humans (hPrp2 and hPrp16p) (Hegele et al. 2012). GPKOW is necessary for 
splicing in vitro, though it does not appear to be recruiting the helicases. Mostly likely its 
G-patch motif is necessary for stimulating hPrp2p, making it a potential human ortholog 
of Spp2p (Lin RJ, personal communication). Other G-patch proteins have been identified 
in humans that also have potentially interesting interactions with helicases (see Chapter 
5.2 for details).  
1.4.6 Prp43 function in gene expression 
Of the DEAH-box helicases, Prp43p is one of two that is known to be involved in 
more than one cellular pathway, ribosome biogenesis and pre-mRNA splicing 
(Jankowsky 2011). In S. cerevisiae Prp43p is essential and can be functionally 
complemented by its homolog in higher eukaryotes (Arenas and Abelson 1997; Gee et al. 
1997). Its ATPase activity is essential for cell viability, as evidenced by lethality in prp43 
mutants harboring alanine substitutions in the conserved ATPase motifs (Martin et al. 
2002). Prp43p uses its ATPase activity to preform different functions in the two pathways 
in which it is associated (Martin et al. 2002; Combs et al. 2006). 
1.4.6.1 Prp43p function in pre-mRNA splicing  
Prp43p was first characterized as a splicing factor whose ATPase activity is 
necessary for cell survival. Temperature sensitive mutants of PRP43 were created based 
on mutations in other spliceosomal helicases and found to accumulate both actin pre-
mRNA and excised lariat introns, indicating that Prp43p acts at the end of splicing in 
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spliceosome disassembly (Arenas and Abelson 1997). The cold sensitive prp43Q423N 
mutant accumulates both in vivo actin and U3A snoRNA introns (Leeds et al. 2006); 
however, it is not specified whether this is the lariat or as pre-mRNA. In in vitro splicing 
assays, the dominant negative mutant prp43T123Ap, which has a 94% reduced ATPase 
activity, accumulates the lariat intron retained within the post-splicing lariat RNP. 
Therefore, Prp43p promotes spliceosome disassembly by removing the lariat intron from 
the post-splicing lariat RNP. The released lariat intron is then debranched by Dbr1p. Also 
in vitro assays indicate that the T123A mutant does not appear impede the production of 
mature mRNA (Martin et al. 2002). In addition to its established role in canonical 
disassembly, Prp43p has been shown to disassemble stalled spliceosome intermediates 
either at the first or second step of splicing, making Prp43p a general disassembly factor. 
Prp43p prevents the accumulation of stalled spliceosomes bound to suboptimal substrates 
by discarding the substrates at steps throughout the splicing cycle (Mayas et al. 2006). In 
fact, it can act even before the 5' SS cleavage event (Koodathingal et al. 2010).  
Prp43p is stably associated with the lariat intron and U2, U5, and U6 snRNAs, 
which are a part of the corresponding snRNPs in the post-splicing lariat RNP. It does not 
associate stably with either U1 or U4 snRNAs (Combs et al. 2006). However, Prp43p 
only crosslinks to U6 snRNA, but not the U5 or U2 snRNAs. Prp43p binding to U6 was 
mapped to positions 18-43 and 76-83, with this second peak partially overlapping with 
the U4 binding site in U6 (Bohnsack et al. 2009).  
Ntr1 and Ntr2 proteins, which have a weak association to the NTC (Prp19- 
associated complex, see 1.2.4 for details), are important for the association of Prp43p 
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with the spliceosome. The Ntr1p/Ntr2p/Prp43p (NTR) complex can disassemble the 
spliceosome in an ATP-dependent manner, so that the snRNPs, lariat intron, and NTC are 
separated (Tsai et al. 2005). Ntr1p/Ntr2p can bind the spliceosome in the absence of 
Prp43p, and then recruit it to form the NTR complex on the spliceosome. While the 
addition of Prp43p or Ntr1p/Ntr2p is not an ATP-dependent step, ATP is needed for 
disassembly. Ntr2p mediates the association between the NTR complex and Brr2p as a 
component of the U5 snRNP (see Chapter 3.1 for details) (Tsai et al. 2007).  
1.4.6.2 Prp43p function in ribosome biogenesis  
Microarray analyses using recessive prp43 ATPase mutants indicated a strong 
reduction in ribosomal RNAs (18S, 25S, 5.8S and 5S). Additionally, these gene 
expression profiles cluster PRP43 with other ribosome biogenesis genes rather than 
splicing genes (Combs et al. 2006). Consistent with these data, Prp43p was shown to 
stably associate with snoRNAs and rRNA precursors. Immunoprecipitation of Prp43p 
indicated it associates with the 35S primary pre-rRNA transcript, as well as both the 27S 
and 20S pre-rRNA transcripts (Combs et al. 2006; Leeds et al. 2006; Lebaron et al. 
2005). In contrast, Prp43p does not associate with the mature rRNAs (Combs et al. 
2006). prp43 ATPase mutants result in an early ribosomal processing defect, so that the 
35S pre-rRNA accumulates and all other downstream precursors are reduced (Leeds et al. 
2006; Combs et al. 2006). These defects in rRNA processing are evident in polysome 
profiles as well. prp43G429A and prp43S247A mutants have reduced levels of 80S 
ribosomes and the presence of halfmers was noted, indicating an imbalance in the ratio of 
subunits. These mutants do not properly export the precursor ribosomes; both Rpl25p and 
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Rps2p, large and small subunit factors respectively, accumulate in the nucleoli (Combs et 
al. 2006).  
Prp43p also interacts with both box C/D (e.g. U14, snR64 and snR47) and box 
H/ACA (e.g. snR46 and snR3) snoRNAs (Combs et al. 2006). Loss of Prp43p function 
disrupts the association or removal of snoRNAs from the rRNA, which can result in loss 
of methylation (Bohnsack et al. 2009; Leeds et al. 2006). prp43 ATPase mutants also 
result in increased levels of snR41, snR39, snR50, snR39b, and snR59 remaining on the 
ribosome. In contrast, reduced levels of snR64 and snR65 are associated with the 
ribosome (Bohnsack et al. 2009). The reduction in snR64 association is correlated to the 
loss of 2'-O-methylation at C2337 in the 25S rRNA (Leeds et al. 2006). Though cross-
linking and cDNA analysis (CRAC) data does not indicate that Prp43p binds near the 
C2337 site, the hypothesis is that its action remodeling the rRNA elsewhere could allow 
this site to be exposed to allow the snoRNA to bind. CRAC data indicate that multiple 
Prp43p binding sites exist along the rRNA. CRAC data indicate that Prp43p binds near 
helix 44 at the 3' end of the 18S rRNA (ntds. 1713-1727 and 1743-1762) (Fig. 1.1). This 
helix is located near the D site (ntd. 1800) and the dimethylation site of Dim1p (ntd. 1781 
& 1782). While this is the only predicted binding site within the 18S rRNA, there are four 
predicted binding sites within the 25S rRNA: bridging helix 23 & 24 (ntds. 360-378), 
between helix 39 & 40 (ntds. 1141-1154), along helix 34 (ntds. 703-717), and along helix 
84 (ntds. 2656-2675) (Fig. 1.2). Nearby helix 34 of the LSU, the snoRNAs snR39b and 
snR39 or snR59 methylate positions G805 and A809, respectively. Prp43p appears to be 
necessary in removing these snoRNAs from the ribosome, since loss of Prp43p function 
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results in increased levels of these snoRNAs on the ribosome. Additionally, snR50 also 
methylates nearby at position G867 and is affected similarly in the absence of Prp43p 
function. In contrast, decreased levels of snR67, which methylates at U2724 near helix 
83, were observed on the ribosomal precursors under these conditions (Bohnsack et al. 
2009). Overall, Prp43p has been shown to extensively remodel the pre-rRNA during the 
course of maturation. The evidence for the action of Prp43p to allow the D site cleavage 
event is strengthened by its genetic interaction with Ltv1p, a non-essential component of 
the late pre-40S (see Chapter 2.1) (Schäfer et al. 2006; Pertschy et al. 2009).  
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Figure 1.1 Prp43p binding site on 18S S. cerevisiae rRNA.  
Prp43p binding sites mapped to the secondary structure of the 18S rRNA to helix 
44 (in purple). The site is shown in spatial relationship to the Dim1p methylation sites (in 
green) and the methylation sites directed by snR41 (in blue). The D cleavage site at 
nucleotide 1800 also lies near the Prp43p binding site (as indicated) The secondary 
structure of the yeast 18S rRNA was obtained from the CRW project 
(http://www.rna.ccbb.utexas.edu/) (Cannone et al. 2002) .  
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 Figure 1.2 Prp43p binding sites on 25S S. cerevisiae rRNA.
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(Figure 1.2 contd.)  
Prp43p binding sites map on the secondary structure of the 25S rRNA to multiple places 
(purple). The bindings sites of the snoRNAs that are affected by Prp43p action are 
highlighted in blue. Sites for the snoRNAs snR39/snR59 and sNR39b lie in close 
proximity to the binding site of Prp43p on helix 34. Additionally, both modification sites 
of snR67 are shown in close relationship to the binding site of Prp43p on helix 83. The 
secondary structure of yeast 18S rRNA was obtained from the CRW project 
(http://www.rna.ccbb.utexas.edu/) (Cannone et al. 2002). 
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1.5 DISSERTATION OBJECTIVES  
Our lab has previously proposed that Prp43p works as a communication conduit 
that links RNA Pol I and RNA Pol II processing pathways (Combs et al. 2006). If Prp43p 
plays a role in the crosstalk between the two pathways, we would expect its activity to be 
closely regulated by cells. Moreover, Prp43p localization within cells might be controlled 
since these two processes are physically separated in different nuclear subcompartments, 
with ribosome biogenesis occurring in the nucleolus and pre-mRNA splicing occurring in 
the nucleoplasm (rev. in Wahl et al. 2009). Shortly after beginning my work, the G-patch 
protein Ntr1p was found to recruit Prp43p for spliceosomal disassembly (Tsai et al. 2007; 
Tanaka et al. 2007). It was unknown how Prp43p is directed to its substrates in ribosome 
biogenesis, but the interaction of Prp43p with two other G-patch proteins suggested they 
might be similarly involved in Prp43p recruitment. My dissertation work explored the 
possibility that these three G-patch proteins work together to modulate Prp43p within 
cells. I then set out to determine if and how the G-patch proteins related to Prp43p affect 
ribosome biogenesis and pre-mRNA splicing. I hypothesized that each G-patch protein 
interacts with Prp43p in a mutually exclusive manner and competes with one another to 
recruit Prp43p to spliceosome disassembly, early or late ribosome biogenesis. In this aim, 
I sought to understand if and how the G-patch proteins impact one another and their 
relationships with Prp43p. From my data, I built a network of G-patch protein and Prp43p 
interactions.  
Additionally, Prp43p does not have inherent substrate specificity (Tanaka et al. 
2007), which suggests it must be directed to its substrates and/or stimulated within the 
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appropriate ribonuceloprotein context. Since the C-terminus of Prp43p is unique, I set out 
to create and characterize prp43 alleles with mutations in its C-terminus that only affect 
either pre-mRNA splicing or ribosome biogenesis. By characterizing these alleles we 
hoped to determine specificity domains of Prp43p, which we predicted to lie in its C-
terminus. These domains might be interaction surfaces for the G-patch proteins or innate 
regions with differential functions. The work was begun before the crystal structure of 
Prp43p was published (He et al. 2010, Walbott et al. 2010), but we feel that the structure 
provides crucial insight into the nature of the alleles I have identified.  
My findings contribute to our understanding of the relationship between Prp43p 
and its cofactors and as well as provide in vivo data for prp43 mutants with a range of 
effects on ribosome biogenesis and splicing. I believe that my work will be useful in 
building a cohesive model for Prp43p regulation and function. Since Prp43p is conserved 
in higher eukaryotes we anticipate our understanding of Prp43p function in S. cerevisiae 
will be instructive in unraveling its function and regulation in humans.   
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Chapter 2: Pfa1p acts as a negative regulator of splicing and early 
ribosome biogenesis by modulating Prp43p trafficking 
2.1 INTRODUCTION TO PFA1P  
Pfa1p (Prp Forty-three Associated) was first identified as an interacting factor 
with Prp43p by mass spectrometry and it proved to be the most abundant protein present 
in Prp43p purified material. Pfa1p was implicated as a component of pre-40S particles 
due to its association with the 20S pre-rRNA, and possibly 18S rRNA. It does not 
associate with the 35S or 27S pre-rRNA species, nor the mature 25S rRNA (Lebaron et 
al. 2005). Pfa1p was further shown to be partially responsible for the maturation of the 
pre-40S subunit (Pertschy et al. 2009), and deletion of PFA1 reduces the efficiency of 
Prp43p association with 20S pre-rRNA (Lebaron et al. 2009). The data suggest that 
Pfa1p also interacts with Prp43p outside the context of the pre-40S since Prp43p appears 
to be stoichiometric with Pfa1p and in excess over the co-purified pre-40S components in 
Pfa1p-TAP purified material (Lebaron et al. 2009). 
2.1.1 Role of Pfa1p in small subunit ribosome biogenesis  
Pfa1p was implicated in the maturation of the small subunit through a negative 
genetic interaction with the small subunit factor LTV1 (Pertschy et al. 2009). Ltv1p was 
characterized as a late pre-40S component associated with Enp1, Hrr25p, Nob1p, Rio1p, 
Tsr1p, Dim1p and Dim2p (Schäfer et al. 2006). Ltv1p has also been proposed to function 
as an NES for pre-40S subunits in a Crm1-dependent manner; however, export is only 
partially blocked in an ltv1! strain (Seiser et al. 2006). Strain background appears to 
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affect the extent of the ltv1! on phenotype; in a W303 background ltv1! has minimal 
growth defects at 23°C and 30°C (Pertschy et al. 2009), but in the S288C background the 
ltv1! mutant is significantly cold sensitive (Seiser et al. 2006). The growth defects 
observed in ltv1! at 23°C are exacerbated in the ltv1!pfa1! double mutant. 
Interestingly, the loss of the G-patch domain of Pfa1p is sufficient to produce this effect, 
indicating this region of the protein is responsible for this genetic interaction (Pertschy et 
al. 2009). In an ltv1! mutant the processing of the 20S pre-rRNA into the 18S rRNA is 
aberrant, and the 20S pre-rRNA partially accumulates in the cytoplasm (Seiser et al. 
2006; Pertschy et al. 2009). The ltv1!pfa1! double mutant not only accumulates 20S 
pre-rRNA, but an unusual 17S species also accumulates due to the incorrect trimming of 
the 20S pre-rRNA by the exosome. The accumulation of the 20S pre-rRNA in the 
cytoplasm is greatly exacerbated in the ltv1!pfa1! double mutant compared to the ltv1". 
Interestingly, the growth defects and 20S processing defects in the ltv1!pfa1! double 
mutant can be rescued by overexpression of Nob1p. The endonuclease Nob1p cleaves at 
the D site of 20S pre-rRNA to yield the 18S rRNA. Nob1p mutants that are deficient in 
the endonuclease activity are unable to rescue the phenotypes observed in ltv1!pfa1!, 
indicating its activity is necessary for the suppression. While ltv1!pfa1! has ribosome 
biogenesis defects, pfa1! alone does not. The loss of Pfa1p does not result in rRNA 
processing defects or growth defects at any temperature. Ltv1p also genetically interacts 
with an allele of PRP43, prp43S414F (Pertschy et al. 2009). This point mutation lies near 
the base of the ! hairpin between motifs V and VI (Fig. 4.1A). Despite a mutation in such 
a critical area of the helicase, prp43S414F does not have any obvious growth or rRNA 
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processing defects. However, the ltv1! prp43S414F double mutant has 20S pre-rRNA 
processing defects similar to ltv1!pfa1!. Similarly, Nob1p overexpression can rescue 
ltv1!prp43S414F phenotypes. These genetic interactions lead to a model that defines 
Prp43p and Pfa1p as factors involved in the D site cleavage event. Together they 
contribute to the stability of the 3' end of the 18S rRNA and prevent exosome access 
(Pertschy et al. 2009).  
Pfa1p can act as a cofactor for Prp43p by stimulating its helicase and ATPase 
activity. Pfa1p physically interacts with Prp43p through two structural domains at the N- 
and C-termini of Pfa1p (1-202 aa and 574-767 aa). Each domain can interact with Prp43p 
independent of the other, and the interaction is further stabilized through the presence of 
the intervening domain. The G-patch domain of Pfa1p lies in its C-terminus and interacts 
with C-terminus of Prp43p (1-657 aa) (Lebaron et al. 2009; Walbott et al. 2010). This 
interaction is necessary to stimulate the ATPase and helicase activity of Prp43p, and the 
stimulation is not based on an increased binding of ATP by Prp43p (Lebaron et al. 2009). 
The model for the role of Prp43p in small subunit biogenesis postulates that the 
stimulation of Prp43p by Pfa1p is needed to restructure the rRNA at helix 44 (Fig. 1.1) to 
allow Nob1p access to the D site (Pertschy et al. 2009; Lebaron et al. 2009). Nob1p is 
prevented from acting prematurely in late pre-40S particles, either by proteins or RNA 
duplexes which are resolved by Prp43p/Pfap1p (Pertschy et al. 2009; Lebaron et al. 
2009; Walbott et al. 2010). Alternatively, the effect of Prp43p and Pfa1p on 20S pre-
rRNA processing could be secondary. They could be affecting the overall structure of the 
pre-rRNA due to an inability to remove snoRNAs or proteins. Since neither pfa1! nor 
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prp43S414F mutants have any growth defects, the essentiality of this regulation is 
unclear. Further work will need to done to understand if the role if Prp43p in 20S 
processing is direct or indirect.  
2.1.2 Effect of Pfa1p on splicing efficiency  
In contrast to the pfa1! mutant, overexpression of Pfa1p results in a slow growth 
effect (Pandit et al. 2009). The deletion of the G-patch domain from Pfa1p does not 
alleviate its effect on growth when overexpressed; therefore, regions of Pfa1p outside the 
G-patch domain drive the growth defect (Pandit et al. 2009). Since the G-patch domain of 
Pfa1p is necessary for stimulating the ATPase and helicase activity of Prp43p, (Lebaron 
et al. 2009), the overstimulation of Prp43p activity is not likely to the underlying cause of 
the defect.  
Excess Pfa1p results in a first step pre-mRNA splicing defect so that pre-mRNA 
accumulates (Pandit et al. 2009). However, it is unlikely that Pfa1p functions directly in 
splicing as it does not stably interact with any snRNAs (Lebaron et al. 2005). Increased 
levels of Pfa1p can also affect rRNA processing so that all pre-rRNAs are downregulated 
(Pandit et al. 2009). Our results show different rRNA processing defects during Pfa1p 
overexpressed compared to previously published data. These discrepancies are perhaps 
due to strain background, considering the differences seen in the ltv1! mutant in different 
strains. The previous studies used a W303 background (Pandit et al. 2006) while we have 
used a S288C background.  
To understand how Prp43p is regulated through cofactors, we further investigated 
its relationship with Pfa1p. We sought to understand how Pfa1p influences splicing and 
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ribosome biogenesis with the hypothesis that overexpressed Pfa1p sequesters Prp43p 
from participating in both processes. Since Pfa1p is involved in a late ribosome 
biogenesis step, we considered how its overexpression might be affecting the function of 
Prp43p at an earlier step. Our data indicate that Pfa1p can act as a negative regulator of 
Prp43p, possibly functioning to pause gene expression in response to environmental 
stress conditions. 
2.2 MATERIALS AND METHODS 
2.2.1 Construction of yeast strains 
TAP-tagged strains were obtained from the TAP collection and verified by 
Western blotting (Howson et al. 2005). C-terminal GFP tagging of Prp43p was achieved 
through PCR amplification of the eGFP tag and KANr (Kanamycin resistance) marker 
from the genomic DNA of strain ss599 (Combs et al. 2006). The PCR amplified epitope 
cassette was introduced via homologous recombination by lithium acetate transformation 
as previously described (Gietz and Woods 2002). Colonies growing on YPD media 
supplemented with 200 !g/mL geneticin (Gibco BRL Life Technologies, Inc.) were 
screened by Western blotting and fluorescence for proper integration of the GFP tag. The 
C-terminal myc tags were amplified from pFA6a-13Myc-TRP1 (Longtine et al. 1998) or 
pFA6a-13Myc-URA3 vectors. PCR amplification from the pFA6a-13Myc-URA3 plasmid 
utilized different reverse primers from the other pFA6a plasmids: Pfa1R1, Gno1R1, and 
Ntr1R1. The N-terminal HIS3-GAL1-3HA cassette was PCR amplified from the pFA6a-
HIS3-GAL-3HA vector (Longtine et al. 1998) using the primers listed in Table 2.2. All 
tags were integrated via homologous recombination as described above. MYC tagged 
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Table 2.1 Yeast strains used in Chapter 2  
Strain Relevant 
Gene(s) 
Genotype Source/Reference 
599 PRP43-GFP MAT! his3"1, leu2"0, met15"0, 
trp1"63, ura3"0, PRP43-
GFP::KANMX 
(Combs et al. 
2006) 
3067 pRS316-PRP43-
TAP pfa1" 
MAT a ura3-52, trp1-63, his3#200, 
leu2-1, ade2-101, lys2-801, 
prp43::KANMX pfa1::HIS3, pRS316-
PRP43-TAP 
This study 
3070 NTR1-TAP MAT a his3?1, leu2?0, met15?0, 
 ura3?0, NTR1-TAP::HIS3 
(Howson et al. 
2005) 
3071 PFA1-TAP MAT a his3?1, leu2?0, met15?0, 
ura3?0, PFA1-TAP::HIS3 
(Howson et al. 
2005) 
3072 GNO1-TAP MAT a his3?1, leu2?0, met15?0, 
ura3?0, GNO1-TAP::HIS3 
(Howson et al. 
2005) 
3073 NTR1-TAP 
PRP43-GFP 
MAT a his3?1, leu2?0, met15?0, 
ura3?0, NTR1-TAP::HIS3, PRP43-
GFP::KANMX 
This study 
3074 PFA1-TAP  
PRP43-GFP 
MAT a his3?1, leu2?0, met15?0, 
ura3?0, PFA1-TAP::HIS3, PRP43-
GFP::KANMX 
This study 
3075 GNO1-TAP 
PRP43-GFP 
MAT a his3?1, leu2?0, met15?0, 
ura3?0, GNO1-TAP::HIS3, PRP43-
GFP::KANMX 
This study 
3099 PFA1-myc MAT a his3#1, leu2#0, met15#0, 
ura3#0, PFA1-13myc::URA3 
This study 
3100 NTR1-TAP 
PRP43-GFP  
PFA1-myc 
MAT a his3?1, leu2?0, met15?0, 
ura3?0, NTR1-TAP::HIS3, PRP43-
GFP::KANMX, PFA1-13myc::URA3 
This study 
3101 GNO1-TAP 
PRP43-GFP 
PFA1-myc 
MAT a his3?1, leu2?0, met15?0, 
ura3?0, GNO1-TAP::HIS3, PRP43-
GFP::KANMX, PFA1-13myc::URA3 
This study 
3102 GNO1-TAP 
PRP43-GFP 
NTR1-myc 
MAT a his3?1, leu2?0, met15?0, 
ura3?0, GNO1-TAP::HIS3, PRP43-
GFP::KANMX, NTR1-13myc::URA3 
This study 
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Strain Relevant 
Gene(s) 
Genotype Source/Reference 
3103 NTR1-myc MAT a his3!1, leu2!0, met15!0, 
ura3!0, NTR1-13myc::URA3 
This study 
3104 PFA1-TAP  
PRP43-GFP 
GNO1-myc 
MAT a his3?1, leu2?0, met15?0, 
ura3?0, PFA1-TAP::HIS3, PRP43-
GFP::KANMX, GNO1-13myc::URA3 
This study 
3107 GNO1-myc MAT a his3!1, leu2!0, met15!0, 
ura3!0, GNO1-13myc::URA3 
This study 
3108 PFA1-TAP  
PRP43-GFP 
NTR1-myc 
MAT a his3?1, leu2?0, met15?0, 
ura3?0, PFA1-TAP::HIS3, PRP43-
GFP::KANMX, NTR1-13myc::URA3 
This study 
3109 NTR1-TAP 
PRP43-GFP 
GNO1-myc 
MAT a his3?1, leu2?0, met15?0, 
ura3?,0 NTR1-TAP::HIS3, PRP43-
GFP::KANMX, GNO1-13myc::URA3 
This study 
3129 pRS316-GAL 
PRP43-GFP  
MAT" his3#1, leu2#0, met15#0, 
trp1#63, ura3#0, PRP43-
GFP::KANMX, pRS316-GAL 
This study 
3131 pGAL-PFA1-
HA/ZZ  
PRP43-GFP  
MAT" his3#1, leu2#0, met15#0, 
trp1#63, ura3#0, PRP43-
GFP::KANMX, pGAL-PFA1-HA/ZZ-
URA 
This study 
3138 pGAL-PFA1-
HA/ZZ  
PRP43-GFP 
NTR1-myc 
MAT" his3#1, leu2#0, met15#0, 
trp1#63, ura3#0, PRP43-
GFP::KANMX, NTR1-13myc::TRP1, 
pGAL-PFA1-HA/ZZ-URA 
This study 
3139 pRS316-GAL 
PRP43-GFP 
NTR1-myc 
MAT" his3#1, leu2#0, met15#0, 
trp1#63, ura3#0, PRP43-
GFP::KANMX, NTR1-13myc::TRP1, 
pRS316-GAL 
This study 
3144 GAL::HA-NTR1 
PRP43-GFP 
MAT" his3#1, leu2#0, met15#0, 
trp1#63, ura3#0, HIS3::GAL::HA-
NTR1, PRP43-GFP::KANMX 
This study 
3145 GAL::HA-GNO1 MAT" his3#1, leu2#0, met15#0, 
trp1#63, ura3#0, HIS3::GAL::HA-
This study 
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Strain Relevant 
Gene(s) 
Genotype Source/Reference 
PRP43-GFP GNO1, PRP43-GFP::KANMX 
3146 GAL::HA-PFA1 
PRP43-GFP 
MAT! his3"1, leu2"0, met15"0, 
trp1"63, ura3"0, HIS3::GAL::HA-
PFA1, PRP43-GFP::KANMX 
This study 
3148 GAL::HA-PFA1 
PRP43-GFP 
NTR1-myc 
MAT! his3"1, leu2"0, met15"0, 
trp1"63, ura3"0, HIS3::GAL::HA-
PFA1, PRP43-GFP::KANMX, NTR1-
13myc::TRP1 
This study 
3149 GAL::HA-PFA1 
PRP43-GFP 
GNO1-myc 
MAT! his3"1, leu2"0, met15"0, 
trp1"63, ura3"0, HIS3::GAL::HA-
PFA1, PRP43-GFP::KANMX, GNO1-
13myc::TRP1 
This study 
3153 GAL::HA-NTR1 
Prp43-GFP  
PFA1-myc 
MAT! his3"1, leu2"0, met15"0, 
trp1"63, ura3"0, HIS3::GAL::HA-
NTR1, PRP43-GFP::KANMX, PFA1-
13myc::TRP1 
This study 
3154 GAL::HA-NTR1 
PRP43-GFP 
GNO1-myc 
MAT! his3"1, leu2"0, met15"0, 
trp1"63, ura3"0, HIS3::GAL::HA-
NTR1, PRP43-GFP::KANMX, GNO1-
13myc::TRP1 
This study 
3155 GAL::HA-GNO1 
PRP43-GFP 
NTR1-myc 
MAT! his3"1, leu2"0, met15"0, 
trp1"63, ura3"0, HIS3::GAL::HA-
GNO1, PRP43-GFP::KANMX, NTR1-
13myc::TRP1 
This study 
3156 GAL::HA-GNO1 
PRP43-GFP 
PFA1-myc 
MAT! his3"1, leu2"0, met15"0, 
trp1"63, ura3"0, GAL:HA-
GNO1::HIS3, PRP43-GFP::KANMX, 
PFA1-13myc::TRP1 
This study 
3157 pRS316-GAL 
PRP43-GFP 
GNO1-TAP 
MAT a his3"1, leu2"0, met15"0, 
ura3"0, GNO1-TAP::HIS3, PRP43-
GFP:: KANMX, pRS316-GAL 
This study 
3159 pGAL-PFA1-
HA/ZZ  
PRP43-GFP 
MAT a his3?1, leu2?0, met15?0, 
ura3?0, GNO1-TAP::HIS3, PRP43-
This study 
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Strain Relevant 
Gene(s) 
Genotype Source/Reference 
GNO1-TAP GFP::KANMX, pGAL-PFA1-HA/ZZ  
3169 pRS411 
PRP43-GFP 
MAT! his3"1, leu2"0, met15"0, 
trp1"63, ura3"0, PRP43-
GFP::KANMX, pRS411 
This study 
3170 pRS411  
PRP43-GFP 
GAL::HA-PFA1 
MAT! his3"1, leu2"0, met15"0, 
trp1"63, ura3"0, PRP43-
GFP::KANMX, HIS3::GAL::HA-PFA1, 
pRS411  
This study 
3181 GAL::HA-NTR1 
PRP43-GFP 
pfa1" 
MAT! his3"1, leu2"0, met15"0, 
trp1"63, ura3"0, PRP43-GFP:: 
KANMX, HIS3::GAL::HA-NTR1, 
pfa1#::URA3 
This study 
3182 GAL::HA-GNO1 
PRP43-GFP 
pfa1" 
MAT! his3"1, leu2"0, met15"0, 
trp1"63, ura3"0, PRP43-GFP:: 
KANMX, HIS3::GAL::HA-GNO1, 
pfa1#::URA3 
This study 
3183 PRP43-GFP 
pfa1" 
MAT! his3"1, leu2"0, met15"0, 
trp1"63, ura3"0, PRP43-GFP:: 
KANMX, pfa1#::URA3 
 
This study 
3213 pGAL-GNO1-
HA/ZZ 
MAT a his3#1, leu2#0, met15#0, 
ura3#0, pGAL-GNO1-HA/ZZ 
This study 
3214 pGAL-NTR1-
HA/ZZ 
MAT a his3#1, leu2#0, met15#0, 
ura3#0, pGAL-NTR1-HA/ZZ 
This study 
 
Table 2.2 Oligonucleotides used in Chapter 2  
Name Sequence 
Ntr1 R1  5’TCTAATCAATTTTGTTTTTCGACAATAATATATAAATCGTGCCTATCTCATCTG
GAGGAAGTTTGAGAGG3’ 
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Name Sequence 
NTR1 F2 5’AGGATTCCAGTGGGACCTTTAAGCCAATTTATTTATGGGCCCTTGACCTCGGT
CGACGGATCCCCGGGTT 3’ 
Gno1 F2 5’CGTTGATGGACTCCAAGGCACTGAATGAGATCTTTATGATAACAAACGACGGT
CGACGGATCCCCGGGT 3’ 
Gno1 R1 5’TCCCCACTCTATATATCTTGCTGCGTGTGCAGACTGGCCAGCTGCTCACATCTG
GAGGAAGTTTGAGAGG 3’ 
PFA1F2 5’TTTTTGCCAAAATTAAAAAGAATAGATCGGGTTTAAGACACAGTGAAAGTGG
TCGACGGATCCCCGGGTT 3’  
Pfa1 R1  5’AAAATAAAAAAATATGTATATACGCAATTGTTAAGAAAATGAGGATTAAATC
TGGAGGAAGTTTGAGAGG 3’ 
Pfa1 R1 
Longtine 
5’AAAATAAAAAAATATGTATATACGCAATTGTTAAGAAAATGAATTCGAGCTC
GTTTAAAC3’  
Ntr1 R1 
Longtine 
5’TTTGTTTTTCGACAATAATATATAAAATCGTGCCTATCTCAGAATTCGAGCTCG
TTTAAAC 3’  
Gno1 R1 
Longtine 
5’TATATATCTTGCTCGTGTGCAGACTGGCCAGCTGCTCACGAATTCGAGCTCGT
TTAAAC 3’  
E-C2 5’ GAAAAGGCCAGCAATTTCAAGTTAACTCCAAAGAGTATCACTCAC 3’  
D-A2 5’ AAACTTACAAGCCTAGCAAGACCGCGCACTTAAGCGCAGGCCCGG 3’  
scR1 5’ CGTGTCTAGCCGCGAGGAAGGATTTGTTCC 3’  
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Name Sequence 
U3 PE 5' CCAAGTTGGATTCAGTGGCTC 3'  
U1  5' GAATGGAAACGTCAGCAAACA 3' 
NTR1-R3 5’AAAAGAACTTTTATCTGTGTTGGAGTCCGAATCCTCCATGCACTGAGCAGCGT
AATCTG 3’ 
PFA1-R3 5’TACGTCTGCTTCCTTGATAATGACTATGCCTTTTTGCCATGCACTGAGCAGCGT
AATCTG 3’ 
GNO1-R3 5’AACCAAACCGCTGTTTGGTTCTTGTAGCTGCCAAACCCATGCACTGAGCAGCG
TAATCTG 3’ 
NTR1-F4 5’TTCGAAATAGTACAACCGAGAGAGGTCGAAGAACTTAAGCGAATTCGAGCTC
GTTTAAAC 3’ 
PFA1-F4 5’AGAAGTGATTTAATCGCAGAGTCAAATATAAGCATAAATTGAATTCGAGCTC
GTTAAAC 3’ 
GNO1-F4 5’GAGATGAGTACTCAATAGTAACATATAGGCAGCTTACACCGAATTCGAGCTC
GTTTAAAC3’ 
35S 5’CGCTGCTCACC AATGG3’ 
U1 North 5' GAATGGAAACGTCAGCAAACA 3'  
U2 North 5' AAAAGAACAGATACTACACTTGA 3'  
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Name Sequence 
U4 North 5' ACCATGAGGAGACGGTCTGG 3'  
U5 North 5' ACACCCGGAATGGTTCTGGTA 3' 
U6 North 5' AACGAAATAAATCTCTTTGTAAAAC 
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strains were verified by PCR amplification of genomic DNA, and by western blotting, 
while HA tagged strains were verified by Western blotting.  
2.2.2 Plasmids  
The pFA6a-13Myc-URA3 vector was a kind gift from Won-Ki Huh (Sung et al. 
2008), but due to the lack of successful cloning with this construct the 13MYC cassette 
from pFA6a-13Myc-KANr, was subcloned into the pFA6a-13Myc-URA backbone using 
Xma1 and BglII. The following Yeast ORF clones were obtained from Open Biosystems 
and verified through DNA sequencing: YLR424W (YSC3869-9520126), YNL224C 
(YSC3869-9516572), and YGR280C (YSC3869-9514962). Yeast transformations of 
plasmids were performed as previously described (Gietz and Woods 2002). 
2.2.3 Time Course Western Analysis  
Whole cell protein extracts from indicated time points were prepared as 
previously described with minor modifications (Yaffe and Schatz 1984). Cell cultures 
were lysed after adjusting to 2N NaOH, 8% 2-mercaptoethanol. Proteins were 
precipitated with acetone and solubilized in 2X LDS buffer with 200 mM DTT, separated 
by SDS-PAGE, and transferred to nitrocellulose. Antibodies used in western blot analysis 
were as follows: 1:5000 anti-c-myc purified from Myc 1-9E10.2 (ATCC CRL-1729), 
1:5000 anti-HA (Covance HA.11 Clone 16B12, MMS-101R), 1:5000 anti-GFP 
(GenScript) conjugated to HRP using Innova Biosciences Lightning-Link HRP 
conjugation kit, 1:5000 goat anti-mouse HRP conjugated (Rockland, 610-1302) or 
1:30,000 goat anti-mouse HRP conjugated (JacksonImmunoresearch, 115-035-062), 
1:10,000 Rabbit PAP (Rockland, P300-0025), 1:8000 rabbit anti-Rpl8 (A. Johnson, UT 
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Austin), 1:5000 anti-rabbit HRP (Rockland, 611-303-122). All blots were performed in 
BLOTTO [5% dry milk in 1x PBST (137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 2 
mM KH2PO4, 0.2% Tween-20)] for 1 hour. Washes were performed with 1x PBST. Blots 
were visualized on X-ray film by chemiluminescence using Perkin Elmer Western 
Lightning Plus ECL substrate. Membranes used for multiple western blots were stripped 
with Restore western stripping buffer (Thermo Scientific) and removal of signal was 
determined by film or on a Molecular Dynamics Storm 860 imager 
2.2.4 Serial Dilutions 
Yeast strains were grown in non-repressive YP media + 2% sucrose until OD600 
1.0. Serial dilutions of 10-2 were made and 3 !L of each dilution was plated onto either 
YP + 2% dextrose or YP + 2% galactose plates. When selection was required, cells were 
grown in S-URA + 2% sucrose and plated on S-URA + 2% dextrose or 2% galactose 
plates. Plates were incubated at 31°C for 3 days before photographing.  
2.2.5 TAP Coimmunoprecipitations 
Cells were grown at 31°C in YPD, unless otherwise indicated. Cells were 
harvested, resuspended (1:1 w:v), frozen in AGK buffer (10 mM HEPES pH 7.9, 200 
mM KCl, 1.5 mM MgCl2, and 8% glycerol) and lysed cryogenically in a Retch ball mill 
(Mayas et al. 2006). Approximately 1 g of cell material was used for each of these 
experiments. After addition of leupeptin/pepstatin (1 mM each), DTT (1 mM), and PMSF 
(0.4 mM), proteins were extracted for 30 minutes by rotating at 4ºC and clarified by 
centrifugation at 15,000 x g for 20 minutes. Extracts were normalized by OD (A595) using 
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a BioRAD Bradford assay. TAP coimmunoprecipitations were carried out using IgG 
sepharose resin as previously described (Puig et al. 2001). IgG beads were washed with 
IPP150 (10 mM Tris, pH 8.0, 150 mM NaCl, 0.1% NP-40, 1.5 mM MgCl2, 8% glycerol, 
1 mM DTT) 4X at 2500 x g. Bound proteins were eluted by boiling in 2X LDS + 200 
mM DTT. For glycerol gradient sedimentation, IgG beads were incubated with 1 u of 
TEV protease (prepared in the Stevens laboratory) and 100 u of murine RNase inhibitor 
(NEB, M0314L) at 16˚C for 1-2 hours. The eluted material was divided and incubated 
with or without 2 mM ATP at 25˚C for 10 minutes before layering on a 10-30% glycerol 
gradient prepared in 20 mM HEPES, pH 7.9, 1.5 mM MgCl2, 0.02% NP-40, 150 mM 
KCl, 1 mM DTT, 0.4 mM PMSF. Gradients were centrifuged at 29,000 rpm for 16 hours 
at 4°C in an SW-41 rotor at 4°C. Fractions were phenol/chloroform extracted, and RNA 
was precipitated with 0.1 volume of 3 M sodium acetate, pH 5.3 and 2.5 volumes of 
100% ethanol. RNAs were separated through denaturing 8M Urea 1X TBE 40% PAGE 
[19:1 acrylamide:bis] gel and transferred to nylon membrane (Whatman) by 
electrophoresis in 25 mM sodium phosphate, pH 7.0. RNA was crosslinked to the 
membrane by exposure to 254 nm UV light for 1 minute before northern blotting for all 
snRNAs 
2.2.6 GFP Coimmunoprecipitations  
GFP coimmunoprecipitations were performed with either with abcam anti-GFP 
antibody (ab1218) or Chromotek-GFP-TRAP beads (Allele Biotech, ACT-CM-
GFA0050). Extracts was prepared as described above. Using anti-GFP antibody ab1218, 
the extract was first incubated with rProtein G Agarose (Invitrogen, #15920-010) for 30 
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minutes at 4ºC with rotation. Pre-cleared extract was removed and proteins were 
quantitated by BioRAD Bradford assay as described above, then incubated with 1:250 
v:v anti-GFP antibody at 4º C for 1 hour with rotation. Proteins were then captured on 
rProtein G Agarose beads for 30 minutes at 4º C with rotation. rProtein G beads were 
washed four times with Na2HPO4 IPP150 (10 mM, Na2HPO4 pH 7.0, 150 mM NaCl, 
0.1% NP-40, 1.5 mM MgCl2, 8% glycerol, 1 mM DTT) and harvested by centrifugation 
at 2500 x g. Bound material was removed either by boiling in 2X LDS + 200 mM DTT or 
by phenol-chloroform extraction. For experiments using Chromotek-GFP-TRAP beads, 
prepared extracts were added to 15 !L of resin and incubated at 4ºC with rotation for 2 
hours. Chromotek-GFP-TRAP Beads were washed four times with IPP150 by 
centrifugation at 2500 x g. Proteins were removed by boiling in 2X LDS + 200 mM DTT 
or by phenol-chloroform extraction. Western blot analysis was performed as described 
above. Amersham ECL Plus Western blotting detection system (RPN2132) was used for 
quantitation by chemifluorescence, and blots were scanned using a Molecular Dynamics 
Storm 860 imager or GE Typhoon TRIO. 
2.2.7 rRNA analysis 
Whole cell RNA was prepared by lysing cells in 1:1 volume of acid phenol to 
AES buffer (50 mM NaOAc, pH 5.3, 10 mM EDTA, 1% SDS) at 65ºC with vortexing 
(Wise 1991). After chilling on ice for 5 minutes, RNA was purified using 5 Prime Phase 
Lock Gel tubes (5 Prime, #2302830) and as directed by manufacturer, with the addition 
of one organic extraction. RNA was precipitated by isopropanol and pellets washed with 
70% ethanol. RNA (10 !g) was lyophilized, denatured, and separated on a 1% agarose 
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2.2 M formaldehyde gel as described (Sambrook and Russell 2001). RNAs were 
transferred to nylon membrane (Whatman) in a downward capillary transfer and northern 
blotted using 10 picomoles of 32P-!-labelled oligo in Church Buffer (500 mM Na2HPO4 
pH 7.0, 7% SDS, 1 mM ETDA pH 8.0) at 42°C for 12 hours to overnight. 
Oligonucleotide sequences used for northern blotting were previously described (Combs 
et al. 2006) and (Table 2.2). 
2.2.8 Pulse chase analysis 
Cultures were grown to an OD (A600) of 0.3-0.4 at 31°C in either S-MET or S-
MET –URA medium supplemented with 2% sucrose. Cells were shifted to media 
containing 2% galactose + 1% sucrose for six hours and a low OD (A600) was maintained 
throughout. Forty OD (A600) units were harvested by centrifugation and resuspended in 12 
ml of medium lacking methionine. After a 2 minute pulse with 175 "Ci of [3H]-L-methyl-
methionine, aliquots were withdrawn at 0, 1, 2, 5, 10 and 20 min after the addition of 150 
"g cold methionine. Cells were immediately frozen either with liquid nitrogen or dry ice, 
and RNA prepared as described above in Chapter 2.2.7. Signals were captured on a 
Kodak Tritium Storage screen for five days.  
2.2.9 Primer extensions  
Primer extension analysis was performed on U3 as described as previously 
described (Stevens and Abelson 2002), with the following modifications. One unit of 
laboratory-prepared reverse transcriptase was added per reaction with the U1 and U3 
oligos described in Table 2.2, and the reactions incubated at 42°C for 1 hour. Precipitated 
cDNAs were resuspended in formamide loading buffer (80% formamide, 10 mM EDTA, 
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10 mM XC/BPB). Samples separated by electrophoresis through a denaturing gel (7% 
19:1 acrylamide: bisacrylamide, 1x TBE, 8 M urea) at 25 mA for 2 hours and 30 minutes. 
After electrophoresis, gels were soaked in a fix solution (50% methanol 10% acetic acid) 
for 10 minutes, followed by 3% glycerol for 10 minutes before drying.  
2.2.10 Glycerol gradient sedimentation of whole cell splicing extract 
Extracts were prepared as described above; however, further clarification was 
achieved by centrifugation at 100,000 x g for 1 hour in a Beckman TLA 100.3 rotor. 
Protein concentration was determined by Bradford assay and 25 OD (A595) units were 
loaded on a 10-30% glycerol gradient. Gradients were centrifuged and fractions 
processed for northern blotting as described in Chapter 2.2.5.  
2.2.11 Native gel analysis 
Extracts were prepared as described above in Chapter 2.2.9, followed by dialysis 
in Buffer D (20% glycerol, 20 mM HEPES, pH 7.9, 50 mM KCl, 0.5 mM DTT, 1.5 mM 
MgCl2) twice for a total of 2 hours. Following dialysis, extracts were centrifuged at 
20,000 x g for 10 minutes at 4°C, then frozen in liquid nitrogen and stored at -80°C. 
Protein concentrations were determined by Bradford assay and samples normalized to 
load 50 !g. Separation of native snRNPs was performed on 0.5X TAE, 4% PAGE [80:1 
acrylamide:bisacrylamide] gels for at 250 volts for 4 hours at 4°C. RNAs were 
transferred to nylon membranes in 25 mM Na2PO4 and northern blotted with a 
oligonucleotide complementary to U6 snRNA (Combs et al. 2006). 
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2.2.12 Environmental stress conditions  
All cultures were grown in YP media with 2% dextrose. For stationary phase time 
course, cells were harvested at OD (A600) 0.3 for time 0, then at 24 and 48 hours. The heat 
shock time course was performed by shifting cells from 25˚C to pre-warmed media and 
growing at 37˚C for 20 minutes. For osmotic shock, cells were grown to OD (A600) 0.5 at 
31˚C then split and half shifted to YP media with 2% dextrose and 0.7 M NaCl. Both 
treated and non-treated cultures were returned to 31˚C for 45 minutes. All cells pellets 
were frozen in liquid nitrogen before proceeding with whole cell protein preparation and 
western blotting with chemifluorescence as described above. For a normalization control, 
an HRP-conjugated antibody against the endogenous H3 was utilized (Abcam, ab21054) 
at 1:5000 in BLOTTO. 
2.3 RESULTS 
2.3.1 Prp43p associates with G-patch proteins a mutually exclusive manner 
Since Prp43p might function to connect in two gene expression pathways, we 
hypothesized that Prp43p homeostasis may be orchestrated by its interactions with three 
G-patch proteins, Pfa1p, Ntr1p and Gno1p. Since two of the three are known to stimulate 
the activity of Prp43p, this model of recruitment and activation is attractive (Lebaron et 
al. 2009; Tanaka et al. 2007). However, this model would require that each G-patch 
protein bind Prp43p in the absence of the other two so as not to create conflicting 
intracellular signals. Previous evidence has indicated that Pfa1p interacts with Ntr1p by 
the two-hybrid assay (Pandit et al. 2009). We sought to determine if these two, or any 
two cofactors, exist together in the same complex with Prp43p. We constructed a set of 
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strains containing a GFP tag on Prp43p and a TAP tag on one of the G-patch proteins 
(Fig. 2.1A; Table 2.1). In the same strain, we introduced a MYC13 tag (Longtine et al. 
1998) into the locus of one of the other G-patch proteins, making a collection of six 
strains. The TAP tagged G-patch proteins were captured on IgG beads (Puig et al. 2001), 
and the presence of Prp43p or cofactors was determined by western blot. Ntr1p-TAP, 
Gno1p-TAP, and Pfa1p-TAP each copurified with Prp43p-GFP (Fig. 2.1B, C, and D lane 
3), but did not copurify with each other (Fig. 2.1 B, C, and D lanes 6 and 9). All 
antibodies and tags were specific in western blotting and immunoprecipitation (Fig. 
2.1E). Our data indicate that all three G-patch proteins interact with Prp43p in a mutually 
exclusive manner. 
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Figure 2.1 Each G-patch protein associates with Prp43p in a mutually exclusive manner. 
A). Graphical representation of the experimental design. B). Purification of material 
associated with Gno1p-TAP. C). Purification of material associated with Pfa1p-TAP. D). 
Purification of material associated with Ntr1p-TAP. In the top and middle panels of B-D, 
coimmunoprecipitated proteins were western blotted with !-GFP (Prp43p) and !-myc 
(other G-patch proteins), respectively. Bottom panels demonstrate efficiency of TAP 
immunoprecipitation. E). Demonstration of the specificity for immunoprecipitations and 
antibodies used in western blotting.  
IP; immunoprecipitation against the epitope tag noted; WB; Western blotting using the 
primary antibody named; IN, 1% input; FT, 1% unbound; B, 20% bound   
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2.3.2 Expression of G-patch proteins is independent of one another  
Since Prp43p associates with each cofactor independently, we reasoned that they 
compete for Prp43p occupancy. We note that of the three, only Ntr1p is essential and the 
loss of Gno1p results in slow growth (Guglielmi and Werner 2002; Boon et al. 2006). In 
contrast, overexpression of Pfa1p results in cell growth arrest (Pandit et al. 2009). We 
verified these growth phenotypes by placing each protein under a GAL1 promoter at the 
genomic locus of each gene (Fig. 2.2A). All proteins were depleted efficiently within 4 
hours of glucose repression as determined by western blotting for the N-terminal HA-tags 
(Fig. 2.2B). Additionally, we utilized plasmids containing C-terminally HA/ZZ tagged 
NTR1, GNO1 or PFA1 (Open Biosystems) to overexpress each protein. Overexpression 
from the ectopic loci resulted in exacerbated growth defects (Fig. 2.3A). Each ectopically 
expressed HA/ZZ protein was produced to qualitatively similar amounts (Fig. 2.3B) and 
was not expressed prior to galactose induction (Fig. 2.3C). The deleterious effect of 
Pfa1p overexpression from either the genomic or ectopic loci is not due to the N-terminal 
HA or C-terminal HA/ZZ tags. 
We attempted to rescue the growth defects caused by Pfa1p overexpression by 
simultaneously overexpressing Prp43p. If Prp43p were unable to interact with its other 
cofactors due to excess Pfa1p, then increasing the amount of Prp43p in the cell would 
bypass the defect. In a GAL::HA-PFA1 strain carrying a pGAL-PRP43-HA/ZZ construct, 
we simultaneously overexpressed HA-Pfa1p and Prp43p-HA/ZZ. However, serial 
dilutions demonstrated that excess Prp43p-HA/ZZ alone results in cell growth defects, 
and multiple suppressor colonies were evident (Fig. 2.4A). Analyses for aberrant pre-
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mRNA splicing and rRNA processing revealed no differences between wild-type and 
pGAL-PRP43-HA/ZZ (data not shown). Due to its lack of inherent substrate specificity, it 
is possible that overexpressed Prp43p is acting in an unregulated manner on off-pathway 
targets. Further investigation will be necessary to determine the molecular mechanism 
behind this phenotype. Whole cell RNAseq analysis may be useful in identifying which 
gene expression pathways are being targeted.  
Work from Henry and colleagues showed that the levels of Pfa1p are reduced in a 
gno1! strain (Lebaron et al. 2009). If overexpressed Pfa1p outcompetes Gno1p and 
Ntr1p for Prp43p binding, then reducing Pfa1p levels may alleviate the growth defects 
caused by the loss Ntr1p or Gno1p. We observed that pfa1! does not alleviate the growth 
defects or lethality caused by the depletion of Gno1p or Ntr1p, respectively (Fig. 2.4B). 
This is consistent with a model where Ntr1p is necessary to bring Prp43p into the 
spliceosome (Tsai et al. 2007).  
If the timing of RNA Pol I and Pol II processing is coordinated though Prp43p, 
cells might upregulate or downregulate these factors to influence Prp43p localization and 
function. To maintain homeostasis of Prp43p, the expression of the cofactors might be 
co-regulated. To determine if the G-patch proteins are co-regulated, we tested the 
expression level of one cofactor throughout time courses depleting the other two 
cofactors. We did not observe changes in the steady-state levels of Prp43p or its other 
partners during the depletion of any cofactor (Fig. 2.5). We were unable to repeat the 
previously published results in which a correlative relationship between Gno1p and Pfa1p 
was observed (Lebaron et al. 2009).  
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Figure 2.2 Validation of repression of G-patch proteins and their effects on cell growth.  
A). Serial dilutions of genomically-encoded GAL-regulated G-patch proteins controlled 
plated on rich and minimal media supplemented with either dextrose or galactose. Rich 
media plates were photographed after 3 days at 31°C, and SD-HIS plates were 
photographed after 6 days at 31°C. B). Western blot analysis over a time course for 
genomic GAL1-HA tagged Ntr1p (left top panel), Pfa1p (left bottom panel) and Gno1p 
strains (right panel). For each time course, levels of the tagged cofactor (top) and Prp43p-
GFP (bottom) are shown. Complete depletion of all cofactors is achieved within 6 hours. 
When analyzing total protein from yeast cells, the migration of the bands for Gno1p was 
consistently heterogeneous. We did not further investigate the nature of this 
heterogeneity.  
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Figure 2.3 Ectopic expression of G-patch protein constructs results in growth phenotypes 
similar to genomic overexpressions.  
 
A). Serial dilutions of PRP43-GFP strains carrying empty vector or vectors encoding the 
indicated C-terminally tagged HA/ZZ cofactors and plated on the indicated media at 
31˚C. Plates were photographed after 3 days. B). Western blot analysis of ectopically 
overexpressed GAL-driven cofactors at either 3 or 4.5 hours growth in 2% galactose and 
1% sucrose. For comparison, levels of the genomic TAP tagged versions of these strains 
for each G-patch protein are also shown. Western blotting against Rpl8p serves as a 
loading control. C). Western blot analysis of proteins from strains shown in (D) after shift 
to media supplemented with 2% galactose plus 1% sucrose demonstrates maximal 
overexpression within 3 hours (top panel). Western blot analysis of Prp43p-GFP is also 
shown (bottom panel) and indicates that total Prp43p-GFP levels do not change during 
the overexpression of any cofactor.   
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Figure 2.4 pfa1! does not alleviate the growth defects of Gno1p or Ntr1p depletion. 
A). Serial dilutions of strains overexpressing Prp43p-HA/ZZ reveal growth defects. The 
wild-type or the genomic HA-Pfa1p depletion strain with either an empty vector or the 
pGAL-PRP43-HA/ZZ vector was grown on S-URA media with 2% dextrose or 2% 
galactose. Plates were incubated at 31˚C for 4 days before photographing. B). Serial 
dilutions of HA-GNO1 or HA-NTR1 pfa1! can not rescue either the loss of Gno1p nor 
Ntr1p. Strains were grown in media supplemented with galactose and serial dilutions 
were plated on rich media containing either 2% galactose or 2% dextrose. Plates were 
incubated at 31°C for 3 days before photographing.  
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Figure 2.5 Expression of cofactors is not co-regulated. 
Western blot analysis for G-patch cofactor abundance during the metabolic 
depletion of HA-Gno1p (A), HA-Pfa1p (B), or HA-Ntr1p (C). In each, the top !-HA 
western blots demonstrate the depletion of each HA-tagged cofactor. Second and third 
panels of each show !-GFP (Prp43p) and !-myc (other G-patch proteins) western blots 
respectively. An !-Rpl8p western blot is shown as a loading control. Decreases in 
Prp43p-GFP, Pfa1p-myc, Gno1p-myc and Rpl8p signals in the GAL::HA-NTR1 strain are 
likely due to cell death that begins at approximately 6 hours after shift to non-permissive 
media (Boon et al. 2006).  
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2.3.3 Excess Pfa1p results in a early ribosome biogenesis defects  
If excess Pfa1p inhibits the function of Prp43p in ribosome biogenesis, then pre-
rRNA processing defects similar to prp43 ATPase mutants should be evident. Previous 
data have shown that the loss of Pfa1p does not cause rRNA processing defects, but its 
overexpression decreases the levels of all rRNA precursors (Pandit et al. 2009; Pertschy 
et al. 2009). To identify the steps at which ribosome biogenesis is being perturbed, we 
analyzed the steady state rRNA levels during a time-course overexpressing Pfa1p. 
Northern blot analysis for the pre-rRNAs revealed that within 1 hour of inducing Pfa1p 
overexpression, the 35S pre-rRNA rapidly increased and persisted (Fig. 2.6A). 
Remarkably, the aberrant 23S pre-rRNA species also slightly accumulated, indicating 
that cleavages at the A0, A1 and A2 sites are defective (Morrissey and Tollervey 1993). 
The levels of the 20S pre-rRNA decreased, consistent with the increases seen in the 35S 
and 23S species.  
By steady state northern analysis, there was little change in the levels of the 27S 
pre-rRNA. The accumulation of the 35S and 23S species, and the fact that 27S pre-rRNA 
levels did not change, distinguish our results from those previously published (Pandit et 
al. 2009, see below). The effect is not due to the GFP tag on Prp43p as the same rRNA 
processing effects are seen with untagged strains harboring the pGAL-PFA1-HA/ZZ 
vector (data not shown). Depletion of Pfa1p did not result in aberrant pre-rRNA 
processing, similar to previous studies (Pertschy et al. 2009; Fig. 2.6B). We note that the 
pre-rRNA defects caused by Pfa1p overexpression were alleviated as Pfa1p was depleted, 
indicating that this Pfa1p-mediated effect is reversible.  
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Figure 2.6 Early ribosome biogenesis defects during the overexpression of Pfa1p-HA/ZZ. 
A). Steady state levels of 35S pre-rRNA and 23S rRNA increase during Pfa1p-HA/ZZ 
overexpression. 10 !g of total RNA were separated though a formaldehyde agarose gel, 
and northern blot analysis was performed using the D-A2 and E-C2 oligonucleotides (see 
Table 2.2) for the indicated panels. The locations of these oligonucleotides within the 
35S, 23S, 20S, and 27S precursors are graphically represented and the canonical cleavage 
sites are indicated by triangles. sCR1 was used as an internal normalization control.  
B). The aberrant rRNA processing during overexpression of Pfa1p returned to normal as 
Pfa1p is depleted. Northern blot analysis conducted as in (A).   
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Figure 2.7 Overexpression of Pfa1p results in slowed kinetics of rRNA processing. 
 Pulse chase analysis of RNA from PRP43-GFP GAL::HA-PFA1 was performed 
after shift to media supplemented with 1% sucrose 2% galactose for 6 hours. Cultures 
were pulsed with [3H]-L-methyl-methionine and chased with cold methionine for the 
indicated times. The audioradiograph of the tritiated RNAs is shown with pre-rRNA and 
mature rRNAs indicated to the right.  
OE, overexpressed. 
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We further explored effect of Pfa1p overexpression on pre-rRNA processing by 
pulse chase analysis with 3H-L-methyl-methionine (Fig. 2.7). Under wild-type conditions, 
the 35S pre-rRNA was efficiently processed into 20S and 27S pre-rRNAs. These 
precursors were completely processed into the 25S and 18S within 5 minutes. In contrast, 
under conditions of Pfa1p overexpression, the accumulation of the 35S pre-rRNA 
observed by northern blot analysis was apparent, and the aberrant 23S pre-rRNA was also 
detected. Additionally, the processing of the 27S and 20S species was severely delayed 
with respect to wild-type, resulting in the production of very little mature rRNA within 
20 minutes. Therefore, we conclude that overexpression of Pfa1p prohibits an early step 
in ribosome biogenesis, resulting in the slowed kinetics of rRNA processing.  
2.3.4 Pfa1p overexpression abolishes Prp43p association with the 35S pre-rRNA 
Mutants of Prp43p are defective in early cleavage events of ribosome biogenesis, 
A0, A1, and A2 (Combs et al. 2006). Since an early rRNA processing defect was 
detected by pulse chase, we hypothesized that Pfa1p may be able to inhibit the targeting 
of Prp43p to the 35S pre-rRNA. We performed primer extensions analysis for the 35S 
pre-RNA using RNA isolated from Prp43p-GFP RNA immunoprecipitations under 
conditions in which Pfa1p was at normal or elevated levels. Under wild-type conditions, 
Prp43p-GFP associated with the 35S pre-rRNA; however, if the levels of Pfa1p were 
increased, this association was abolished (Fig. 2.8A). Western blot for Prp43p-GFP 
showed similar immunoprecipitation efficiency for both conditions (Fig. 2.8B). Prp43p is 
not able to address the 35S pre-rRNA transcript, resulting in its accumulation and the 
reduction of rRNA precursors, as seen by northern blot and pulse chase analyses. We also  
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Figure 2.8. Overexpression of Pfa1p can preclude Prp43p from associating with the 35S 
pre-rRNA.  
 
A). Primer extension analysis from Prp43p purified material for 35S pre-rRNA and U6 
snRNA. RNA was purified by Prp43p-GFP IP from extracts containing either empty 
vector or pGAL-PFA1-HA/ZZ after shift to media supplemented with galactose for 6 
hours. An untagged pGAL-PFA1-HA/ZZ strain (—, OE) served as a negative control for 
immunoprecipitation. The quantitation for the amount of 35S pre-rRNA present in the 
Prp43p-GFP purified material is shown below. Signals were quantitated and normalized 
to the negative control. 1% input; 50% bound. B). Western blot analysis of Prp43p-GFP 
demonstrating the efficiency of GFP immunoprecipitation. Prp43p-GFP was equally 
immunoprecipitated from extracts prepared under wild-type or Pfa1p-HA/ZZ 
overexpression conditions. 1% input; 20% bound.  
OE, overexpressed levels; WT, wild-type levels   
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noted that Prp43-GFP did not associate with the U6 snRNA when Pfa1p was 
overexpressed, which indicates a concomitant loss of association with its substrates in 
pre-mRNA splicing (see Chapter 2.3.7). 
2.3.5 Pfa1p overexpression impacts Prp43p/Gno1p association  
Due to the ribosome biogenesis defects and loss of association with the 35S pre-
rRNA, we investigated how Prp43p associations are affected in the presence of 
overexpressed Pfa1p. We hypothesized that Pfa1p affects early ribosome biogenesis by 
sequestering Prp43p from its potential cofactor, Gno1p. We performed 
coimmunoprecipitations against Prp43p-GFP and analyzed its association with Gno1p in 
the presence or absence of the overexpressed Pfa1p. Subsequent western blot analysis 
indicated that when Pfa1p was overexpressed the association between Prp43p and Gno1p 
was drastically reduced (Fig. 2.9, cf lanes 9 and 12). Therefore, we conclude that the 
increased levels of Pfa1p are able to compete with Gno1p for Prp43p association. The 
loss of Prp43p/Gno1p association is most likely the reason for the ribosome biogenesis 
defects observed. Indeed, the ribosome biogenesis defects observed during Pfa1p 
overexpression are similar to those reported for gno1!(Guglielmi and Werner 2002). In 
both instances, the 35S and 23S levels are increased and 20S levels are reduced.  
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Figure 2.9 Overexpression of Pfa1p reduces Prp43p/Gno1p association. 
Strains harboring either an empty vector (pRS316-GAL) or pGAL1-PFA1-HA/ZZ 
were shifted to media supplemented with 2% galactose and 1% sucrose for 6 hours, then 
Prp43p-GFP complexes were purified using !-GFP antibodies. Western blots in the top 
panels demonstrate Prp43p-GFP IP efficiency. Bottom panels demonstrate the 
overexpression of Pfa1p-HA/ZZ. Gno1p-TAP control was grown in 2% dextrose. 
Loading and notations are as in Figure 2.1.  
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2.3.6 Splicing defects are observed when Pfa1p is in excess but not when Pfa1p is 
absent 
To further understand the molecular mechanisms underlying the growth 
phenotype of overexpressed Pfa1p, we investigated its relationship to Prp43p and pre-
mRNA splicing. A pre-mRNA accumulation phenotype has previously been observed 
during the overexpression of Pfa1p (Pandit et al. 2009). We verified these results in our 
strains by primer extension analysis for the U3 pre-snoRNA during a time course of 
Pfa1p overexpression (Fig. 2.10A). Unpublished data from our lab suggested that Pfa1p 
might be a part of an uncharacterized pre-mRNA splicing subcomplex along with 
Prp43p. However, the loss of Pfa1p does not impact the association of Prp43p with the 
spliceosome nor its ability to mediate disassembly in an ATP-dependent manner (Fig. 
2.10B). In ATP-depleted extracts prepared from wild-type or pfa1! backgrounds, 
Prp43p-TAP associated with a 16S mono-U5 snRNP and U2/U6!U5 25S-40S particles. 
The addition of ATP to the Prp43p-TAP pfa1! extract still resulted in the disassembly of 
the U2/U6!U5 particle into the individual snRNPs, U2, U6, and U5. The U2 and U6 
signals peaked in fractions 10 and 4, respectively, with the addition of ATP. Therefore, 
we conclude that only the overexpression of Pfa1p results in aberrant splicing.  
We hypothesized that the pre-mRNA splicing defect might be due to a defect in 
spliceosome recycling, which could result in reduced snRNAs. To further investigate the 
pre-mRNA splicing defect observed in the Pfa1p overexpression time courses, we 
analyzed whole cell snRNA distribution (Fig. 2.11A & B). Splicing extracts from strains 
harboring pRS316-GAL or pGAL-PFA1-HA/ZZ vectors were prepared after growth for 6  
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Figure 2.10 Loss of Pfa1p does not affect spliceosome disassembly.  
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(Figure 2.10 contd.)  
A). Overexpression of Pfa1p results in a first-step pre-mRNA splicing defect. PRP43-
GFP strains harboring an empty vector or pGAL-PFA1-HA/ZZ were shifted to media 
supplemented with 2% galactose plus 1% sucrose. RNAs were extracted at the indicated 
time points and subjected to primer extension analysis for pre-U3 snoRNA, U3 snoRNA 
or U1 snRNA. B). Prp43p-TAP associates with the spliceosome and mediates 
disassembly in the absence of Pfa1p. Spliceosomal particles were purified from extracts 
after Prp43p-TAP immunoprecipitation, then separated on a 10-30% glycerol gradient. 
Northern blot analysis for U2, U5 and U6 snRNAs showed Prp43p-TAP associated with 
both 16S U5 and U2/U6!U5 particles in either ATP-depleted wild-type (top) or pfa1! 
(middle) extracts. Incubating with ATP allowed the purified U2/U6!U5 snRNP to be 
disassociated by Prp43p-TAP even in the absence of Pfa1p (bottom). 
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hours in media supplemented with galactose. Separation of the whole cell extracts 
through 10-30% glycerol gradients revealed aberrant distribution of the U4 and U6 
snRNAs in spliceosomal particles with Pfa1p-HA/ZZ overexpression. Most striking was 
the increase in U4 snRNA sedimenting higher in the gradient (fractions 10-12 versus 16-
18) in the presence of excess Pfa1p (Fig. 2.11C, top). While the levels of U4 or U6 
snRNAs were not affected, the overall levels of U5 snRNA were reduced by 44%. These 
characteristics have also been observed when the G-patch protein Ntr1p is depleted 
(Boon et al. 2006).  
We hypothesized these shifts in U4 and U6 sedimentation reflected changes in the 
U4/U6 and U4/U6•U5 snRNP levels under Pfa1p overexpression conditions. We 
separated snRNP complexes on a native gel and visualized tri-snRNP and di-snRNP 
complexes by Northern blotting for the U6 snRNA. Consistent with the glycerol gradient 
analysis, upon overexpression of Pfa1p, we observed a stark decrease in U4/U6•U5 levels 
and a concomitant marked increase in U4/U6 snRNP (Fig. 2.12A). In the presence of 
excess Pfa1p, U4/U6 snRNP levels were 16X that of wild-type and tri-snRNP levels were 
decreased to 25% that of wild-type (Fig. 2.12B). We conclude that the pre-mRNA 
splicing defect observed during Pfa1p overexpression conditions is due to the loss of tri-
snRNP. Previous results indicated that the U5 snRNP was determined to the limiting 
factor in tri-snRNP formation when Ntr1p was depleted (Boon et al. 2006). Similarly, the 
limiting factor in tri-snRNP formation during the overexpression of Pfa1p also appears to 
be the U5 snRNP. 
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Figure 2.11 Distributions of snRNAs are disrupted in Pfa1p overexpression conditions. 
A-B). Splicing extracts were prepared from strains harboring either the empty vector 
pRS316-GAL (A) or pGAL-PFA1-HA/ZZ (B) after growth in media supplemented with 
galactose for 6 hours. Whole cell splicing extracts were centrifuged though a 10-30% 
glycerol gradient for 16 hours at 90,500 x g. RNAs were extracted from alternate 
fractions and analyzed by Northern blotting for U1, U2, U4, U5, and U6 snRNAs, as 
indicated to the left. The two isoforms of U5 snRNA in S. cerevisiae, U5L and U5S, are 
noted. Equal amounts of total RNA prepared from each extract demonstrate the presence 
of all snRNAs in both extracts. C). Quantitation of the U4 (top) snRNA indicated an 
increased amount of free U4 snRNP in fraction 10 in the presence of excess Pfa1p.  
Additionally, a loss of U6 snRNA was observed in fractions 16 and 18 compared to the 
wild-type. SnRNA levels were normalized to total signal over the entire gradient.  
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Figure 2.12 Excess Pfa1p results in decreased tri-snRNP levels.  
A). Representative gel of the U4/U6 defects observed when Pfa1p is overexpressed 
unbalanced. Splicing extracts were prepared from strains after shift to media containing 
galactose for 6 hours, and 50 !g of total protein were separated on a 4% [80:1] 
acrylamide native gel followed by northern blot analysis for the U6 snRNA.  
B). Quantitation for the increase in U4/U6 and decrease in U4/U6•U5 as seen in (A). U6 
snRNA signals were normalized to the pRS316-GAL control. The dashed black line 
represents the wild-type baseline.  
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2.3.7 Overexpression of Pfa1p precludes Prp43p association with Ntr1p 
Since the overexpression of Pfa1p resulted in pre-mRNA splicing and snRNP 
defects, we hypothesized that excess Pfa1p affects the association between Prp43p and its 
spliceosomal cofactor, Ntr1p, in a manner similar to Gno1p (Fig. 2.9). We analyzed the 
association of Prp43p-GFP with Ntr1p in the presence of overexpressed Pfa1p by 
coimmunoprecipitation. Subsequent Western blot analysis indicated that when Pfa1p was 
overexpressed the association between Prp43p and Ntr1p was drastically reduced (Fig. 
2.13, cf. lanes 15 and 21). Therefore, we conclude that the increased levels of Pfa1p are 
able to outcompete Ntr1p for association with Prp43p, in a manner similar to Gno1p. The 
loss of Prp43p/Ntr1p association is most likely the reason for the snRNP assembly 
defects and downstream pre-mRNA accumulation. Therefore, Pfa1p has the ability to 
sequester Prp43p away from the other two G-patch proteins with which it associates. 
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Figure 2.13 Prp43p loses association with Ntr1p when Pfa1p is in excess.  
Coimmunoprecipitations followed by serial Western blotting for the indicated 
tags was completed using extracts from strains either an empty vector (pRS316-GAL) or 
pGAL1-PFA1-HA/ZZ shifted to media supplemented with 2% galactose and 1% sucrose 
for 6 hours. Western blots in the top panels demonstrate Prp43p-GFP IP efficiency. 
Bottom panels demonstrate the overexpression of Pfa1p-HA/ZZ. Control strains Prp43p-
GFP and Ntr1p-myc were grown in 2% dextrose, while the pGAL-PFA1-HA/ZZ only 
control was grown in 2% galactose 1% sucrose. Loading and notations as in Figure 2.1.  
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2.3.8 PFA1 is predicted to connect to ribosome biogenesis or pre-mRNA splicing 
solely via PRP43 
We hypothesized that if Pfa1p has the ability to preclude Prp43p from pre-mRNA 
and pre-rRNA processing pathways, it is likely to be regulated differently than either 
Gno1p or Ntr1p. Perhaps in response to environmental stresses, Pfa1p levels are adjusted 
to halt or pause both of the RNA processing pathways in which Prp43p is involved. 
Using the YeastNet 2.0 database (Lee et al. 2007), we calculated the probability of bona 
fide linkages between genes related to the G-patch proteins. YeastNet 2.0 uses parameters 
such as, but not limited to, co-expression microarray data, mass spectrometry data, and 
yeast two-hybrid interactions to calculate an overall score for each predicted interaction.  
The log-likelihood scores for the interactions of GNO1, PFA1, and NTR1 were 
used to generate a predicted network prepared in Cytoscape (Shannon et al. 2003). Our 
network indicates that GNO1 and NTR1 lie in rRNA processing and pre-mRNA splicing 
clusters, respectively (Fig. 2.14). Node size is dependent upon the score, with more 
significant scores being larger. The cluster surrounding GNO1 contains both large and 
small ribosomal subunit biogenesis factors, including many 90S processing factors, such 
as Mpp10 and multiple UTPs (Dragon et al. 2002). The pre-mRNA splicing and 
ribosome biogenesis clusters are connected by two nodes, PRP43 and CWC22. CWC22 is 
an essential pre-mRNA splicing factor, and its presence is required for the ATP-
dependent function of Prp2p (Yeh et al. 2011) and the removal of the SF3a/b complexes 
prior to the first step of splicing (Lardelli et al. 2010). The edge linking CWC22 to GNO1 
is based on the relatively poorly correlated co-citation score, while the link to NTR1 was   
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Figure 2.14 The regulatory network connections predicted for PFA1 lie outside the pre-
mRNA splicing and ribosome biogenesis clusters.  
 
A predicted network of GNO1, PFA1, and NTR1 was assembled from the YeastNet 2.0 
database. NTR1 and GNO1 lie in pre-mRNA or pre-rRNA processing clusters, 
respectively, while PFA1 is connected to these processes only through PRP43. Pre-
mRNA processing (red nodes) and rRNA processing (blue nodes) are linked to each other 
by PRP43 (purple), is involved in both processes. Light blue nodes are either 
uncharacterized genes or genes not known to contribute to either pathway.   
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determined by mass spectrometry. Strikingly, PFA1 is connected only to ribosome 
biogenesis and pre-mRNA splicing via PRP43, indicating that it is likely to be regulated 
differently than other ribosome biogenesis factors. 
2.3.9 Whole cell Pfa1p levels do not increase in response to environmental stress 
despite increases in mRNA levels  
Systematic microarray experiments suggest that PFA1 transcripts, but not GNO1 
or NTR1 transcripts are significantly increased (!50%) in response to hyper-osmotic 
shock with NaCl treatment (Berry and Gasch 2008). PFA1 transcript levels also rise 
during heat shock at 37°C and during the first two days of stationary phase growth 
(Gasch et al. 2000). Other data sets indicate that PFA1 transcript levels are increased in 
response to ammonium, phosphate, or amino acid starvation (Gasch et al. 2000; Brauer et 
al. 2008). Together, these data suggest that Pfa1p levels increase in response to 
environmental stress in a differential manner from Ntr1p or Gno1p. However, despite 
these transcriptional differences, we found that whole cell protein levels of Pfa1p did not 
significantly change during hyper-osmotic shock, stationary phase growth or heat shock 
(Figure 2.15) We noted that under heat shock a consistent shift in the molecular weight of 
Pfa1-myc was evident, though it has yet to be determined whether this represents a bona 
fide post-translational modification or if such a modification is biologically relevant. It is 
also possible that the presence of increased levels of Pfa1p mRNA serves as a buffer to 
ensure that levels of Pfa1p remain high to enforce Prp43p association. Therefore, how the 
transcriptional changes described above manifest in functional differences is still 
unknown.  
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Figure 2.15 Pfa1p-myc levels do not change in response to stress. 
A). Whole-cell Pfa1p-myc levels do not increase following hyper-osmotic shock with 0.7 
M NaCl for 45 minutes. MYC signals from five biological duplicates were visualized and 
quantitated by western blotting followed by chemifluorescence. All signals were 
normalized to an H3 loading control, and fold change from time 0 was calculated. B). 
Whole-cell Pfa1p-myc levels do not increase during stationary phase. Time courses 
beginning at OD (A600) 0.3 were conducted over 2 days allowing cultures to reach 
saturation. Time points at 24 and 48 hours were analyzed for total Pfa1p-myc levels as in 
(A). C). Cells undergoing heat shock do not upregulate the level of Pfa1p-myc. After 
shifting from 25˚C to 37˚C for 20 minutes, whole cell protein was isolated from five 
biological replicates (rep 1-5), and Pfa1p-myc levels were visualized and quantitated by 
western blotting followed by chemifluorescence. Though Pfa1p-myc levels did not 
increase, we did observe a consistent shift in molecular weight at 37˚C, perhaps 
suggesting some large post-translational during heat shock. Quantitation of Pfa1-myc 
signals by chemifluorescence is graphed to the right. Signals normalized as in (B).  
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2.4 DISCUSSION 
Due to the multifunctional nature of Prp43p and the spatial separation between the 
two processes in which it functions, we set out to understand how Prp43p maintains 
proper distribution between pre-mRNA splicing and ribosome biogenesis, as well as how 
Prp43p may help to coordinately regulate both of these processes. Our work supports a 
working model for Prp43p in which its substrate specificity, activation, and cellular 
distribution is coordinated through the efforts of the three G-patch proteins, Gno1p, 
Ntr1p, and Pfa1p. We demonstrate that the G-patch proteins interact with Prp43p in 
mutually exclusive complexes, which would enforce substrate specificity and/or correct 
spatiotemporal activation of Prp43p in the proper pathway (Fig. 2.1). Additionally, 
despite previously published yeast two-hybrid data for Pfa1p and Ntr1p (Pandit et al. 
2009), we find that none of the cofactors stably associate with one another.  
Others have suggested that a competition exists between Pfa1p and the other G-
patch proteins for Prp43p interaction (Pandit et al. 2009). Here we show that excess 
Pfa1p inhibits both pre-mRNA splicing and ribosome biogenesis pathways directly by 
outcompeting both Gno1p and Ntr1p for Prp43p binding (Figs. 2.9 & 2.13, respectively). 
The depletion of Ntr1p affects the regeneration of snRNPs, particularly the U5 snRNP, so 
that a reduction in the U4/U6•U5 tri-snRNPs and a subsequent accumulation of pre-
mRNA are observed (Boon et al. 2006; see Chapter 3.2). We relate these phenotypes to 
the interaction of Prp43p with Ntr1p. Under Pfa1p overexpression conditions in which 
Prp43p does not interact with Ntr1p, a similar snRNP recycling defect is present (Figs. 
2.11 & 2.12), consistent with the resulting pre-mRNA accumulation (Pandit et al. 2009,   
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Illustration 2.1 pre-mRNA splicing defects are an indirect effect of excess Pfa1p. 
Under normal conditions Ntr1p association with Prp43p allows for the 
dissociation of the post-splicing lariat RNP. This allows for the recycling of the snRNPs 
so that the U5 snRNP rejoins the U4/U6 di-snRNP to make U4/U6•U5 tri-snRNP. In the 
case of Ntr1p depletion, the cellular levels of U5 snRNP decrease (Boon et al.2006), 
resulting in less U4/U6•U5 since the U5 snRNP is the limiting reagent. Similarly, if 
cellular Pfa1p levels increase, the Ntr1p/Prp43p interaction is lost so that U5 is not 
properly recycled, indirectly resulting in a halt in pre-mRNA splicing.  
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Fig. 2.10, Illustration 2.1). The ribosome biogenesis defects observed under Pfa1p 
overexpression conditions are unlikely to solely be indirect effects of defective pre-
mRNA splicing, because Prp43p/35S and Prp43p/Gno1p pre-rRNA associations are 
abrogated (Figs. 2.8 & 2.9). We show that Pfa1p has the ability to titrate Prp43p away 
from its other two cofactors and, thus, their respective RNA processing pathways. 
Therefore, maintaining the proper balance of G-patch proteins is essential for the proper 
cellular distribution and function of Prp43p.  
In situations where cellular stresses are encountered, the modulation of Pfa1p 
abundance seen by microarray experiments (Gasch et al. 2000; Brauer et al. 2008; Berry 
and Gasch 2008) may be the means by which cells are able to disconnect Prp43p from 
both ribosome biogenesis and pre-mRNA splicing, effectively reversibly stalling both 
processes. However, we were unable to relate the reported increases in PFA1 mRNAs to 
the whole cell protein levels of Pfa1p during hyper-osmotic shock, stationary phase 
growth or heat shock (Fig. 2.15). Perhaps some other level of regulatory mechanism 
contributes to the ability of Pfa1p to pause gene expression, such as its post-translational 
modification (Fig. 2.15C). Therefore, it is not yet known how the transcriptional changes 
previously reported manifest in functional differences in response to environmental 
stresses.  
The unique role for Pfa1p in regulating Prp43p is supported by the fact that its 
binding interface with Prp43p is not dependent on its G-patch domain (Pandit et al. 2009; 
Lebaron et al. 2009) unlike that of Ntr1p (Tanaka et al. 2007) or Spp2p in the case of 
Prp2p (Silverman et al. 2004). While other examples of multiple cofactors regulating a 
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single DExH/D-box helicase are not known, two DEAD-box helicases, Dbp5p and 
Ded1p are regulated by a single factor, Gle1p. Like the Prp43p/Ntr1p and Pfa1p 
interfaces, there is some commonality to the Gle1/Dbp5 or Ded1p binding surfaces, but 
genetic data suggest partially distinct regions on Gle1p as well (Bolger and Wente 2011). 
It is yet to be determined whether Ntr1p or Gno1p has exclusive binding surfaces on 
Prp43p; however, considering the extensive contacts that Pfa1p makes with Prp43p, 
surfaces exclusively binding only one G-patch protein may be unlikely (Walbott et al. 
2010). Also, if each G-patch protein can modulate Prp43p activity, then it might be 
expected for all of them to interact with the helicase core or putative regulatory 5’ hairpin 
in the RecA2 domain of Prp43p (He et al. 2010). In contrast to Ntr1p and Pfa1p, which 
both can activate Prp43p, Gle1p functions as an activator with Dbp5p in mRNA export 
and an inhibitor of Ded1p dependent start site scanning of mRNAs for translation 
initiation. Its specificity as an activator or inhibitor is thought to be determined by unique 
interactions with factors that function at the particular step of gene expression. For 
example, Gle1p docks to specific sites in the nuclear pore (e.g. Nup42p) during Dbp5p-
mediated mRNA export and with eIF3 during Ded1p-mediated translation initiation 
(Bolger and Wente 2011). Both cases demonstrate opposite aspects of how helicase 
activity can be spatially regulated for a particular step in gene expression. Also, while 
cofactors of Prp43p contain G-patch domains, Gle1p does not.  
As more factors that impact the activities of DExH/D-box helicases are 
characterized, we anticipate further examples of helicase regulation will be uncovered, 
particularly in higher metazoans. Already, TFIP11 has been demonstrated to be the 
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functional homolog of Ntr1p (Yoshimoto et al. 2009), and the G-patch containing factor 
GPKOW influences hPrp2p and hPrp16p activity (Hegele et al. 2012). It will be 
interesting to determine if other G-patch containing proteins in metazoans are also 
involved in regulating the activity of a helicase by stimulation and/or recruitment. 
Therefore, our understanding of how G-patch proteins govern the substrate specificity, 
activation, and cellular distribution of Prp43p in yeast will shed light on mechanisms of 
general DExH/D helicase function and regulation. 
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Chapter 3: Ntr1p and Gno1p regulation of Prp43p 
3.1 BACKGROUND 
Prp43p interacts with three cofactors, Pfa1p, Gno1p and Ntr1p, all of which 
contain a G-patch domain (Lebaron et al. 2005). Pfa1p is nonessential, and loss of Pfa1p 
does not impact cell growth under normal conditions (Pertschy et al. 2009). In contrast, 
Ntr1p is essential, and cell growth halts after 9 hours of Ntr1p depletion (Fig. 2.2; data 
not shown). Also, the loss of Gno1p results in severely slowed growth (Fig. 2.2; 
Guglielmi and Werner 2002). Unlike Pfa1p, the G-patch domains of Ntr1p and Gno1p 
are both required for proper cell growth (Pandit et al. 2009). Single point mutations in the 
G-patch domains of either Ntr1p or Gno1p lead to growth defects that phenocopy strains 
in which they are depleted or deleted, respectively (Tanaka et al. 2007; Guglielmi and 
Werner 2002). We further investigated the balance of Prp43p between ribosome 
biogenesis and pre-mRNA splicing in the context of Ntr1p and Gno1p to construct a 
complete network for Prp43p regulation.  
3.1.1 Ntr1p  
Ntr1p (Nineteen complex Related) was first determined to be loosely associated 
with Prp19p, a component of the NTC (Tsai et al. 2005; see 1. 2.4). Ntr1p forms a dimer 
with its partner Ntr2p, and both proteins are necessary for the release of the lariat intron 
after pre-mRNA splicing. However, neither plays a direct a role in the pre-mRNA 
splicing reaction. These two factors join with Prp43p to form the trimeric NTR complex. 
However, while Ntr1p and Ntr2p are always found as partners, the majority of Prp43p is 
not found as a part of this complex. Ntr1p mediates the formation of the NTR complex by 
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interacting with Prp43p via its G-patch domain and interacting with Ntr2p via a central 
domain. No direct interaction between Prp43p and Ntr2p is evident (Tsai et al. 2005). 
The NTR complex associates with the spliceosome in an ATP-independent manner via an 
Ntr2p-dependent interaction with the U5 snRNP (Tsai et al. 2007). Once associated, the 
NTR complex disassembles the post-splicing lariat RNP and releases the individual U2, 
U5, and U6 snRNPs (Tsai et al. 2005; Fourmann et al. 2013). 
A single mutation in the G-patch domain of Ntr1p (L68A, L69A or L80A) is 
sufficient for its loss of association with Prp43p, and, therefore, the helicase activity of 
Prp43p can not be stimulated. Surprisingly, ntr1L68A is not deficient for growth at 30˚C, 
but is temperature sensitive. However, ntr1L68A is synthetically lethal in combination 
with prp43Y402A. Both K398A and Y402A mutations, which lie in the !-hairpin of 
Prp43p, cause temperature sensitivity in Prp43p (Tanaka et al. 2007; He et al. 2010; 
Walbott et al. 2010). The prp43Y402Ap mutant loses interaction with wild-type Ntr1p in 
vitro, demonstrating that a direct interaction surface lies between Prp43p and Ntr1p lies 
near the !-hairpin. Moreover, in the presence of wild-type Ntr1p, the Y402A mutant is 
only partially able to release the lariat intron from post-spliceosomal complexes. The 
L68A mutation in Ntr1p renders it completely unable to work with the Y402A Prp43p 
mutant to disassociate the lariat intron (Tanaka et al. 2007). 
A truncation in the CTD of Prp43p (aa 722-767) is also synthetically lethal with 
ntr1L68A, and alanine mutations in the three amino acids 717WLI719 are sufficient for this 
phenotype. Simultaneous mutation of Prp43p at Y402 and deletion of the C-terminal 35 
amino acids also results in synthetic sickness. Together these data suggest that Ntr1p 
  108 
redundantly interacts with Prp43p at Y402A in the tip of the !-hairpin and also within its 
CTD (Tanaka et al. 2007; He et al. 2010; Walbott et al. 2010).  
A mutation in the conserved threonine of motif I in Prp43p (T123A) results in a 
dominant negative mutant that retains the ability to bind the spliceosome but is ATPase 
deficient and unable to unwind the intron lariat from post-splicing lariat RNP (Martin et 
al. 2002; Tanaka and Schwer 2006). Paradoxically, if residues 684IRK650 or 717WLI719 in the 
CTD of Prp43p are replaced with alanines in the T123A mutant, the dominant negative 
phenotype can be relieved (Tanaka et al. 2007). Considering the OB-fold of the CTD is 
important for RNA binding (Walbott et al. 2010), the dominant lethality caused by the 
T123A mutation is most likely relieved because the mutant protein does not bind its RNA 
substrates. Additionally, since Prp43p also serves a purpose in ribosome biogenesis 
(Combs et al. 2006; Lebaron et al. 2005; Leeds et al. 2006), these mutations would be 
expected to relieve the effect of the T123A mutation in that pathway as well.  
3.1.2 Gno1p  
Gno1p is one of the three G-patch proteins that was shown to copurify with 
Prp43p (Lebaron et al. 2005). The G-patch domain of Gno1p is contained between amino 
acids 25-70 of its N-terminus, and contains 6 glycines that are conserved with its human 
homolog, PinX1. Additionally, Gno1p contains KK(E/D) repeats in its C-terminus, which 
are common in other rRNA processing factors. A deletion of Gno1p renders cells slow 
growing, and loss of the G-patch domain is sufficient for this slow growth phenotype. 
Moreover, a single point mutant in a conserved tryptophan of the G-patch domain 
(W38S) produces a slow growth phenotype comparable to the null mutant. It does not 
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appear that the KK(D/E) repeats play as an important role since truncation of Gno1p 
results in a milder growth defect (Guglielmi and Werner 2002). 
The first indication that Gno1p plays a role in ribosome biogenesis was its 
localization to the nucleolus. When cells are deficient in Gno1p, the steady state levels of 
the 35S pre-rRNA increase and an aberrant 23S rRNA species accumulates. These results 
are indicative of impaired A0, A1, and A2 cleavage events (Morrissey and Tollervey 
1993), which are the same cleavage events that prp43 ATPase mutants affect (Combs et 
al. 2006; Lebaron et al. 2005; Leeds et al. 2006). Specifically, the 27S A2/A3 cleavage 
ratio is decreased indicating that the loss of Gno1p affects the A2 cleavage site and 
therefore the upstream sites are affected. The KK(D/E) repeats are not needed for the 
rRNA maturation step, but were shown to be important for the proper trimming of the 3' 
end of the U18 snoRNA. In contrast, the G-patch domain was shown to be necessary for 
both the trimming of U18 and rRNA maturation (Guglielmi and Werner 2002).  
Though the human homolog of Gno1p, PinX1p, has been shown to play a role in 
repressing telomerase activity and maintaining telomere length (Zhou and Lu 2001; see 
5.2), Gno1p does not appear to have this function in yeast. The sequence responsible for 
the telomerase function in humans maps to the C-terminus of PinX1p, which is divergent 
from the yeast homolog. In contrast to humans, gno1! results in a mild shortening of 
telomeres. The G-patch domain appears to be responsible for this phenotype since a 
single mutation, W38S, cannot rescue the phenotype in a gno1! strain. It is speculated 
that the shortened telomeres are actually an indirect effect of slow growth caused by 
gno1! (Guglielmi and Werner 2002). The phenotype has also been observed in DAmP 
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(Decreased Abundance by mRNA Perturbation) alleles of many other nucleolar genes, 
such as POP1 a component of RNase MRP, exhibit shortened telomeres. Surprisingly, 
telomeres are also shortened in the DAmP alleles of PRP22, PRP43, and NTR2 (Ungar et 
al. 2009). However, a mechanistic understanding of the connections between 
spliceosome disassembly or ribosome biogenesis with telomere maintenance in yeast has 
yet to be elucidated.  
Gno1p interacts with Prp43p by yeast two hybrid (Lebaron et al. 2005); and 
unpublished results indicate that Gno1p can directly interact with Prp43p in vitro 
(unpublished, Y. Henry, personal communication). Gno1p sediments with 90S pre-
ribosomal particles in sucrose gradients, though it has not been shown to directly 
associate with the 35S rRNA. Its localization to the nucleolus and the effects on A0, A1 
and A2 cleavage in gno1! implicate its presence there. The rRNA processing defects are 
not due to a reduction in the steady state levels of Prp43p in the absence of Gno1p 
(Lebaron et al. 2009). However, interestingly, Gno1p appears to be connected to Pfa1p. 
A previous report showed that Pfa1p is truncated and its levels are depleted in a gno1! 
strain. In contrast, Gno1p levels are not affected in a pfa1! strain. The steady state levels 
of other 40S pre-ribosomal components are not affected, so this effect is specific to Pfa1p 
and not due to downstream destabilization of pre-40S particles (Lebaron et al. 2009). Our 
attempt to investigate the co-regulation of the three G-patch protein factors, however, 
indicated that there is no change in their steady state levels in response to the depletion of 
another cofactor (Fig. 2.5). Additionally, it was reported that there is an increase in the 
steady state levels of the 40S component Ltv1p in a gno1! strain. The upregulated Ltv1p 
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resulted in an increased in Ltv1p/20S pre-rRNA association. Moreover, the truncated 
version of Pfa1-TAP in this gno1! strain does not interact with Prp43p or the 20S pre-
rRNA. It is possible that in the gno1! strain, the truncated Pfa1p, which does not 
associate with 20S or Prp43p, results in the stalling of Ltv1p on pre-40S particles 
(Lebaron et al. 2009). This interpretation is consistent with the genetic interaction 
between LTV1 and PFA1 (Pertschy et al. 2009; see Chapter 2.1.1).  
3.2 MATERIALS AND METHODS 
3.2.1 Yeast strains and plasmids  
A full listing of yeast strains used in Chapter 3 are listed in Table 3.1. GNO1-
13MYC-TRP1 was amplified from strain SS3160 (Table 4.2) from genomic DNA and 
cloned into pRS316. Mutagenesis of GNO1 was performed using oligonucleotides 
containing the W38S mutation (Ho et al. 1989; Quikchange, Agilent Technologies), and 
the mutation was verified by DNA sequencing. Oligonucleotides for Gno1p cloning and 
tagging of proteins are listed in Table 3.2. Plasmid transformation of yeast was performed 
as previously described (Gietz and Woods 2002). 
3.2.2 Primer extension analysis of RNA  
Primer extension analysis was performed on U3 as described as previously 
described (Stevens and Abelson 2002), with the modifications outlined in Chapter 2.2.8. 
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Table 3.1 Yeast strains used in Chapter 3  
Strain Relevant Gene(s) Genotype Source/Reference 
SRY 
328 
prp2-1 isogenic 
wild-type strain 
MAT ! ade2-101, his3-d300, lys2-
801, ura3-52 
(Ruby et al. 1993)  
599 PRP43-GFP MAT! his3"1, leu2"0, met15"0, 
trp1"63, ura3"0, PRP43-
GFP::KANMX 
(Combs et al. 
2006) 
3043 prp2-1 MAT ! prp2-1, ade2-1, his3-352, 
trp1-289 ura3-52 
(Ruby et al. 1993)  
3072 GNO1-TAP MAT a his3?1, leu2?0, met15?0, 
ura3?0, GNO1-TAP::HIS3 
(Howson et al. 
2005) 
3099 PFA1-myc MAT a his3#1, leu2#0, met15#0, 
ura3#0, PFA1-13myc::URA3 
This study 
3103 NTR1-myc MAT a his3#1, leu2#0, met15#0, 
ura3#0, NTR1-13myc::URA3 
This study 
3107 GNO1-myc MAT a his3#1, leu2#0, met15#0, 
ura3#0, GNO1-13myc::URA3 
This study 
3129 pRS316-GAL MAT! his3"1, leu2"0, met15"0, 
trp1"63, ura3"0, PRP43-
GFP::KANMX, pRS316-GAL 
This study 
3130 !!"#$!%&'$(")**+
PRP43-GFP  
MAT! his3"1, leu2"0, met15"0, 
trp1"63, ura3"0, PRP43-
GFP::KANMX, pGAL-GNO1-
HA/ZZ-URA 
This study 
3132 !!"#$%,-'$(")**+
PRP43-GFP  
MAT! his3"1, leu2"0, met15"0, 
trp1"63, ura3"0, PRP43-
GFP::KANMX, pGAL-NTR1-
HA/ZZ-URA 
This study 
3139 pRS316-GAL 
PRP43-GFP NTR1-
myc 
MAT! his3"1, leu2"0, met15"0, 
trp1"63, ura3"0, PRP43-
GFP::KANMX, NTR1-
13myc::TRP1, pRS316-GAL 
This study 
3140 !!"#$!%&'$(")**+
PRP43-GFP NTR1-
myc 
MAT! his3"1, leu2"0, met15"0, 
trp1"63, ura3"0, PRP43-
GFP::KANMX, NTR1-
13myc::TRP1, pGAL-GNO1-
HA/ZZ-URA 
This study 
  113 
Strain Relevant Gene(s) Genotype Source/Reference 
3141 pGAL-GNO1-
HA/ZZ  
PRP43-GFP  
PFA1-myc 
MAT! his3"1, leu2"0, met15"0, 
trp1"63, ura3"0, PRP43-
GFP::KANMX, PFA1-
13myc::TRP1, pGAL-GNO1-HA/ZZ 
This study 
3142 pRS316-GAL 
PRP43-GFP 
PFA1-myc 
MAT! his3"1, leu2"0, met15"0, 
trp1"63, ura3"0, PRP43-
GFP::KANMX, PFA1-
13myc::TRP1, pRS316-GAL 
This study 
3143 pGAL-NTR1-
HA/ZZ  
PRP43-GFP  
PFA1-myc 
MAT! his3"1, leu2"0, met15"0, 
trp1"63, ura3"0, PRP43-
GFP::KANMX, PFA1-
13myc::TRP1, pGAL-NTR1-HA/ZZ 
This study 
3144 GAL::HA-NTR1 
PRP43-GFP 
MAT! his3"1 ,leu2"0, met15"0, 
trp1"63, ura3"0, HIS3:: GAL::HA-
NTR1, PRP43-GFP::KANMX 
This study 
3145 GAL::HA-GNO1 
PRP43-GFP 
MAT! his3"1 ,leu2"0, met15"0, 
trp1"63, ura3"0, HIS3::GAL::HA-
GNO1, PRP43-GFP::KANMX 
This study 
3157 pRS316-GAL 
PRP43-GFP 
GNO1-TAP 
MAT a his3"1, leu2"0, met15"0, 
ura3"0, GNO1-TAP::HIS3, PRP43-
GFP::KANMX, pRS316-GAL 
This study 
3158 pGAL-NTR1-
HA/ZZPRP43-GFP 
GNO1-TAP 
MAT a his3"1, leu2"0, met15"0, 
ura3"0, GNO1-TAP::HIS3, PRP43-
GFP::KANMX, pGAL-NTR1-HA/ZZ  
This study 
3169 pRS411 
PRP43-GFP 
MAT! his3"1, leu2"0, met15"0, 
trp1"63, ura3"0, PRP43-
GFP::KANMX, pRS411 
This study 
3180 pRS411  
PRP43-GFP 
GAL::HA-NTR1 
MAT! his3"1, leu2"0, met15"0, 
trp1"63, ura3"0, PRP43-
GFP::KANMX, HIS3:: GAL::HA-
NTR1, pRS411 
This study 
3211 GAL::HA-GNO1 
PRP43-GFP 
pRS416-GNO1-
myc 
MAT! his3"1, leu2"0, met15"0, 
trp1"63, ura3"0, PRP43-
GFP::KANMX, HIS3::GAL::HA-
GNO1, pRS416-GNO1-myc 
This study 
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Strain Relevant Gene(s) Genotype Source/Reference 
3212 GAL::HA-GNO1 
PRP43-GFP 
pRS416-gno1 
W38S-myc 
MAT! his3"1, leu2"0, met15"0, 
trp1"63, ura3"0, PRP43-
GFP::KANMX, HIS3::GAL::HA-
GNO1, pRS416-gno1W38S-myc 
This study 
3213 pGAL-GNO1-
HA/ZZ 
MAT a his3#1, leu2#0, met15#0, 
ura3#0, pGAL-GNO1-HA/ZZ 
This study 
3214 pGAL-NTR1-
HA/ZZ 
MAT a his3#1, leu2#0, met15#0, 
ura3#0, pGAL-NTR1-HA/ZZ 
This study 
Table 3.2 Oligonucleotides used in Chapter 3 
Name Sequence 
Ntr1 R1  5’TCTAATCAATTTTGTTTTTCGACAATAATATATAAATCGTGCCTATCTCATCTG
GAGGAAGTTTGAGAGG3’ 
NTR1F2 5’AGGATTCCAGTGGGACCTTTAAGCCAATTTATTTATGGGCCCTTGACCTCGGT
CGACGGATCCCCGGGTT 3’ 
Gno1 F2 5’CGTTGATGGACTCCAAGGCACTGAATGAGATCTTTATGATAACAAACGACGGT
CGACGGATCCCCGGGT 3’ 
Gno1 R1 5’TCCCCACTCTATATATCTTGCTGCGTGTGCAGACTGGCCAGCTGCTCACATCTG
GAGGAAGTTTGAGAGG 3’ 
PFA1F2 5’TTTTTGCCAAAATTAAAAAGAATAGATCGGGTTTAAGACACAGTGAAAGTGG
TCGACGGATCCCCGGGTT 3’  
Pfa1 R1  5’AAAATAAAAAAATATGTATATACGCAATTGTTAAGAAAATGAGGATTAAATC
TGGAGGAAGTTTGAGAGG 3’ 
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Name Sequence 
Pfa1 R1 
Longtine 
5’AAAATAAAAAAATATGTATATACGCAATTGTTAAGAAAATGAATTCGAGCTC
GTTTAAAC3’  
Ntr1 R1 
Longtine 
5’TTTGTTTTTCGACAATAATATATAAAATCGTGCCTATCTCAGAATTCGAGCTCG
TTTAAAC 3’  
Gno1 R1 
Longtine 
5’TATATATCTTGCTCGTGTGCAGACTGGCCAGCTGCTCACGAATTCGAGCTCGT
TTAAAC 3’  
E-C2 5’ GAAAAGGCCAGCAATTTCAAGTTAACTCCAAAGAGTATCACTCAC 3’  
D-A2 5’ AAACTTACAAGCCTAGCAAGACCGCGCACTTAAGCGCAGGCCCGG 3’  
scR1 5’ CGTGTCTAGCCGCGAGGAAGGATTTGTTCC 3’  
U3 PE 5' CCAAGTTGGATTCAGTGGCTC 3'  
U1  5' GAATGGAAACGTCAGCAAACA 3' 
NTR1-R3 5’AAAAGAACTTTTATCTGTGTTGGAGTCCGAATCCTCCATGCACTGAGCAGCGT
AATCTG 3’ 
PFA1-R3 5’TACGTCTGCTTCCTTGATAATGACTATGCCTTTTTGCCATGCACTGAGCAGCGT
AATCTG 3’ 
GNO1-R3 5’AACCAAACCGCTGTTTGGTTCTTGTAGCTGCCAAACCCATGCACTGAGCAGCG
TAATCTG 3’ 
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Name Sequence 
NTR1-F4 5’TTCGAAATAGTACAACCGAGAGAGGTCGAAGAACTTAAGCGAATTCGAGCTC
GTTTAAAC 3’ 
PFA1-F4 5’AGAAGTGATTTAATCGCAGAGTCAAATATAAGCATAAATTGAATTCGAGCTC
GTTAAAC 3’ 
GNO1-F4 5’GAGATGAGTACTCAATAGTAACATATAGGCAGCTTACACCGAATTCGAGCTC
GTTTAAAC3’ 
35S 5’CGCTGCTCACC AATGG3’ 
GNO1 
PCR3 
5’TTAGCGATGTTATGCTTTCCAC 3’ 
GNO1 
PCR5 
5’TAGCCTTGCCCACTCTCTTTCTC3’  
GNO1 
W38SBtm 
 5’CCATACCGGGTTTCGATCCAAACTTTTC 3' 
GNO1 
W38STop 
 5’GAAAAGTTTGGATCG AACCCGGTATGG 3' 
3.2.3 Whole cell splicing extract sedimentation through glycerol gradients  
Extracts were prepared as described in Chapter 2.2.5 with an additional 100,000 x 
g centrifugation clarification for 1 hour and sedimented through 10-30% glycerol 
gradients as described in Chapter 2.2.9. Northern blotting for snRNAs was performed as 
in Chapter 2.2.9. 
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3.2.4 GFP Coimmunoprecipitations  
GFP coimmunoprecipitations were performed with either with Abcam anti-GFP 
antibody (ab1218) or Chromotek-GFP-TRAP beads (Allele Biotech, ACT-CM-
GFA0050) as described in Chapter 2.2.5. For immunoprecipitations followed by primer 
extension analysis, RNAs were removed from resin by extraction with 1:1 volume of 
phenol-chloroform to wash buffer.  
3.2.5 rRNA analysis 
Whole cell RNA was prepared and transferred for northern blotting as in Chapter 
2.2.6. Oligonucleotide sequences used for northern blotting were previously described 
(Combs et al. 2006) and (Table 3.2). 
3.2.6 Pulse chase analysis 
For HIS3::GAL::HA-NTR1, cultures were grown to an OD (A600) of 0.3-0.4 at 
31°C in S-MET medium supplemented with 2% galactose and 1% sucrose. Cells were 
shifted to media containing 2% dextrose for 3 hours, and a low OD (A600) was maintained 
throughout. For prp2-1, cultures were grown to an OD (A600) of 0.3-0.4 at 31°C in YPD 
then shifted to YPD media pre-warmed to NPT. prp2-1 cultures were grown at 37°C for 
1 hour before harvesting 40 OD (A600) units for pulse chase as in Chapter 2.2.7.  
3.2.7 Native gel analysis 
Extracts were prepared as described above; however, further clarification and 
buffer dialysis was performed as in Chapter 2.2.9. Native gel analysis and U6 snRNA 
northern blotting was completed as described in Chapter 2.2.9.  
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3.2.8 Fluorescence microscopy 
Cultures were shifted from non-repressive media to SD-URA media 
supplemented with 2% galactose and 1% sucrose for 9 hours. Formaldehyde was added 
to 10% and samples incubated at 25°C for 30 min. Cells were pelleted and washed once 
with 1X PBS. Pellets were then resuspended in KSORB (1.1M sorbitol, 0.1 M KPO4, 
0.05% TritonX-100, pH 6.6) and incubated at room temperature for 6 minutes. Cells were 
washed once more with 1X PBS and resuspended in Vectashield mounting medium 
containing DAPI (Vector Labs, #H-1500) prior to fluorescence microscopy. Images were 
captured using a Leica DM IRBE microscope with a Leica DFC350 FX fluorescence 
camera. Merged images were processed in Photoshop.  
3.2.9 MYC immunoprecipitations  
SS3211 (GAL::HA-GNO1 PRP43-GFP pRS416-GNO1-myc) and SS3212 
(GAL::HA-GNO1, PRP43-GFP, pRS416-gno1 W38S-myc) were grown in 1% galactose 
and 2% sucrose until OD (A600) 0.4 then shifted to medium supplemented 2% dextrose 
for 6 hours. Extracts were prepared as described in 2.2.5 and incubated with anti-myc 
conjugated agarose (Sigma, #A7470) for 2 hours at 4°C with rotation. Resin was washed 
with IPP150 (10 mM Tris, pH 8.0, 150 mM NaCl, 0.1% NP-40, 1.5 mM MgCl2, 8% 
glycerol, 1 mM DTT) 4X at 2500 x g. Bound proteins and RNAs were eluted by adding 
1:1 phenol-chloroform to beads resuspended in wash buffer. 
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3.3 RESULTS 
3.3.1 A dominant negative prp43 mutant exhibits a first step splicing defect similar 
to the depletion of Ntr1p  
Ntr1p has been shown to be necessary for proper snRNP recycling, and its 
absence results in a first-step splicing defect (Boon et al. 2006). Using our GAL::HA-
NTR1 depletion strain, we verified that U3 pre-snoRNA transcripts accumulate when this 
disassembly factor is not present (Fig. 3.1A). If this phenotype were dependent upon the 
stimulation of Prp43p by Ntr1p, it would be predicted that mutations in the ATPase 
domain of Prp43p would also result in a first-step splicing defect. Our laboratory has 
previously demonstrated that U3 pre-snoRNAs do not accumulate in two cold sensitive 
PRP43 ATPase mutants (Combs et al. 2006). However, other alleles of PRP43, such as 
G395A and the cold sensitive dominant negative mutant Q423N, have been shown to 
accumulate introns (Arenas and Abelson 1997; Leeds et al. 2006). We analyzed U3 pre-
snoRNAs after shifting the Q423N mutant from PT to NPT. U3 pre-snoRNA levels did 
increase at NPT (Fig. 3.1B), indicating the lack of Prp43p helicase activity manifests in 
defects at an earlier step in pre-mRNA splicing.  
The steady state snRNP distribution is also disrupted when Ntr1p is depleted, due 
to a deficiency in the amount of the U5 snRNP (Boon et al. 2006). We analyzed whole 
cell snRNP distribution in the prp43Q423Np mutant at NPT by separating whole cell 
splicing extract though 10-30% glycerol gradients. The snRNAs present in each fraction 
of the gradient were detected by northern blotting (Fig. 3.1C & 3.1D). Similar to the 
depletion of Ntr1p, the distribution of the U4 and U6 snRNAs in spliceosomal particles 
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was perturbed in the Q423N mutant compared to wild-type (Boon et al. 2006; cf. Figs. 
3.1C & 3.1D). In the Q423N mutant, the U4 snRNA sedimented higher in the gradient 
(fractions 10-14) compared to wild-type (fractions 16-22). These data suggest that the U4 
snRNP is not being incorporated into larger splicing complexes. Additionally, we noted 
that the amount of the free U6 snRNP, which runs in fractions 8-12 in the wild-type, was 
reduced in the Q423N mutant. The total amount of the U5 snRNP was reduced by 30% in 
the Q423N mutant and the sedimented deeper in the gradient (Fig. 3.1E), which 
phenocopies the depletion of Ntr1p (Boon et al. 2006). We also found the same 
perturbation in snRNP distribution when the G-patch cofactor Pfa1p was overexpressed 
(Fig. 2.11).  
3.3.2 Overexpression of Gno1p also affects the first-step of pre-mRNA splicing 
If Gno1p is capable of competing with Ntr1p for Prp43p occupancy, it would be 
expected that the overexpression of Gno1p could indirectly inhibit pre-mRNA splicing. 
As in Figure 3.1A, we analyzed total RNA harvested from different time points 
throughout a time course in which Gno1p-HA/ZZ is overexpressed. After growth in non-
repressive media, cells containing the overexpression vector pGAL-GNO1-HA/ZZ were 
shifted to media supplemented with 2% galactose and 1% sucrose. In the presence of 
overexpressed Gno1p-HA/ZZ, U3 pre-snoRNAs accumulated to a modest level (Fig. 
3.2A), indicative of a mild pre-mRNA splicing defect. The U3 pre-snoRNA levels were 
only approximately two fold higher when Gno1p-HA/ZZ was present, (Fig. 3.2B), which 
was more modest than the effect of Ntr1p depletion. This intermediate effect on pre- 
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Figure 3.1 snRNP distributions are abrogated in prp43Q423N.  
A). U3 pre-snoRNAs accumulated as Ntr1p was depleted. Primer extension analysis for 
U3 pre-snoRNAs were conducted on total RNA throughout a 9 hour time course 
depleting HA-Ntr1p. The U1 snRNA has been included as an internal control. 
B). U3 pre-snoRNAs accumulated in the Q423N mutant when shifted to NPT. Total 
RNA was harvested at the time points indicated after shifting from 31°C to 16°C. Primer 
extensions same as (A). The positive control shown is from the 6 hour time point in (A).  
C-D). Splicing extracts were prepared either wild-type PRP43-TAP (C) or prp43Q423N-
TAP (D) after shift to 16°C for 3 hours. Glycerol gradients and northern blotting are 
presented as in Figure 2.11. 
E). Quantitation of the U5 snRNA revealed decreased amount of mono-U5 snRNP.  
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Figure 3.2 Gno1p overexpression impacts pre-mRNA splicing. 
A). A mild splicing defect presents during the overexpression of Gno1p-HA/ZZ. Primer 
extension analysis for the U3 pre-snoRNA from total RNA prepared at the indicated time 
points after shift to S-URA media supplemented with 1% sucrose and 2% galactose. 
RNA prepared from a snu66! strain grown at 16°C for 6 hours was used as a positive 
control for pre-snoRNA accumulation (Stevens et al. 2001).  
B). Quantitation for the relative fold increase of pre-U3a signals in (A) and trendline is 
graphed. U3a levels were normalized to corresponding wild-type time points to account 
for the influence of shifting to a different carbon source.   
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mRNA would be expected if Gno1p does partially compete with Ntr1p for Prp43p 
binding (see below). 
3.3.3 Loss of Prp43p stimulation affects tri-snRNP assembly 
We previously observed a defect in the assembly of tri-snRNP in the presence of 
overexpressed Pfa1p-HA/ZZ (Fig. 2.12), and proposed a model in which excess Pfa1p 
inhibits Ntr1p binding and stimulation of Prp43p so that proper snRNP assembly is 
indirectly affected (Illustration 2.1). The loss of Ntr1p binding or a mutation in the 
ATPase domain of Prp43p would be expected to produce similar tri-snRNP formation 
defects. As described above, we prepared whole cell splicing extracts from GAL::HA-
NTR1 after depleting HA-Ntr1p for 6 hours and from the prp43Q423N-TAP mutant strain 
after growth at NPT. Splicing extracts were separated through a native gel and complexes 
detected by northern blotting. As predicted, the steady-state snRNP levels shifted from 
tri-snRNP to di-snRNP when HA-Ntr1p is depleted (Fig. 3.3A, lanes 1 & 2; Boon et al. 
2006). We also show a strong decrease in U4/U6•U5 levels in the Q423N at 16˚C (Fig. 
3.3A, cf. lanes 7 & 8). The U4/U6 di-snRNP levels were increased by over 6-fold in the 
Q423N compared to the wild-type at NPT (Fig. 3.3B). The amount of tri-snRNP was 
reduced by half in the prp43 ATPase mutant. Additionally, the U6 snRNP levels were 
decreased in prp43Q423N relative to wild-type, as well as in the depletion of HA-Ntr1p 
or the overexpression of Pfa1p-HA/ZZ. Therefore, Prp43p stimulation appears to be 
required for proper snRNP equilibrium and spliceosome assembly, most likely due to a 
lack of U5 recycling (Boon et al. 2006). 
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Overexpression of Gno1p-HA/ZZ results in a mild accumulation of U4/U6 di-
snRNP (Fig. 3.3, cf. lanes 5 & 6). While U4/U6 di-snRNP levels increase to over 2-fold 
that of wild-type, there is little measurable decrease in tri-snRNP (Fig. 3.3B). This 
intermediate effect on tri-snRNP assembly correlates to the moderate effect on pre-
mRNA splicing in the presence of excess Gno1p (Fig. 3.2). These data further suggest 
that overexpression of Gno1p can compete with Ntr1p for Prp43p occupancy.  
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Figure 3.3 Fluctuation in G-patch protein levels result in pre-mRNA splicing defects and 
affects tri-snRNP assembly. 
A). Native gel northern blot analysis of the U4/U6 and U4/U6!U5 defects observed when 
G-patch protein levels are lowered or increased. Splicing extracts were prepared from 
strains under the conditions indicated, and 50 !g of total protein were separated on a 4% 
[80:1] acrylamide native gel followed by northern blot analysis for the U6 snRNA.  
B). Graphical representation of the data from (A). The graph represents the fold increase 
or decrease in U4/U6 (black bars) and U4/U6•U5 (grey bars) seen in each of the 
conditions relative to its corresponding WT sample. The dashed black line represents the 
wild-type baseline.   
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3.3.4 Prp43p subcellular localization is affected by overexpression of Gno1p or 
Ntr1p 
Gno1p and Ntr1p localize to the nucleolus and the nucleoplasm, respectively 
(Guglielmi and Werner 2002; Huh et al. 2003). If Gno1p and Ntr1p compete for Prp43p 
binding, the localization of Prp43p-GFP should shift from one subcellular compartment 
to the other. Under wild-type circumstances, Prp43p localized primarily to the nucleolus 
(Combs et al. 2006), but a nucleoplasmic signal was evident was well (Fig. 3.4A & 3.4B, 
first row). We analyzed Prp43p-GFP localization in the presence of overexpressed 
Gno1p-HA/ZZ, Ntr1p-HA/ZZ or Pfa1p-HA/ZZ. Interestingly, Prp43p-GFP localization 
to the nucleoplasm was not observed when Gno1p-HA/ZZ was in excess (Fig. 3.4A, 
second row). In the majority of the cells analyzed, a clear separation was apparent 
between the DAPI stained DNA and the Prp43p-GFP signal (Fig. 3.4B, second row) 
indicating increased partitioning to the nucleolus. In contrast, if Ntr1p-HA/ZZ was 
overexpressed, Prp43p-GFP localization to the characteristic nucleoli caps in the nucleus 
was disrupted (Fig. 3.4A, third row). The Prp43p-GFP was more diffuse within the 
nucleoplasm under these conditions, and very little difference between the GFP and 
DAPI signals was observed (Fig. 3.4B, third row). Unlike either the overexpression of 
Ntr1p-HA/ZZ or Gno1p-HA/ZZ, increased levels of Pfa1p-HA/ZZ did not significantly 
affect the subcellular localization of Prp43p-GFP (Fig. 3.4A, last row). Perhaps since 
Pfa1p localizes to the nucleoplasm and is predicted to reside in the nucleolus (Huh et al. 
2003; Lebaron et al. 2009), no overall change in Prp43p-GFP localization occurred even 
though Ntr1p and Gno1p associations are disrupted (Fig. 2.8). However, these data   
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Figure 3.4 Prp43-GFP delocalizes upon cofactor overexpression.  
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(Fig. 3.4 contd.)  
A). Fluorescent microscopy visualization of Prp43p-GFP after shift to media containing 
2% galactose and 1% sucrose for 6 hours in the presence of either empty vector (top 
row), pGAL-GNO1-HA/ZZ (second row), pGAL-NTR1-HA/ZZ (third row), or pGAL-
PFA1-HA/ZZ (fourth row). Fields for phase contrast (PC) (first column), DAPI [4ʼ,6ʼ-
diamidino-2-phenylindole] (second column) and GFP (third column) channels are shown. 
DAPI and GFP channels are merged in fourth column. Dashed boxes indicated cells 
presented at higher magnification in (B). B). Selected cells are shown at higher 
magnification to highlight nucleoplasmic versus nucleolar localization.  
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further suggest that Ntr1p and Gno1p have the ability to compete with each other for 
Prp43p since changes in their steady state levels impact Prp43p localization. 
3.3.5 Increased levels of Gno1p can preclude Ntr1p association with Prp43p 
The moderate tri-snRNP assembly defect (Fig. 3.3) along with the shift in Prp43p-
GFP localization away from the nucleoplasm (Fig. 3.4) indicates that Gno1p-HA/ZZ can 
sequester Prp43p from Ntr1p and the pre-mRNA splicing machinery. By performing 
coimmunoprecipitations against Prp43p-GFP in the presence of wild-type or 
overexpressed levels of Gno1p, we analyzed Prp43p-GFP/Ntr1p-myc association. Strains 
carrying either an empty vector or pGAL-GNO1-HA/ZZ plasmid were shifted to media 
supplemented with 2% galactose 1% sucrose for 6 hours. Subsequent western blot 
analysis of the Prp43p-GFP purified material for Ntr1p-myc indicated that under wild-
type conditions, Ntr1p still associated with Prp43p-GFP (Fig. 3.5, lane 12). In contrast, 
when Gno1p-HA/ZZ was overexpressed, Ntr1p-myc/Prp43p-GFP complexes were 
reduced (Fig. 3.5, lane 15). These data indicate that the pre-mRNA splicing defects 
observed when Gno1p-HA/ZZ is overexpressed are a result of the loss of interaction 
between Prp43p-GFP and Ntr1p-myc. We note that little Gno1p-HA/ZZ actually 
associated with Prp43p-GFP (WB PAP, lane 15). Perhaps a more complex sequestration 
of Prp43p-GFP in the nucleolus independent of Gno1p is at work downstream of the 
competition between Gno1p and Ntr1p.  
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Figure 3.5 Overexpression of Gno1p reduces the levels of Prp43p-GFP/Ntr1p complexes. 
Strains harboring either an empty vector (pRS316-GAL) or pGAL-GNO1-HA/ZZ were 
shifted to media supplemented with 2% galactose and 1% sucrose for 6 hours, then 
Prp43p-GFP complexes were purified using !-GFP antibodies. Anti-GFP western blots 
in the top panels demonstrate Prp43p-GFP IP efficiency. The anti-myc western blots in 
the second row show Ntr1p-myc signals. Ntr1p-myc is present in Prp43p-GFP purified 
material in the presence of the empty vector (lane 12), but a reduced amount is present 
when Gno1p-HA/ZZ is overexpressed (lane 15). Bottom panels demonstrate the 
overexpression of Gno1p-HA/ZZ.  
IP, immunoprecipitated; WB, western blot; IN, 1% input; FT, 1% flow-through; B, 20% 
bound 
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3.3.6 A mutation in GNO1 abrogates Gno1p and Prp43p association with 35S rRNA 
The study initially characterizing Gno1p as a ribosome biogenesis factor also 
showed that its G-patch domain is critical for its function (Guglielmi and Werner 2002). 
A single mutation in a conserved tryptophan of the G-patch domain (W38S) resulted in a 
growth defect similar to gno1! (Guglielmi and Werner 2002). Since the G-patch domain 
of Ntr1p is also necessary for its interaction with Prp43p (Tanaka et al. 2007), we 
hypothesized that the G-patch domain in Gno1p may have a similar role. We created 
centromeric plasmids harboring either myc-tagged wild-type GNO1 or gno1W38S, under 
the control of its own promoter and introduced them into the GAL::HA-GNO1 depletion 
strain. While the plasmid-borne GNO1 rescued the growth of GAL::HA-GNO1 in the 
presence of dextrose, gno1W38S did not (Fig. 3.6A). Using these strains, we depleted the 
HA-Gno1p and analyzed the association of the wild-type or mutant Gno1p-myc with 
Prp43p-GFP. We immunoprecipitated Prp43p-GFP and western blotted for the presence 
of wild-type or mutant Gno1p-myc. We also performed the reverse immunoprecipitation 
using the MYC tag on Gno1p and western blotted for the presence of Prp43p-GFP. In 
both cases, Prp43p-GFP/Gno1p-myc association was reduced by 60% in the G-patch 
mutant (Fig. 3.6B). These data indicate that the G-patch domain of Gno1p is important 
for its interaction with Prp43p in vivo.  
We then analyzed the ability of gno1W38Sp-myc to associate with the 35S pre-
rRNA since Prp43p and Gno1p exist together in 90S particles. After immunoprecipitating 
with wild-type Gno1p or the W38S mutant, we used primer extension analysis to 
determine the amount of 35S pre-rRNA in the same purified material as in Fig. 3.6B. We 
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found that the W38S mutation in Gno1p decreased its association with the 35S pre-rRNA 
by 80% (Fig. 3.6C, right bars). We performed a similar experiment to determine if 
Prp43p/35S pre-rRNA association was also abrogated in the gno1W38S mutant. 
Consistent with a function for Gno1p in recruiting Prp43p to the 35S transcript, we found 
that the amount of pre-rRNA associated with Prp43p-GFP was also decreased in the 
W38S mutant (Fig. 3.6C, left bars). A previous study had indicated that Prp43p 
association with the pre-35S rRNA was not dependent on Gno1p (Lebaron et al. 2009). 
However, we consistently found that after depletion of HA-Gno1p the amount of Prp43p-
GFP associated with the 35S pre-rRNA was reduced (Fig. 3.6D). This is likely due to the 
fact that we have transiently depleted Gno1p in our experiments, and they use a gno1! 
strain has additional collateral PFA1 and LTV1 defects which could provide suppressor 
phenotypes to this phenomenon (Lebaron et al. 2009). Neither the depletion of Gno1p 
nor the W38S mutation resulted in complete loss of Prp43p-GFP association with the 35S 
pre-rRNA, but our data indicate that Gno1p greatly enhances its incorporation into 90S 
particles. Furthermore, the G-patch domain of Gno1p is important in these interactions, 
making it similar to that of Ntr1p (Tanaka et al. 2007). 
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Figure 3.6 The gno1W38S mutant is impaired for Prp43p and 35S pre-rRNA association.  
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(Fig. 3.6 contd.)  
A. Growth assays of GAL::HA-GNO1 depletion strains harboring empty vector 
(pRS416), pRS416-GNO1-MYC or pRS416-gno1W38S-MYC on media supplemented 
with either galactose or dextrose. Plates were photographed after 3 days growth at 31˚C. 
B. Gno1p-myc and Prp43p-GFP associate with less 35S pre-rRNA in the gno1W38S  
(Fig 3.6 contd.) mutant. Quantitation of 35S pre-rRNA signal associated with Gno1p-myc 
or Prp43p-GFP after depletion of HA-Gno1p for 6 hours is shown. Gno1p-myc wild-type 
(dark grey) or gno1W38Sp-myc (light grey) associated material was immunoprecipitated 
and the presence of 35S pre-rRNA determined by primer extension. The averages and 
standard deviations of 35S pre-rRNA association in biological replicates (n=3) are 
graphed (p-value= 0.025).! Similarly, from the same extracts, Prp43p-GFP was 
immunoprecipitated and 35S pre-rRNA association determined by primer extension (light 
gray bars); p-value= 0.0087. C. Prp43p/Gno1p association is disrupted in the gno1W38S 
mutant. From the immunoprecipitations described in (B), western blot analysis was 
performed for Prp43p-GFP or Gno1p-myc. Anti-myc western blots were performed to 
detect Gno1p-myc (dark grey) or gno1W38Sp-myc (light grey) contained in Prp43p-GFP 
purified material. Averages and standard deviations are graphed (n=3; p-value=0.027)"!
The reverse immunoprecipitations for Prp43p-GFP from the same extracts were 
performed followed by western blot for Gno1p-myc or gno1W38Sp-myc (right bars) 
(n=3; p-value= 0.013). D. Prp43p consistently associates with a reduced amount of 35S 
pre-rRNA in the absence of Gno1p. The 35S pre-rRNA immunoprecipitated with Prp43p-
GFP after HA-Gno1p depletion was analyzed by primer extension as described in (C). 
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3.3.7 Loss of Ntr1p indirectly affects ribosome biogenesis  
Through a screen of ts alleles of essential genes, NTR2 was determined to have an 
effect on ribosome biogenesis. The NTR2 ts allele had increased steady state levels of the 
35S pre-rRNA, as well as the 23S aberrant species. Concomitantly, both the 20S and 27S 
pre-rRNA species were decreased (Ben-Aroya et al. 2008). Since Ntr1p is found 
primarily in a complex with Ntr2p (Tsai et al. 2005), similar ribosome biogenesis defects 
might be expected in cells deficient for Ntr1p function. We show that as HA-Ntr1p is 
depleted the 35S pre-rRNA and the 23S aberrant species accumulated, and the 20S pre-
rRNA levels concomitantly decreased (Fig. 3.7A). Additionally, the 27S levels increased 
until all of the rRNA signals drastically decreased at the time of cell death, approximately 
9 hours after shift to dextrose (Fig. 3.7A; data not shown). Indeed, loss of Ntr2p and 
Ntr1p function results in similar ribosome biogenesis defects.  
We further explored the pre-rRNA processing defect in the GAL::HA-NTR1 
depletion strain by pulse chase analysis. After depletion of HA-Ntr1p for 3 hours, we 
observed that the 35S precursor persisted until 2 minutes after the chase (Fig. 3.7B). The 
kinetics of 27S rRNA processing was slowed as well, as evidenced by its presence 5 
minutes after the chase. The amount of 20S pre-rRNA at time 0 was decreased, consistent 
with the northern blot results.  
Although Ntr1p is a factor involved in spliceosome disassembly, its interaction 
and stimulation of Prp43p is necessary for proper spliceosome recycling and the first step 
of pre-mRNA splicing (Fig. 3.1 & 3.3). Historically, mutants of pre-mRNA splicing 
factors that affect the first step of splicing also impact ribosome biogenesis (Warner and 
  136 
Udem 1972; Shulman and Warner 1978). To determine how the rRNA processing defects 
observed when HA-Ntr1p is depleted compares to that of a spliceosome assembly 
mutant, we analyzed rRNA processing by northern blotting and pulse chase analysis in 
the ts prp2-1 mutant. A shift to NPT inactivates Prp2p in this strain so that it does not 
join the spliceosome to make the essential rearrangements for the first transesterification 
reaction (King and Beggs 1990). Northern blotting for the rRNA species in prp2-1 at 
NPT we observed that the 35S pre-rRNA accumulated, while the levels of 27S and 20S 
pre-rRNA species decreased, as in GAL::HA-NTR1 (Fig. 3.7C). The 23S aberrant species 
is not as evident by northern blot, but is observed by pulse chase analysis in prp2-1 after 
a 1 hours shift to NPT (Fig. 3.7D). These data suggest that the loss of Ntr1p results in 
similar rRNA processing defects as other spliceosomal factors; therefore, these defects 
are most likely to be indirect and due to the loss of r-proteins (Shulman and Warner 
1978).  
  137 
 
Figure 3.7 Loss of Prp2p and Ntr1p result in similar ribosome biogenesis defects.  
A). Loss of Ntr1p results in accumulation of the 35S pre-rRNA and eventual cell death. 
Northern blot analysis of pre-rRNA intermediates in the presence of Ntr1p (lanes 1-5) 
and in cells where HA-Ntr1p is depleted over a time course (lanes 6-10). Increases in the 
35S pre-rRNA and the aberrant 23S intermediate, along with a concomitant decrease in 
20S pre-rRNA are observed until 9 hours at which time cells are likely to be dying. The 
scR1 RNA loading control is shown at the bottom of the panel. B). Pulse chase analysis 
of rRNA intermediates after metabolic depletion of HA-Ntr1p for 3 hours. Cells 
containing Ntr1p show normal rRNA processing kinetics after chase with cold 
methionine (lanes 1-6). After Ntr1p has been depleted for 3 hours, delayed kinetics of 
35S, 27S and 20S rRNAs are evident (lanes 7-12). C). Loss of Prp2p function correlates 
with a 35S rRNA accumulation and a severe 20S depletion phenotype. Northern blot 
analysis of pre-rRNA intermediates in RNA harvested from PRP2 cells (lanes 1-5) is 
shown. RNA harvested from prp2-1 cells after growth at the NPT for the indicated times 
are shown in lanes 6-10. Steady state accumulation of the 35S pre-rRNA and rapid 
decrease in the 20S pre-rRNA levels are noted. The scR1 RNA loading control is shown 
at the bottom of the panel. D). Pulse chase analysis of RNA harvested from prp2-1 cells 
after shift to non-permissive temperature for 1 hour is shown.  
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3.3.8 Overexpression of Ntr1p-HA/ZZ impacts rRNA processing and Prp43p 
binding with Gno1p-TAP 
If Ntr1p and Gno1p can directly compete for Prp43p binding, then overexpression 
of Ntr1p-HA/ZZ would be expected to perturb ribosome biogenesis. We analyzed steady 
state rRNAs by northern blot from a time course in which Ntr1p-HA/ZZ was 
overexpressed. In the presence of excess Ntr1p-HA/ZZ there was a mild increase in the 
steady state levels of the 35S pre-rRNA, but there was no reciprocal decrease in the 27S 
and 20S pre-RNAs (Fig. 3.8A). These results are milder but similar to what we observed 
in our pGAL-PFA1-HA/ZZ overexpression strain (Fig. 2.6).  
To directly determine if Ntr1p-HA/ZZ overexpression can disrupt Gno1p/Prp43p 
binding, we performed coimmunoprecipitations against Prp43p-GFP in the presence of 
wild-type or overexpressed levels of Ntr1p. Ntr1p-HA/ZZ was overexpressed by shifting 
strains to media supplemented with 2% galactose 1% sucrose for 6 hours. Western blot 
analysis for Gno1p-TAP in the Prp43p-GFP purified material indicates that Gno1p-TAP 
associated with Prp43p-GFP under wild-type conditions (Fig. 3.8, lane 12). However, 
when Ntr1p-HA/ZZ was overexpressed, Prp43p-GFP interacted with a reduced amount 
of Gno1p-TAP (Fig. 3.5, lane 15). Together with the shift of Prp43p-GFP localization 
and the rRNA processing defects, these data indicate that excess Ntr1p can compete with 
Gno1p for Prp43p occupancy. In both cases, Gno1p and Ntr1p exert milder effects over 
one another, in contrast to the dominant effect of overexpressed Pfa1p over the other two 
cofactors.  
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3.3.9 Pfa1p/Prp43p association is not disrupted by overexpression of Ntr1p or 
Gno1p 
If Ntr1p and Gno1p can directly compete with Pfa1p for Prp43p occupancy, then 
overexpression of either Gno1p-HA/ZZ or Ntr1p-HA/ZZ would be expected to affect 
Prp43p association with Pfa1p. We performed coimmunoprecipitations against Prp43p-
GFP in the presence of wild-type or overexpressed levels of Ntr1p and observed that 
Pfa1p still efficiently associated with Prp43p even when Ntr1p-HA/ZZ was 
overexpressed (Fig. 3.9, lane 24). Similarly, we found that the overexpression of Gno1p-
HA/ZZ did not disrupt Prp43p/Pfa1p complexes (Fig. 3.9, lane 30). Therefore, neither the 
overexpression of Ntr1p nor Gno1p affects Prp43p association with Pfa1p, consistent 
with the strength of the interaction discussed above.  
.  
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Figure 3.8 Ntr1p overexpression disrupts Gno1p/Prp43p association. 
A). Northern blot analysis of rRNAs during a time course overexpressing Ntr1p-HA/ZZ 
shows a mild ribosome biogenesis defect. rRNA species are indicated to the left. 
Quantification of normalized signals for 35S, 27S, and 20S pre-rRNAs are shown below 
the panel. B). Prp43p-GFP association with Gno1p-TAP is disrupted in Ntr1p-HA/ZZ 
overexpression. Western blot analysis for Prp43p-GFP (top), Gno1p-TAP (middle), and 
Ntr1p-HA/ZZ (bottom) were performed following Prp43p-GFP immunoprecipitation 
from strains with wild-type (lanes 10-12) or overexpressed (lanes 13-15) levels of Ntr1p.  
IP, immunoprecipitated; WB, western blot; IN, 1% input; FT, 1% flow-through; B, 20% 
bound  
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Figure 3.9 Neither overexpressed Ntr1p nor Gno1p disrupt Prp43p/Pfa1p complexes. 
Strains harboring either an empty vector (pRS316-GAL), pGAL-NTR1-HA/ZZ, or pGAL-
GNO1-HA/ZZ were shifted to media supplemented with 2% galactose and 1% sucrose for 
6 hours, then Prp43p-GFP complexes were purified using !-GFP antibodies. Anti-GFP 
western blots in the top panels demonstrate the efficiency of the Prp43p-GFP 
immunoprecipitation. Pfa1p-myc association with Prp43p-GFP is shown in the middle 
panels (WB !-myc). Bottom panels demonstrate the overexpression of Ntr1p-HA/ZZ or 
Gno1p-HA/ZZ.  
IP, immunoprecipitated; WB, western blot; IN, 1% input; FT, 1% flow-through; B, 20% 
bound 
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3.4 DISCUSSION 
We have previously shown that Ntr1p, Gno1p, and Pfa1p interact with Prp43p in 
a mutually exclusive manner (Figure 2.1), and that the interaction of Pfap1p with Prp43p 
is dominant over that of Gno1p or Ntr1p (Figures 2.9 & 2.13). We further investigated 
the relationships between Ntr1p and Gno1p to construct a complete network of Prp43p 
cellular distribution by the G-patch proteins. For Prp43p to be regulated by these 
cofactors, each cofactor would be expected to be function in different steps of gene 
expression. Mass spectrometry, biochemical and genetic data indicate that Gno1p 
functions in 90S pre-ribosomal particles and is not present in mature 60S or 40S pre-
ribosomal subunits (Guglielmi and Werner 2002; Lebaron et al. 2009). We show that 
Gno1p associates with the 35S pre-rRNA as expected (Fig. 3.6). To date, Gno1p has no 
known connection to pre-mRNA splicing.  
Mass spectrometry data indicate that Ntr1p only associates with splicing factors 
(Lebaron et al. 2009), but the depletion of Ntr1p has a strong effect on both pre-mRNA 
splicing and ribosome biogenesis, suggesting that it may play two roles (Fig. 3.7). 
However, we demonstrate that Ntr1p depletion phenocopies the rRNA processing defects 
as well as the pre-mRNA splicing defect (Boon et al. 2006, Fig. 3.1A) of the temperature 
sensitive prp2-1 pre-mRNA splicing mutant (Warner and Udem 1972, Fig. 3.7). Since the 
loss of Ntr1p leads to the same first-step splicing defect as prp2-1, the effect on ribosome 
biogenesis is likely results from the loss of r-proteins, as is the case for prp2-1 (Warner 
and Udem 1972; Shulman and Warner 1978; Bromley et al. 1982). Our investigations of 
Pfa1p have shown that it is not necessary for the role of Prp43p in spliceosome 
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disassembly (Fig. 2.10B) nor for ribosome biogenesis (Pertschy et al. 2009). While Pfa1p 
associates with pre-20S rRNA, it does not associate with snRNAs (Lebaron et al. 2005), 
so while Pfa1p may play an accessory role in 40S subunit maturation, it is unlikely that it 
also plays a similar role in pre-mRNA splicing. Therefore, we believe each G-patch 
protein functions in a distinct step of ribosome biogenesis or pre-mRNA splicing, so that 
it can faithfully regulate the activity of Prp43p in the proper pathway.  
We have previously shown that excess Pfa1p competes with Ntr1p for Prp43p 
binding so that snRNPs are not recycled properly and U4/U6•U5 tri-snRNP levels 
decrease (Fig. 2.12). Data from Beggs and colleagues demonstrated a role for Ntr1p in 
the recycling of U5 (Boon et al. 2006), and our results indicate that if HA-Ntr1p is 
depleted, cells become deficient in tri-snRNP (Fig. 3.2). Our data suggests that the 
stimulation of the ATPase activity of Prp43p is necessary for U5 recycling. Steady state 
snRNP levels in the cs mutant prp43Q423N-TAP at NPT mimic that of GAL::HA-NTR1 
(Figs. 3.1C & 3.1D; Boon et al. 2006). Consequently, the Q423N mutant accumulates 
increased levels of U4/U6 di-snRNP and decreased levels of tri-snRNP (Fig. 3.3). This 
inability to recycle the spliceosome in vivo is consistent with the defect in the first step of 
splicing that is observed in either the Q423N mutant or when Ntr1p is depleted (Fig. 3.1A 
& 3.1B). Moreover, the overexpression of Gno1p, which moderately impacts 
Prp43p/Ntr1p association (Fig. 3.5), also results in a mild effect on pre-mRNA splicing 
(Fig. 3.2). Once again, under these conditions, the association of Prp43p with Ntr1p is 
abrogated leading to a 2-fold increase in U4/U6 levels (Fig. 3.3). Therefore, disassembly 
of the U2/U6•U5 complex by Prp43p through Ntr1p-mediated interaction with the   
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Illustration 3.1 Model of Prp43p regulation by G-patch protein cofactors. 
Ntr1p and Gno1p can compete for Prp43p occupancy with each other, thereby 
moderating the incorporation of Prp43p in pre-mRNA splicing or pre-90S complexes. 
The G-patch domains of both Ntr1p and Gno1p are important in mediating their 
interactions with Prp43p. In contrast, the G-patch domain of Pfa1p is dispensable for its 
interaction with Prp43p. Additionally, Pfa1p can strongly inhibit the association of 
Prp43p with the other two cofactors, resulting in the pausing of both mRNA and rRNA 
processing pathways.  
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spliceosome is necessary for maintaining the proper equilibrium of snRNP levels. Such 
defects in disassembly quickly impact the processing of pre-mRNAs by the spliceosome 
in vivo.  
Of the four G-patch proteins characterized in yeast, three have proven to play 
some role in recruitment and/or stimulation of RNA helicase activity. The G-patch 
domain of Spp2p is necessary for the incorporation of Prp2p into the spliceosome for the 
first step of splicing (Silverman et al. 2004). Similarly, the G-patch domain of Ntr1p is 
required for its interaction with Prp43p and via Ntr2p mediates incorporation into stalled 
spliceosomes or the post-splicing lariat RNP (Tsai et al. 2005; Tanaka et al. 2007). 
Likewise, Prp43p associates with less pre-20S in a pfa1! strain, indicating Pfa1p may 
facilitate Prp43p incorporation into pre-40S complexes (Lebaron et al. 2009). However, 
these G-patch cofactors appear to differentially impact Prp43p activity; the helicase 
activity of Prp43p has been shown to be stimulated by Ntr1p, and Pfa1p enhances both its 
helicase and ATPase activities (Tanaka et al. 2007; Walbott et al. 2010). It is yet to be 
determined whether Spp2p stimulates the activities of Prp2p.  
While the G-patch domain of Pfa1p is not necessary for Prp43p binding, it is 
responsible for the stimulation of its activities (Pandit et al. 2009; Walbott et al. 2010). In 
contrast, the G-patch domains of Spp2p and Ntr1p are necessary to associate with Prp2p 
or Prp43p, respectively (Silverman et al. 2004; Tanaka et al. 2007). The G-patch domain 
of Gno1p is important for cell growth, like that of Ntr1p (Tanaka et al. 2007), and is 
necessary for its function in ribosome biogenesis (Guglielemi and Werner 2002). The 
recruitment of Prp43p to the 35S pre-rRNA was previously reported to not be strictly 
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dependent upon the presence of Gno1p (Lebaron et al. 2009), but Prp43p activity is 
stimulated by Gno1p in vitro, implying a functional regulatory relationship with Prp43p 
(Y. Henry, unpublished results). Our data demonstrate that the G-patch domain of Gno1p 
plays a role in its stable association with Prp43p. A single serine substitution at the 
conserved W38 in the G-patch domain reduced Gno1p/Prp43p complexes by 80% in vivo 
(Fig. 3.7B). Perhaps other secondary interfaces or proteins are present between Gno1p 
and Prp43p, but the G-patch domain appears to significantly stabilize their interaction. 
Furthermore, we show that the W38S mutant associated with less 35S pre-rRNA in vivo, 
and Prp43p also associated with less 35S pre-rRNA in the W38S mutant (Fig. 3.7C). 
While the association of neither Gno1p nor Prp43p with the pre-rRNA is completely lost, 
our data suggest that the G-patch domain functions in the stable association with the pre-
rRNA. These data could support two separate models of Gno1p/Prp43p interaction. 
Gno1p could interact with Prp43p via its G-patch domain and together they incorporate 
into 90S complexes. Alternatively, Prp43p can associate with the 35S pre-rRNA 
independently, then Gno1p, which interacts via its G-patch domain with the rRNA, 
stabilizes this interaction. Further in vitro analysis of Gno1p and Prp43p will be 
necessary to elucidate the nature of this interaction. Nevertheless, the G-patch of Gno1p 
and Ntr1p are necessary for their Prp43p-mediated functions in vivo. We predict that 
these two cofactors work in a similar manner with Prp43, in contrast to Pfa1p. The ability 
of Ntr1p and Gno1p to compete with one another, while Pfa1p has a dominant interaction 
over both, supports this model. 
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Chapter 4: Characterization of prp43 alleles identifies three classes 
4.1 INTRODUCTION TO PRP43P STRUCTURE  
In Saccharomyces cerevisiae there are six essential DEAH-box helicases: the pre-
mRNA splicing factors Prp2p, Prp16p, and Prp22p (Burgess et al. 1990; Chen and Lin 
1990; Company et al. 1991), ribosome biogenesis factors Ecm16p and Dhr2p (Colley et 
al. 2000), and Prp43p, which functions in both processes (Martin et al. 2002; Lebaron et 
al. 2005; Combs et al. 2006; Leeds et al. 2006). Additionally, there is a non-essential 
putative DEAH-box helicase, YLR419W (Shiratori et al. 1999) which has yet to be 
characterized and has no obvious ortholog (Sanjuán and Marín 2001). To date, Prp43p is 
the only DEAH-box helicase for which there is a crystal structure of the full-length 
protein. It is composed of six domains: an N-terminal region, two RecA domains 
composing the RNA helicase domain, and a region common to all DEAH-box proteins 
(DEAH-C) (Stevens 2010) containing a degenerated winged helix domain (WHD), a 
ratchet domain, and a C-terminal domain (CTD) including an 
oligonucleotide/oligosaccharide binding (OB) fold (He et al. 2010; Walbott et al. 2010, 
Fig. 4.1A). While the DEAH-box helicases all share the highly conserved helicase core 
with other superfamily 2 (SF2) RNA and DNA helicases, the homology between them 
extends into their DEAH-C, indicating potential functional similarity.  
The four DEAH-box helicases involved in splicing share 30% amino acid 
similarity in the region directly downstream of motif VI, which spans amino acids 431-
720 in Prp43p (Tanaka and Schwer 2006). In fact, the C-terminal domain of hPrp22p (aa 
950-1183) adopts a domain structure similar to Prp43p, including a degenerated winged-
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helix domain, ratchet domain, and OB-fold. Comparison of the CTDs using the crystal 
structures of hPrp22 and ScPrp43, and homology modeling of hPrp16 shows a putative 
common RNA binding surface in the helicases (Kudlinzki et al. 2012). Divergent 
sequences or structures in the C-terminal domains of the spliceosomal DEAH-box 
helicases have been hypothesized to be necessary for their specific interactions and 
functions (Kudlinzki et al. 2012; Tanaka and Schwer 2006).  
Like other RNA helicases, Prp43p has poor inherent unwinding and ATPase 
activities, as well as lacking substrate specificity (Tanaka and Schwer 2006; Walbott et 
al. 2010). Dynamic movements of its RecA domains with respect to the WHD are 
thought to be necessary in the course of its ATPase cycle, and may be enhanced by 
interactions with cofactors (Tanaka et al. 2007; Walbott et al. 2010). Prp43p can 
hydrolyze all NTPs and dNTPs (Tanaka and Schwer 2006), which is similar to DEAH-
box helicases Prp2p (Kim et al. 1992), Prp16p (Schwer and Guthrie 1992), and Prp22p 
(Tanaka and Schwer 2005). The NTP binding site of Prp43p is formed between its two 
RecA domains, and RecA-1 interfaces intimately with the WHD. The Prp43p co-crystal 
structure with ADP indicates the adenine base stacks between Phe359 and Arg159, and 
though Ser155 and Gln354 coordinate water molecules to form hydrogen bonds with the 
base, there is no specificity for adenine (He et al. 2010; Walbott et al. 2010). By 
modeling Prp43p/RNA interaction using the structurally similar Ski2-like archeal DNA 
helicase Hel308 in complex with DNA (Büttner et al. 2007), the RecA-1 domain of 
Prp43p is predicted to bind to the 3’ end of ssRNA and the RecA-2 domain binds to the 
5’ end (Walbott et al. 2010). A long ! hairpin (5' HP, aa 396-415) existing between the 
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motifs V and VI of RecA-2 inserts physically between the WHD and the CTD. Putatively 
it blocks the binding pocket for ssRNA, so that when bound to ADP, Prp43p cannot bind 
RNA. The binding of ATP is predicted to induce a conformational change in Prp43p so 
that the 5’ HP is released from the RNA binding pocket, allowing ssRNA to bind. 
Alternatively, when ssRNA binds to the RecA domains, a closed conformation is induced 
which produces an optimal ATP binding site (He et al. 2010), which would account for 
the stimulation of the ATPase activity of Prp43p by ssRNA (Tanaka and Schwer 2006). 
Therefore, the 5’ HP is hypothesized to have two simultaneous roles: an autoinhibitory 
role preventing the binding of ssRNA in the ADP conformation and a role in active 
strand separation or RNA-protein remodeling (He et al. 2010). The 5’ HP shows genetic 
interaction with the G-patch protein Ntr1p (Tanaka et al. 2007), and a mutation in the 5’ 
HP has also been shown to be partially defective in 20S rRNA cleavage (Pertschy et al. 
2009; Fig. 4.1A), indicating that this hairpin is potentially involved in the mechanism of 
Prp43p function in both splicing and ribosome biogenesis.  
The WHD and ratchet domains (aa 455-520 and 521-634, respectively) of Prp43p 
have structural similarity to the Ski2-like family member Hel308 (Büttner et al. 2007; 
Walbott et al. 2010). Hel308 has a long ! helix with two residues (Arg592 and Trp599) 
that have been proposed to stack on the nucleotides bases and act a hooks on the ssDNA 
(Büttner et al. 2007). Prp43p also contains equivalent arginines in this ! helix (Arg611 
and Arg625) that could act as the hooks for its processivity (Walbott et al. 2010), but 
their contributions to helicase activity have yet to be demonstrated. Also like Prp43p, 
Hel308 contains a " hairpin (5’ HP) (Büttner et al. 2007). The proposed model is for the 
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ratchet ! helix of Prp43p to pull ssRNA into the cavity in a 3' to 5' manner, then the " 
hairpin actively separates the duplex (Walbott et al. 2010).  
In Hel308, the C-terminal domain works as an autoinhibitory domain (Richards et 
al. 2008), but in contrast this region of Prp43p has been proven to be necessary for 
stimulating its RNA unwinding activity and is essential in vivo (Walbott et al. 2010; 
Martin et al. 2002; Tanaka et al. 2007). The OB-fold in the CTD (aa 660-712) and the 
groove formed by the " strands has a positive electrostatic surface for interacting with 
nucleic acid (He et al. 2010; Walbott et al. 2010). 
Though the C-terminal 35 amino acids (aa 732-767) have been shown to be 
essential for cell growth (Martin et al. 2002; Tanaka et al. 2007), their loss does not 
affect the basal ATPase activity of Prp43p. However, a mutant truncated from the OB-
fold has an RNA-stimulated ATP hydrolysis rate 20-fold lower than wild-type. The 
decrease in RNA stimulation in the truncation is consistent with the 200-fold decrease in 
its RNA affinity (Walbott et al. 2010). Similarly, in ScPrp22p the CTD is necessary for 
the RNA stimulation of its helicase activity, but it also stimulates the inherent ATPase 
activity (Kudlinzki et al. 2012). Therefore, RNA binding by the OB-fold may actively 
participate in the ATPase cycle. Additionally, the OB-fold is may be providing some of 
the selectivity for the RNAs to which Prp43p binds (Walbott et al. 2010). The N-terminus 
of Prp43p wraps back towards the CTD and residues 10-36 make intimate contact (He et 
al. 2010); however, it has been shown that the N-terminal helices are not necessary for 
cell growth (Walbott et al. 2010; Martin et al. 2002). 
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The C-terminus of Prp43p also makes important contacts with a set of three G-
patch proteins. Pfa1p (Walbott et al. 2010; see Chapter 2.1.1) or Ntr1p (Tanaka et al. 
2007; see Chapter 3.1.1) have been shown to stimulate Prp43p to unwind helices both in 
the 3' to 5' or 5' to 3' direction. Additionally, Pfa1p can stimulate the ATPase activity of 
Prp43p, but Ntr1p does not (Walbott et al. 2010; Tanaka et al. 2007). The last 110 amino 
acids of Prp43p are necessary to mediate its interaction with the C-terminal domain of 
Pfa1p, which contains its G-patch domain. The N-terminal portion of Pfa1p can still 
associate with Prp43p in the absence of the C-terminus of Pfa1p, however this interaction 
does not stimulate the ATPase activity of Prp43p (Walbott et al. 2010). In contrast, the 
G-patch domain of Ntr1p is essential for its interaction with Prp43p. Single point mutants 
in the hydrophobic leucines render Ntr1p unable to bind Prp43p (Tanaka et al. 2007).  
We sought to understand how the C-terminus of Prp43p impacts its function in 
either ribosome biogenesis or pre-mRNA splicing. We hypothesized that specificity 
domains existed downstream of the conserved helicase core to provide substrate 
specificity for Prp43p. Through mutagenesis of the C-terminus of Prp43p, we 
characterized new prp43 mutants and determined that Gno1p and Ntr1p binding sites on 
Prp43p at least partially overlap. 
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4.2 MATERIALS AND METHODS 
4.2.1 Plasmids 
pRS316-PRP43-TAP::KANMX (pJPS1162) was isolated from yeast strain 
yJPS797/SS3017 (Leeds et al. 2006), and PRP43-TAP was subcloned into pRS415 using 
SalI and BamHI/BglII. The PRP43 ortholog from S. pombe was PCR amplified from 
genomic DNA (Strain SP6 from Jon Huibregtse/Susan Forsberg) using oligonucleotides 
S.p. Prp43 3NotI and S.p. Prp43 5BglII (Table 4.2) and cloned into pRS426 behind a 
GPD promoter. Directed prp43 point mutants and 5’ HP deletion were created by 
adapting Quikchange mutagenesis (Stratagene) using oligonucleotides described in Table 
4.2. Plasmids containing random prp43 alleles were isolated, transformed into E. coli and 
sequenced.  
4.2.2 Construction of yeast strains 
SS3105 was created by deleting TRP1 through MPY-URA3 replacement 
(Schneider et al. 1996). MPY-URA3 PCR fragments were introduced via lithium acetate 
transformation (Gietz and Woods 2002) and transformants were selected on SD-URA. 
Serial dilutions in non-selective minimal media allow MPY repeats to recombine, 
resulting in the loss of URA3. Isolates deficient in both TRP1 and URA3 were then 
transformed with pRS316-PRP43-TAP::KANMX, and pRS415-PRP43-TAP was lost 
through dilution in SD-URA. 13MYC tags for each G-patch protein were incorporated 
into SS3105 using methods described in 2.2.1 and oligonucleotides in Table 2.2.  
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4.2.3 Gap repair mutagenesis 
Random mutants of prp43 were generated by degenerative PCR using 1 u of Taq 
polymerase (Stevens lab) with primers PRP43 GapL and PRP43 GapR (Table 4.2). 
pRS415-PRP43-TAP was digested with StuI and AscI and transformed with mutagenized 
prp43 PCR fragments into a SS3076 at a 3:1 molar ratio. Gap-repaired transformants 
were patched on SD-LEU plates then replica plated and screened at 25˚C, 37˚C and 16˚C 
on SD-LEU plates containing 5’FOA. Approximately 20,000 colonies were screened, and 
we did not recover the same mutation more than once. 
4.2.4 Serial dilutions 
prp43 mutants were grown in liquid medium at 25˚C and adjusted to OD (A600) of 
1.0. Dilutions of 10-2 were made and equal volumes plated on SD-LEU or SD-LEU + 
5’FOA media. Plates were photographed after 3 days of incubation at 25˚C and 37˚C, and 
after 6 days for growth at 25˚C and 16˚C.  
4.2.5 Primer extensions 
Primer extensions were conducted as described above (Chapter 2.2.7) using total 
RNA prepared from the time points indicated at NPT. Cultures were maintained between 
OD (A600) 0.3-0.4 throughout the time course.  
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Table 4.1 Yeast strains used in Chapter 4  
Strain Relevant 
Gene(s) 
Genotype Source/Reference 
3017/ 
yJPS797 
pRS316-PRP43-
TAP 
MAT a his3!1, leu2!0, met15!0, 
ura3!, prp43::HIS3 pRS316-
PRP43-TAP:: KANMX 
(Leeds et al.2006) 
3005 
 
pRS415-PRP43-
TAP 
MAT a his3!1, leu2!0, met15!0, 
ura3!, prp43::HIS3, pRS415-
PRP43-TAP 
This study 
3010 pRS415-
prp43D638N-
TAP 
MAT a his3!1, leu2!0, met15!0, 
ura3!, prp43::HIS3, pRS415-
prp43D638N-TAP 
This study 
3011 pRS415-
prp43L649R-
TAP 
MAT a his3!1, leu2!0, met15!0, 
ura3!, prp43::HIS3, pRS415-
prp43L649R-TAP 
This study 
3053 pRS426-GPD-
S.pombe PRP43 
MAT a his3!1, leu2!0, met15!0, 
ura3!, prp43::HIS3, pRS426-
GPD-S. pombe PRP43  
This study 
3105 pRS316-PRP43-
TAP trp1! 
MAT a his3!1, leu2!0, met15!0, 
ura3!, prp43::HIS3, trp1!, 
pRS316-PRP43-TAP 
This study 
3111 pRS316-PRP43-
TAP  
NTR1-myc 
MAT a his3!1, leu2!0, met15!0, 
ura3!, prp43::HIS3, trp1!, 
NTR1-13myc::TRP1, pRS316-
PRP43-TAP  
This study 
3112 pRS316-PRP43-
TAP  
PFA1-myc 
MAT a his3!1, leu2!0, met15!0, 
ura3!, prp43::HIS3, trp1!, 
PFA1-13myc::TRP1, pRS316-
PRP43-TAP 
This study 
3113 pRS316-PRP43-
TAP  
GNO1-myc 
MAT a his3!1, leu2!0, met15!0, 
ura3!, prp43::HIS3, trp1!, 
GNO1-13myc::TRP1, pRS316-
PRP43-TAP  
This study 
3114 pRS415-PRP43-
TAP 
PFA1-myc 
MAT a his3!1, leu2!0, met15!0, 
ura3!, prp43::HIS3, trp1!, 
PFA1-13myc::TRP1, pRS415-
PRP43-TAP  
This study 
3115 pRS415-
prp43WLI-TAP 
PFA1-myc  
MAT a his3!1, leu2!0, met15!0, 
ura3!, prp43::HIS3, trp1!, 
PFA1-13myc::TRP1, pRS415-
prp43WLI-TAP  
This study 
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Strain Relevant 
Gene(s) 
Genotype Source/Reference 
3116 pRS415-
prp43L469R-
TAP 
PFA1-myc  
MAT a his3!1, leu2!0, met15!0, 
ura3!, prp43::HIS3, trp1!, 
PFA1-13myc::TRP1, pRS415-
prp43L469R-TAP 
This study 
3117 pRS415-
prp43IRK-TAP 
PFA1-myc  
MAT a his3!1, leu2!0, met15!0, 
ura3!, prp43::HIS3, trp1!, 
PFA1-13myc::TRP1, pRS415-
prp43IRK-TAP 
This study 
3119 pRS415-PRP43-
TAP  
NTR1-myc 
MAT a his3!1, leu2!0, met15!0, 
ura3!, prp43::HIS3, trp1!, 
NTR1-13myc::TRP1, pRS415-
PRP43-TAP  
This study 
3120 pRS415-
prp43WLI-TAP  
NTR1-myc 
MAT a his3!1, leu2!0, met15!0, 
ura3!, prp43::HIS3, trp1!, 
NTR1-13myc::TRP1, pRS415-
prp43WLI-TAP  
This study 
3121 pRS415-
prp43IRK-TAP  
NTR1-myc 
MAT a his3!1, leu2!0, met15!0, 
ura3!, prp43::HIS3, trp1!, 
NTR1-13myc::TRP1, pRS415-
prp43IRK-TAP  
This study 
3122 pRS415-
prp43IRK-TAP  
 
MAT a his3!1, leu2!0, met15!0, 
ura3!, prp43::HIS3, pRS415-
prp43IRK-TAP 
This study 
3123 pRS415-
prp43WLI-TAP  
 
MAT a his3!1, leu2!0, met15!0, 
ura3!, prp43::HIS3, pRS415-
prp43WLI-TAP 
This study 
3125 pRS415-
prp43WLI-TAP 
NTR1-myc 
MAT a his3!1, leu2!0, met15!0, 
ura3!, prp43::HIS3, trp1!, 
NTR1-13myc::TRP1, pRS415-
prp43WLI-TAP  
This study 
3126 pRS415-
prp43L469R-
TAP GNO1-myc 
MAT a his3!1, leu2!0, met15!0, 
ura3!, prp43::HIS3, trp1!, 
GNO1-13myc::TRP1, pRS415-
prp43L469R-TAP 
This study 
3127 pRS415-
prp43WLI-TAP 
GNO1-myc 
MAT a his3!1, leu2!0, met15!0, 
ura3!, prp43::HIS3, trp1!, 
GNO1-13myc::TRP1, pRS415-
prp43WLI-TAP 
This study 
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Strain Relevant 
Gene(s) 
Genotype Source/Reference 
3147 pRS415-
prp43G395R-
TAP 
MAT a his3!1, leu2!0, met15!0, 
ura3!, prp43::HIS3, pRS415- 
prp43G395R-TAP 
This study 
3150 pRS415-
prp43A565E-
TAP  
NTR1-myc 
MAT a his3!1, leu2!0, met15!0, 
ura3!, prp43::HIS3, trp1!, 
NTR1-13myc::TRP1, pRS415-
prp43A565E-TAP 
This study 
3151 pRS415-
prp43A565E-
TAP 
PFA1-myc  
MAT a his3!1, leu2!0, met15!0, 
ura3!, prp43::HIS3, trp1!, 
PFA1-13myc::TRP1, pRS415-
prp43A565E-TAP 
This study 
3152 pRS415-
prp43A565E-
TAP 
GNO1-myc 
MAT a his3!1, leu2!0, met15!0, 
ura3!, prp43::HIS3, trp1!, 
GNO1-13myc::TRP1, pRS415-
prp43A565E-TAP 
This study 
3160 pRS415-PRP43-
TAP 
GNO1-myc 
MAT a his3!1, leu2!0, met15!0, 
ura3!, prp43::HIS3, trp1!, 
GNO1-13myc::TRP1, pRS415-
PRP43-TAP 
This study 
3163 pRS415-
prp43IRK-TAP 
GNO1-myc 
MAT a his3!1, leu2!0, met15!0, 
ura3!, prp43::HIS3, trp1!, 
GNO1-13myc::TRP1, pRS415-
prp43IRK-TAP 
This study 
3166 pRS415-
prp43A565E-
TAP 
MAT a his3!1, leu2!0, met15!0, 
ura3!, prp43::HIS3, pRS415-
prp43A565E-TAP 
This study 
3099 PFA1-myc MAT a his3!1, leu2!0, met15!0, 
ura3!, PFA1-13myc::URA3 
This study 
3103 NTR1-myc MAT a his3!1, leu2!0, met15!0, 
ura3!, NTR1-13myc::URA3 
This study 
3107 GNO1-myc MAT a his3!1, leu2!0, met15!0, 
ura3!, GNO1-13myc::URA3 
This study 
3174  pRS415-prp43 
Q732STOP 
MAT a his3!1, leu2!0, met15!0, 
ura3!, prp43::HIS3, pRS415- 
prp43Q732STOP 
This study 
3176 pRS415-
prp43E451D 
M492T-TAP 
MAT a his3!1, leu2!0, met15!0, 
ura3!, prp43::HIS3, pRS415-
prp43E451D M492T-TAP 
This study 
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Strain Relevant 
Gene(s) 
Genotype Source/Reference 
3178 pRS415-
prp43G473D 
R493K-TAP 
MAT a his3!1, leu2!0, met15!0, 
ura3!, prp43::HIS3, pRS415-
prp43G473D R493K-TAP 
This study 
3179 pRS415-prp43 
F437L A502P-
TAP 
MAT a his3!1, leu2!0, met15!0, 
ura3!, prp43::HIS3, pRS415-
prp43F437L A502P-TAP 
This study 
3186 pRS415-
prp43L469R-
TAP pRS411 
MAT a his3!1, leu2!0, met15!0, 
ura3!, prp43::HIS3, pRS415-
prp43L469R-TAP pRS411 
This study 
3187 pRS415-PRP43-
TAP pRS411 
MAT a his3!1, leu2!0, met15!0, 
ura3!, prp43::HIS3, pRS415-
PRP43-TAP pRS411 
This study 
3190 pRS415- 
prp43E451D 
M492T-TAP 
NTR1-myc 
MAT a his3!1, leu2!0, met15!0, 
ura3!, prp43::HIS3, trp1!, 
NTR1-13myc::TRP1, pRS415-
prp43E451D M492T-TAP  
This study 
3191 pRS415-
prp43G395R-
TAP NTR1-myc 
MAT a his3!1, leu2!0, met15!0, 
ura3!, prp43::HIS3, trp1!, 
NTR1-13myc::TRP1, pRS415-
prp43G395R-TAP NTR1-13myc 
This study 
3192 pRS415-
prp43G473D 
R493K-TAP 
MAT a his3!1, leu2!0, met15!0, 
ura3!, prp43::HIS3, trp1!, 
NTR1-13myc::TRP1, pRS415-
prp43G473D R493K-TAP 
This study 
3194 pRS415- 
prp43E451D 
M492T-TAP 
pRS411 
MAT a his3!1, leu2!0, met15!0, 
ura3!, prp43::HIS3, pRS415-
prp43E451D M492T-TAP, 
pRS411 
This study 
3195 pRS415- 
prp43G473D 
R493K-TAP 
pRS411 
MAT a his3!1, leu2!0, met15!0, 
ura3!, prp43::HIS3, pRS415- 
prp43G473D R493K-TAP, 
pRS411 
This study 
3196 pRS415- 
prp43E451D 
M492T-TAP 
PFA1-myc 
MAT a his3!1, leu2!0, met15!0, 
ura3!, prp43::HIS3, trp1!, 
PFA1-13myc::TRP1, pRS415-
prp43E451D M492T-TAP 
This study 
3197 pRS415- 
prp43G473D 
R493K-TAP 
PFA1-myc 
MAT a his3!1, leu2!0, met15!0, 
ura3!, prp43::HIS3, trp1!, 
PFA1-13myc::TRP1, pRS415-
prp43G473D R493K-TAP 
This study 
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Strain Relevant 
Gene(s) 
Genotype Source/Reference 
3198 pRS415- 
prp43E451D 
M492T GNO1-
myc 
MAT a his3!1, leu2!0, met15!0, 
ura3!, prp43::HIS3, trp1!, 
GNO1-13myc::TRP1, pRS415-
prp43E451D M492T 
This study 
3199 pRS415- 
prp43G473D 
R493K-TAP 
GNO1-myc 
MAT a his3!1, leu2!0, met15!0, 
ura3!, prp43::HIS3, trp1!, 
GNO1-13myc::TRP1, pRS415-
prp43G473D R493K-TAP 
This study 
3200 pRS415-
prp43Q732STOP 
pRS411 
MAT a his3!1, leu2!0, met15!0, 
ura3!, prp43::HIS3, pRS415- 
prp43Q732STOP, pRS411 
This study 
 
Table 4.1 Oligonucleotides used in Chapter 4  
Name Sequence 
43demut 
BTM 
5’ AATTTGCAAAACAGTACGAATGGCAGAATCTAAATAGTCCC 3’  
43demut 
TOP 
5’ GGGACTATTTAGATTCTGCCATTCGTACTGTTTTGCAAATT 3’ 
5'HP 
TOP 
5’ CGTCGTTGACCCAGGAATCTCCAAGGCTTCTGCCCAACAAAG 3’ 
5'HP Bottom 5’ CTTTGTTGGGCAGAAGCCTTGGAGATTCCTGGGTCAACGACG 3’ 
S.p.PRP43 
seq-1 
5’ GAAATGATTCCAACACCAGTCAGC 3’ 
S.p.PRP43 
seq-2 
5’ TGCACTGGCTTTGCTAATAGGAC 3’ 
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Name Sequence 
S.p.PRP43 
seq-3 
5’ ATATCAGTTGCCAAGGTACGCTC 3’ 
S.p.Prp43 
3Not1 
5’ GCGGCCGCTTAACGAGCGTTCTTTTTTGATC 3’ 
S.p.Prp43 
5BglII 
5’ AGATCTATGGAACCAGCTCAGAAGAAACTAAGG 3’ 
E-C2 5’ GAAAAGGCCAGCAATTTCAAGTTAACTCCAAAGAGTATCACTCAC 3’  
D-A2 5’ AAACTTACAAGCCTAGCAAGACCGCGCACTTAAGCGCAGGCCCGG 3’  
scR1 5’ CGTGTCTAGCCGCGAGGAAGGATTTGTTCC 3’  
U3 PE 5' CCAAGTTGGATTCAGTGGCTC 3'  
U1  5' GAATGGAAACGTCAGCAAACA 3' 
PRP43 GapL 5’ TACCACCGCATCAACAACAAAG 3’ 
PRP43 GapR 5’ CCCTGTTATCCCTAGCGGATCTGC 3’ 
Prp43IRK 
TOP 
5’ GCCCTAAATACTTTGACAACGCCGCAGCGGCTCTTGCGTCTGG 3’ 
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Name Sequence 
Prp43IRK 
Bottom 
5’ CCCAGACGCAAGAGCCGCTGCGGCGTTGTCAAAGTATTTAGGGC 3’ 
Prp43WLI 
Top 
5’ CTCGGTCAGGCCCGAAGCGGCGGCTGAAATAGCGCCTGCATAC 3’ 
Prp43WLI 
Bottom 
5’ GTATGCAGGCGCTATTTCAGCCGCCGCTTCGGGCCTGACCGAG 3’ 
35S 5’CGCTGCTCACC AATGG3’ 
4.2.6 Native snRNP gels 
Splicing extracts were prepared as described above from cultures shifted from 
25˚C to 37˚C for 3 hours. Native gel analysis and subsequent northern blotting for the U6 
snRNA was carried out as described in Chapter 2.2.9. U6 signals for U4/U6 or 
U4/U6!U5 were quantitated in Quantity One (BioRAD) and normalized to the wild-type 
signal for each species.  
4.2.7 rRNA analysis 
Wild-type PRP43 and mutants were grown at 25˚C until approximately OD (A600) 
0.3-0.4, then shifted to 37˚C by harvesting and resuspending in pre-warmed media. 
Cultures were maintained at low OD (A600) < 0.5 throughout the time course, and whole 
cell RNA was prepared from 0, 0.5, 1, 2 or 3 hours time points as described in Chapter 
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2.2.6. The primers used for northern blotting of the rRNAs were previously described 
(Combs et al. 2006). 
4.2.8 Pulse chase analysis 
Wild-type and mutant prp43 strains harboring pRS411 were utilized for pulse 
chase analysis (Table 4.1). Strains SS3187, SS3186, SS3174 were grown to an OD (A600) 
of 0.3-0.4 at 25˚C in S-MET medium supplemented with 2% dextrose. After growth in 
pre-warmed media for 1 hour, forty OD (A600) units were harvested by centrifugation and 
resuspended in 12 ml of pre-warmed SD-MET medium. Pulse chase was performed as 
described in Chapter 2.2.7. Pulse chase analysis for SS3176 and SS3178 were begun once 
cultures reached OD600 0.3-0.4 at 25˚C  
4.2.9 TAP immunoprecipitations  
For Pfa1p-myc or Gno1p-myc coimmunoprecipitations, cells were grown at 25˚C 
in YP media containing 2% dextrose to approximately OD (A600) 0.3-0.4 before shifting 
to pre-warmed media and grown at 25˚C for 3 hours. For Ntr1p-myc 
coimmunoprecipitations, cultures were grown to OD600 0.8, as for splicing extract 
conditions, before shifting to pre-warmed media for 3 hours. TAP purifications were 
carried out as described in Chapter 2.2.5.  
4.2.10 RNA immunoprecipitations  
Extracts were prepared as described above for 35S pre-rRNA analysis (Chapter 
2.2.5), but for snRNA association, extracts were clarified with an additional 
centrifugation step of 100,000 x g for 1 hour as in splicing extract preparation (Chapter 
2.2.9). In either case, TAP complexes were isolated as described above and eluted from 
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beads by boiling in IPP150 (10 mM Tris, pH 8.0, 150 mM NaCl, 0.1% NP-40, 1.5 mM 
MgCl2, 8% glycerol, 1 mM DTT). Eluted material was phenol/chloroform extracted and 
RNAs precipitated with 1/10th volume NaOAc under 2.5 volumes of 100% ethanol. To 
analyze immunoprecipitated snRNAs, 1% of RNA from total and flow-through fractions 
and 20% of RNA from bound fractions were separated though an 8M urea 7% acrylamide 
denaturing gel. Northern blot analysis was performed as previously described (Combs et 
al. 2006). For 35S RNA immunoprecipitations, primer extensions were performed as 
describe above (Chapter 2.2.8) with either 1% input RNA or 50% bound RNA using the 
35S oligonucleotide (Table 2.2)  
4.2.11 Polysome profiling 
 Cultures were grown at 25º C in YP + 2% dextrose media to OD (A600) 0.3-0.4 
before shifting to pre-warmed media and grown at 37˚C for 3 hours. OD (A600) was 
maintained between 0.3-0.4 throughout the shift to ensure ribosome production. 
Cycloheximide was added at 150 µg/ mL to lock polysomes in situ and incubated for 10 
minutes at 37º C. Cells were pelleted in ice and washed once with cold 1X PBS then once 
in lysis buffer (10 mM Tris-CL, pH7.5, 10 mM MgCl2, 150 µg/ mL cycloheximide, 200 
µg/mL heparin, 100 mM KCl, 6 mM !-mercaptoethanol). Cells were lysed by vortexing 
four times with 1 volume of glass beads and extracts were clarified by centrifugation at 
20,000 x g for 10 minutes. 20 OD units (A260) were layered on 7-47% sucrose gradient 
and centrifuged at 274,000 x g for 2.5 hours. Gradients were fractionated and OD (A254) 
recorded for polysome traces.  
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4.3 RESULTS  
4.3.1 Identification of mutations in the C-terminus of Prp43p that confer 
conditionality 
The C-terminal 55 amino acids of Prp43p have been shown to be essential in vivo 
(Martin et al. 2002). This region includes the C-terminal two ! helices adjacent to the 
OB-fold and affects the RNA-dependent stimulation of the ATPase activity of Prp43p 
(Walbott et al. 2010). We hypothesized that ATPase stimulation might occur 
concurrently with substrate binding and/or cofactor binding by the DEAH-C. The in vivo 
responsibilities of the DEAH-C domains of Prp43p have not been investigated. An 
alanine screen of amino acids 431-720 revealed 13 lethal or conditional alleles (Tanaka 
and Schwer 2006), although their effects in pre-mRNA splicing and ribosome biogenesis 
are not yet known.  
We set out to identify alleles that might illuminate the in vivo function of the C-
terminus of Prp43p using a gap-repair mutagenesis screen. The C-terminal 1.2 KB region 
of PRP43 was randomly mutagenized via degenerate PCR (Fig. 4.1B) and gap-repaired 
in a prp43" strain harboring Schizosaccharomyces pombe PRP43 on a URA3 vector. By 
using the S. pombe ortholog of PRP43 our observed frequency of gap-repair from the 
wild-type ectopic S. cerevisiae PRP43 was reduced. To identify conditional prp43 alleles, 
colonies were screened at 37°C and 16°C and compared to growth at 25˚C (Fig. 4.2B 
&C). A total of sixteen conditional alleles were isolated and sequence verified 
(Appendix, Table A1); however, we focused on seven containing only one or two 
mutations in this region (Fig. 4.2A). The only cold sensitive (cs) mutant identified, 
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prp43D638N, shows only a mild growth defect. Most of the mutants in our collection do 
not correspond to the previously identified mutants from the alanine screen (Tanaka and 
Schwer 2006); however, the screen did produce a truncation mutant (Q732STOP), which 
is very similar to one previously shown to be ts (temperature sensitive) (Martin et al. 
2002). Also, we identified G359R, which is a mutant in the same residue as the prp43-1 
allele, G395E (Arenas and Abelson 1997), and lies eleven amino downstream of motif V 
at the base of the 5’ HP. The prp43G395E allele was previously characterized as ts, 
though this sensitivity can be rescued by shifting back to PT (Arenas and Abelson 1997). 
Additionally, we directly reproduced triple alanine mutants 648IRK650 and 717WLI719 for 
further analysis (Tanaka and Schwer 2006). Some alleles, such as prp43G395R and 
prp43L494R, showed growth defects even at PT, which were exacerbated at NPT. 
Interestingly, two separate alleles prp43-1248 and prp43-1504 contain mutations that 
include two adjacent residues, M492 and R493. 
Based on the structure of Prp43p, we also deleted the 5’ HP to confirm its 
necessity in vivo (Fig. 4.1C, bottom panels). The deletion of this hairpin was lethal, 
which is consistent with the proposal that it slices through duplexes (Walbott et al. 2010). 
Though it is possible that the 5’ HP also plays an autoinhibitory role to prevent the 
binding of ssRNA (He et al. 2010), its essentiality implies autoinhibition is likely not its 
only function. 
Mapping our alleles on the known crystal structure of Prp43p (Walbott et al. 
2010; He et al. 2010), we observed that we have isolated mutations in each domain (Fig. 
4.3A). Unfortunately, we had not anticipated the complex structure of the RecA-2   
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Figure 4.1 Mutagenesis of the DEAH-C of Prp43p. 
A). Prp43p domains are shown as described in Walbott et al. and He et al. ADP-Mg lies 
between the RecA-1 (green) and RecA-2 (purple) domains. Characteristic residues of the 
SF2 conserved motifs are modeled as sticks, along with the polar contacts to ADP and 
Mg2+ (inset). The 5’ HP (yellow) extends into the center of the enzyme. The S414F  
(Figure 4.1 contd.) mutant (Pertschy et al. 2009; grey) maps near the base of this hairpin. 
The degenerate WHD (orange) lies mostly on the face opposite of the ratchet domain 
(cyan). At the C-terminus is the CTD (red), composing the OB-fold and ending with an 
extended ! helix. The last five amino acids were not solved in the structure but are 
modeled in. The NTD (blue) contacts the CTD and the ratchet domain, and through a 
long unstructured linker it connects to the RecA-1 domain. File obtained from PBD 
(DOI:10.2210/pdb3kx2/pdb) and manipulated in MacPyMOL. B). The region of Prp43p 
targeted for mutagenesis (grey). Due to the complex structure of the RecA-2 domain, we 
unknowingly targeted a portion of that domain that could directly affect the inherent 
activity of Prp43p. PBD file same as in (A).   
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domain with the 5’ HP injected between the motifs V and VI; therefore, alleles 
containing R370G and F437L lie closer to the conserved SF2 motifs than expected. These 
cluster in the upper back portion of the RecA-2 domain, and, though they are removed 
from the substrate binding site, it is possible that they affect the inherent activity of 
Prp43p. 
Additionally, most of the mutations are predicted to lie on the surface of the 
protein (Fig. 4.3B). The prp43IRK and prp43WLI mutants line a small pocket beneath the 
OB-fold in the CTD, and the prp43Q732STOP mutant neatly truncates the ! helix that 
also contributes to this pocket.  
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Figure 4.2 prp43 conditional mutants isolated from the gap repair mutagenesis screen 
A). Schematic diagram of mutations identified with respect to the domains of Prp43p.  
B & C). Serial dilutions of ts prp43 (C) or cs (D) alleles demonstrate growth defects at 
PT and/or NPT. Additionally, the prp43 5’HP deleting the entire 5’ HP is lethal (C, 
bottom panels).  
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4.3.2 CTD mutants result in a strong first step pre-mRNA splicing defect.  
To gain an understanding of the molecular basis underlying the growth phenotypes for 
each of the prp43 mutants, we began by analyzing pre-mRNA splicing. Prp43p removes 
the lariat intron from the post-splicing lariat RNP (Martin et al. 2002); however, we did 
not identify any mutants which accumulated the U2/U6!U5 species in vivo (data not 
shown). Instead, we tested for pre-mRNA accumulation, which we have also detected for 
the dominant cs mutant prp43Q423N (Fig. 3.1B). The Q423 residue lies in motif VI, 
which affects ATP binding and hydrolysis. Indeed, the Q423A mutant is dominant 
negative, and prp43Q423Ap hydrolyzes ATP at only 13% the rate of wild-type (Martin et 
al. 2002). Notably, other alleles with mutations in the helicase core, prp43S247A and 
prp43G429A, which lie in motifs III and VI, respectively, do not lead to this splicing 
defect (Combs et al. 2006). Despite the lack of a splicing defect, the S247A mutation 
reduces ATP hydrolysis by 35% (Martin et al. 2002), and a mutation to leucine in the 
same position renders a dominant negative phenotype (Arenas and Abelson 1997).  
Through primer extension analysis for the pre-snoRNA U3 we found that mutants in the 
CTD strongly accumulate pre-U3 snoRNA, indicating they have a defect in the first-step 
of pre-mRNA splicing (Fig. 4.4A). Specifically, prp43IRK and prp43Q732STOP 
accumulated U3a precursors up to 4- and 8- fold greater than wild-type at NPT, 
respectively (Fig. 4.4B). The pre-mRNA splicing defect observed in the CTD mutants 
was less pronounced than the snu66! control, which is expected considering Snu66p is 
directly involved in tri-snRNP assembly rather than indirectly, like Prp43p. However, not 
all prp43 mutants, such as prp43L469R and prp43A565E, displayed this pre-mRNA  
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Figure 4.3 prp43 mutants mapped on Prp43p crystal structure. 
A). All prp43 mapped on a cartoon model of the Prp43p crystal structure (He et al. 2010; 
DOI:10.2210/pdb3kx2/pdb). Each allele is colored as follows: prp43R370G I619T, light 
lavender; prp43G395R, purple; prp43F467L A502P, pink; prp43L469R, orange; prp43 
1248, yellow; prp43-1504, olive; prp43A565E, light blue; prp43IRK, red; prp43WLI, 
burnt orange; prp43Q732STOP truncation, blue. B). Most prp43 alleles map to predicted 
surface residues. The IRK, WLI and Q732STOP mutants cluster in the CTD and make a 
pocket. Along the WHD face both mutations in the alleles prp43E451D M492T and 
prp43G473D R492K lie on the surface. From the top, the mutations near the RecA-2 
domain, F437L and G395R are visible. Other mutated residues, R370G, A565E and 
I619T, are predicted to be on the surface, while L469R and A502P are not (not depicted).  
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Figure 4.4 pre-U3 snoRNAs accumulate in prp43IRK and prp43Q732STOP mutants. 
A). Primer extension analysis for the pre-U3 snoRNAs in each of the prp43 mutants after 
shift to NPT. RNAs from each time point were primed with U3 or U1 oligonucleotides. 
Both U3a and b precursors and the mature mRNA are visualized using the same U3 
probed. Extensions for the U1 snRNA are utilized as an internal loading control.  
B). Quantitation of audioradiographs in (A). pre-U3a signals were normalized to the U1 
internal control before computing fold change compared to the shifted wild-type control. 
Similar results are observed when U3a signals are normalized to time 0 for each mutant 
(not shown).  
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accumulation phenotype, making them more similar to the prp43S247A or prp43G429A 
mutants. Moreover, our prp43G395R allele did not drastically increase pre-U3 snoRNA 
levels, which might have been predicted based on the results for prp43G395E. 
4.3.3 CTD mutants have imbalances in snRNP levels.  
The loss of ATPase function in prp43Q423N results in snRNP imbalance so that U5 
snRNPs levels are decreased resulting in a corresponding increase in U4/U6 di-snRNP 
levels (Fig. 3.3). Proper snRNP recycling is also dependent on the association of Prp43p 
with Ntr1p (Fig. 2.12 &13; Fig. 3.3; Boon et al. 2006). We hypothesized that mutants 
that accumulated pre-U3 snoRNAs would also be deficient in tri-snRNP, as in 
prp43Q423N at NPT. We further analyzed the snRNP composition in each mutant after 
growth at NPT for 3 hours. snRNPs were analyzed on a native gel by Northern blotting 
for U6 snRNA. Since the U4/U6 di-snRNP is present in low concentrations under wild-
type conditions, slight changes in the abundance of this species is easier to identify in the 
mutants than differences in the highly abundant tri-snRNP. Indeed, we observed that the 
CTD alleles (prp43IRK, prp43WLI and prp43Q732STOP) have a strong increase in the 
steady-state U4/U6 snRNP levels with slight measurable decreases in tri-snRNP (Fig. 
4.5). Our data are supported by previous work that shows the WLI surface is important 
for Prp43p binding to Ntr1p (Tanaka et al. 2007). In contrast, prp43 alleles that did not 
show first step pre-mRNA splicing defects, prp43L469R, prp43G395R, and prp43A565E, 
had only minor effects on U4/U6 snRNP levels. Once again, this is in contrast to what 
might be expected for prp43G395R considering the previously mentioned data for 
prp43G359E. Splicing activity assays showed that prp43G395E results in increased pre-  
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Figure 4.5 prp43 mutants with pre-U3 accumulation also have defects in snRNP 
recycling. 
A). Representative native gels probed for U6 snRNA to visualize U4/U6!U5, U4/U6, and 
mono-U6 species in prp43 mutants at NPT. snRNP species are indicated to the left, and 
multiple samples of the wild-type are included as a reference. The ATPase allele prp43 
Q423N is included for comparison. 
B). Quantitation of the U6 counts for either U4/U6 snRNP or tri-snRNP species were 
determined in Quantity one and normalized to wild-type.  
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mRNA levels due to a failure to dissociate the spliceosome (Arenas and Abelson 1997). 
While Prp43p has also been shown to be able to trigger the discard of splicing 
intermediates at either the first or second step of pre-mRNA splicing (Koodathingal et al. 
2010), under wild-type conditions we do not think this role would result in a defect 
leading to conditionality. 
4.3.4 prp43 mutants range from milder to more severe ribosome biogenesis defects 
than ATPase mutants.  
In addition to the ATPase mutants prp43S248A, prp43G429A (Combs et al. 
2006), and prp43Q423N (Leeds et al. 2006) that were characterized as deficient in 
ribosome biogenesis, one other prp43 allele has been linked to ribosome biogenesis, 
prp43S414F (Pertschy et al. 2009). S414 lies in the 5’ HP (Fig. 4.1A) and is 
hypothesized to be partially responsible for RNA unwinding (He et al. 2010). However, 
the effects of this mutation on rRNA processing are only seen with the additional loss of 
Ltv1p, a 20S biogenesis factor and proposed small subunit export adaptor (Pertschy et al. 
2009; Seiser et al. 2006). The 20S pre-rRNA accumulates in the cytoplasm in the ltv1! 
mutant, and the accumulation is exacerbated in the ltv1! prp43S414F double mutant 
(Pertschy et al. 2009). In contrast, the prp43S248A, prp43G429A and prp43Q423N 
mutants are deficient in early cleavages of the 35S pre-rRNA, resulting in its transient 
accumulation and drastic turnover so that both 20S and 27S pre-rRNAs are depleted 
(Leeds et al. 2006; Combs et al. 2006). Previously, prp43IRK and prp43WLI were shown 
to relieve the dominant negative effect of prp43T123A, and, therefore, hypothesized to 
mediate the interaction of Prp43p with the spliceosome (Tanaka et al. 2007). However, 
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the effects of prp43IRK and prp43WLI on ribosome biogenesis have not been 
investigated, and considering the essential role of Prp43p in ribosome biogenesis, perhaps 
this pathway is partially involved in their suppression of prp43T123A. 
For each prp43 allele we analyzed rRNA processing by Northern blotting using 
D-A2 and E-C2 probes to visualize each species (Fig. 4.6; Combs et al. 2006). We 
observed four classes of ribosome biogenesis defects. The most severe effect was 
observed in prp43L469R, in which the steady-state levels of both the 20S and 27S 
precursors were reduced to ~25% that of wild-type. Interestingly, there was no 
corresponding increase in the 35S precursor, making ribosome biogenesis defects in 
prp43L469R distinct from the prp43S247A or prp43G429D mutants (Combs et al. 2006). 
In contrast, prp43IRK, and to an extent prp43WLI, phenocopied the ATPase mutants, 
with strong increases in the 35S precursor and decreases in the downstream products. 
Unlike prp43L469R, we noted the presence of a 23S aberrant species in these mutants, as 
well as prp43Q732STOP. Considering the stronger effect on pre-mRNA splicing in these 
CTD mutants, this ribosome biogenesis defect could be partially due to the incomplete 
splicing of U3. However, it is peculiar that prp43Q732STOP should have such a 
profound increase in 35S pre-rRNA levels, but not a corresponding decrease in the 
downstream products, as seen in prp43IRK and prp43WLI. Additionally, the double 
mutants in the WHD, prp43E451K M492T and prp43G473D R493K, had increases in the 
steady-state levels of the 35S precursor, but this did not translate to downstream 
decreases in the 20S or 27S pre-rRNAs. These two alleles showed a mild phenotype that  
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Figure 4.6 Mutations in CTD or WHD have different rRNA processing defects.  
prp43L469R-TAP PRP43-TAP prp43F437L A502P-TAP prp43G473D R493K-TAP prp43E451DM492T-TAP 
prp43G395R-TAP prp43A565E-TAP prp43IRK-TAP prp43Q732STOP prp43WLI-TAP 
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(Fig. 4.6 contd.)  
The levels of steady-state rRNAs are perturbed in prp43 mutants. RNAs were harvested 
at the indicated time point after shift to 37° C, and pre-RNAs were detected by northern 
blotting using either D-A2 or E-C2 probes (Combs et al.2006). A probe for scR1 is used 
as a loading control. For quantitation, all signals were normalized to the scR1 loading 
control before determining fold change compared to wild-type at the indicated time point. 
By comparing mutant steady-state rRNA levels to the corresponding wild-type time point 
we account for the effect of heat shock on rRNA processing, which is evident at 30 min 
in the wild-type. Quantitative increases of over 2.0 are colored green, and decreases 
under 0.3 are colored red. 
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is distinct from the CTD mutants or ATPase mutants. Finally, prp43A565E did not have 
any significant effect on ribosome biogenesis.  
4.3.5 WHD prp43 mutants have slowed rRNA processing kinetics. 
Because the effect of some prp43 mutants on ribosome biogenesis was ambiguous 
by Northern blot, we further investigated using pulse chase analysis. First, for 
prp43L469R we would expect to see an accumulation of the 35S rRNA precursor 
considering the loss of the downstream pre-rRNAs. By pulsing with radiolabeled 
[3H]methyl-methionine and chasing with cold methionine, we detected a slight 35S pre-
RNA signal that did not persist (Fig. 4.7A). Only trace amounts of downstream products 
were seen, even at 20 minutes. Therefore, a L469R mutation leads to more severe rRNA 
defects than either S247A or G429A. The 35S precursor was quickly turned over in the 
prp43L469R allele.  
While we were not able to capture the reductions in 20S and 27S pre-rRNAs by 
northern blot in prp43Q732STOP, by pulse chase we observed their processing was 
reduced (Fig. 4.7B). Even at 20 minutes, very little 20S and 27S precursors or 18S and 
25S mature rRNAs were evident. The 35S accumulation we observed by northern 
blotting was evident by pulse chase. Together, the pre-mRNA splicing and ribosome 
biogenesis defects in prp43Q732STOP most closely resemble that of prp43Q423N (see 
Fig. 3.1B; Leeds et al. 2006).  
We also further questioned how prp43E451K M492T and prp43G473D R493K 
accumulates 35S but no changes were evident in the downstream products. We noted that 
even at permissive temperature, the WHD double mutants both accumulated 35S pre-
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rRNA. Pulse chase analysis in each of these mutants revealed that the 35S pre-rRNA 
persisted, partially processed into 27S and 20S pre-rRNAs, and further matured into 25S 
and 18S rRNAs, respectively (Fig. 4.7C). Overall, the final levels of the mature rRNAs 
were reduced in the WHD mutants. The rate of ribosome biogenesis is generally slowed 
in each of these mutants, and this partial effect on ribosome biogenesis is distinct from 
any previously characterized prp43 mutant.  
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Figure 4.7 Pulse chase analysis for prp43 mutants.  
Audioradiographs are shown for tritiated RNAs isolated from the time points 
indicated during cold methionine chase in prp43L469R (A) and prp43Q732STOP (B) 
mutants after growth at 37° C for 1 hour, or in WHD mutants (C) at 25° C. 
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4.3.6 prp43 mutants outside of the ATPase domain have aberrant polysome profiles 
The rRNA processing defects of prp43 ATPase mutants result in aberrant levels 
of mature ribosomal subunits and polysomes. In prp43G429A and prp43S247A, 
characteristic halfmers are present, indicating the loss of the 60S subunits (Combs et al. 
2006). We assayed our mutants possessing variable rRNA processing defects to 
determine their effect on mature subunits and translation (Fig. 4.8). In the prp43L469R 
mutant (Fig. 4.8B), which has the most severe ribosome biogenesis defect, we observed 
decreased 80S and polysome peaks, and, similar results were seen in the prp43 truncation 
mutant (Fig. 4.8C). Though the ratio of 40:60S subunits in both mutants were not 
observably different from wild-type, halfmers were present in the 80S and polysome 
peaks. Both L469R and Q732STOP mutants obviously contain aberrant subunits that 
result in decreased subunit joining and loading on mRNAs. In contrast, the WHD double 
mutants did not show any obvious changes in 80S or polysomes (Figs. 4.8D & E). The 
overall levels 80S and polysomes were slightly reduced, in agreement with the pulse 
chase analysis of these mutants (Fig. 4.8D & E). These WHD mutants do not appear to 
have substantial defects in translation.  
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Figure 4.8 prp43 mutants have less severe defects in mature ribosomal subunits and 
polysomes. 
Polysome profiles in PRP43-TAP wild-type (A), prp43L469R-TAP (B), 
prp43Q732STOP (C), prp43E451D M492T-TAP (D), or prp43G473 R493K-TAP (E) 
after shift to NPT. prp43 L469R and prp43Q732STOP mutants both show aberrant 80S 
and polysome peaks, while double WHD mutants do not. Peaks from left to right: 40S, 
60S, 80S, polysomes.  
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4.3.7 Double WHD mutants accumulate snR41 on pre-ribosomal particles. 
Prp43p plays a role in removing certain snoRNAs either directly from pre-
ribosomal particles or indirectly by driving the rearrangements necessary for their 
removal (Bohnsack et al. 2009). If the ATPase activity of Prp43p is defective, four 
snoRNAs are retained in pre-ribosomal complexes: snR39, snR39b, snR50 and snR59, all 
of which have binding sites on the large subunit (Bohnsack et al. 2009; Fig. 1.2). In 
prp43 ATPase mutants, the distributions of the U14 and snR41 snoRNAs shift from 
mostly 40S and 60S fractions to 80S/90S and polysome fractions (Bohnsack et al. 2009; 
Fig. 1.1). Due to the mild phenotype observed in prp43E451K M492T and G473D 
R493K, we sought to determine if snoRNAs are not properly removed in these alleles. 
We separated ribosomal subunits through sucrose gradients then northern blotted for 
snR41, snR39, and snR50. We observed that snR41 consistently accumulated in higher 
sucrose fractions in the mutants compared to wild-type (Fig. 4.9). In contrast, we were 
unable to consistently observe the same change in sedimentation in snR39 or snR50 (Fig. 
4.9 and data not shown). To account for any decrease in the total subunit levels in the 
mutants, we utilized 5.8S rRNA as a loading control. Both WHD mutants have a unique 
mild rRNA processing defect and they are unable to remove snR41 from pre-ribosomes, 
which is distinct from the prp43 ATPase mutants (Bohnsack et al. 2009).  
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Figure 4.9 WHD mutants do not properly remove snR41. 
RNA fractions from PRP43-TAP wild-type (A), prp43E451D M492T-TAP (B) or 
prp43G473D R493K-TAP (C) polysome profiles were northern blotted for snR41 or 
snR30 (top panels). For RNA loading control, 5.8S was also visualized by Northern 
blotting (bottom panels). Fractions encompassing pre-ribosomal subunits or polysome 
peaks are indicated below the northern blots.  
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4.3.8 prp43 mutants still associate with Pfa1p-myc. 
The G-patch protein Pfa1p makes extensive contacts with Prp43p and can 
stimulate both its ATPase and helicase activities (Walbott et al. 2010). We hypothesized 
that prp43 mutants lose or gain association with Pfa1p at NPT, which might contribute to 
the observed molecular phenotypes in each allele. An increase of Pfa1p association 
would be consistent with Pfa1p overexpression phenotypes (see Chapter 2) but would be 
unlikely due to the temperature sensitive nature of the mutants. Additionally, we would 
not anticipate that the loss of Pfa1p association would have a drastic effect on cell growth 
considering that Pfa1p is non-essential, and we would not expect its robust contacts with 
Prp43p to be disrupted by individual amino acid changes. Indeed, none of the prp43 
mutants showed a decrease or obvious increase in Pfa1p-myc association at NPT (Fig. 
4.10). Therefore, it is unlikely that the RNA processing defects observed in each mutant 
are linked to Pfa1p.  
4.3.9 prp43 mutants do not associate with Gno1p at NPT. 
Another G-patch protein, Gno1p, has also been reported to stimulate the activity 
of Prp43p (Y. Henry, unpublished results) and sediments with Prp43p in 90S particles 
(Lebaron et al. 2009). We hypothesized that prp43 mutants with defects in ribosome 
biogenesis might have an aberrant relationship with Gno1p. We performed 
immunoprecipitations with TAP-tagged constructs of each mutant after growth at NPT 
for 3 hours and western blotted for the presence of Gno1p-myc. Interestingly, Gno1p-
myc association was lost at NPT in the prp43G395R, prp43L469R, prp43IRK, and 
prp43WLI alleles, but the double WHD mutants still associated with Gno1p (Fig. 4.11A).   
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Figure 4.10 prp43 mutants do not lose association with Pfa1p-myc. 
After growth at NPT, each prp43 mutant still immunoprecipitates with Pfa1p-
myc. Complexes were precipitated using TAP tag on PRP43 wild-type or mutants, and 
serially western blotted for Pfa1-myc (top panels) or Prp43p-TAP (bottom panels). Pfa1-
myc extract was used as negative control for anti-TAP immunoprecipitation.  
1% input; 20% bound 
  
  186 
 
 
 
 
 
 
Figure 4.11 prp43 mutants do not bind Gno1p-myc at NPT.  
A). After growth at NPT for 3 hours, PRP43-TAP or prp43-TAP complexes were 
immunoprecipitated and analyzed for Gno1p-myc association by serial western blot 
(myc, top panels; TAP, bottom panels). Gno1-myc extract was utilized as negative 
control. B). Prp43 alleles that showed loss of Gno1p association at 37° C were analyzed 
for Gno1p association at 25° C.  
1% input; 20% bound 
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For each mutant that was affected at 37°C, we verified that Gno1p binding was not 
constitutively abrogated. Indeed, at 25° C all four prp43 mutants still associated with 
Gno1p-myc (Fig. 4.11B). These data indicate that the loss of Prp43p/Gno1p association 
partially drives the growth and ribosome biogenesis defects observed in these mutants. 
4.3.10 prp43 mutants constitutively lose association with Ntr1p  
Ntr1p, stimulates the helicase activity of Prp43p (Tanaka et al. 2006) and is 
necessary for the recruitment of Prp43p to the spliceosome (Tsai et al. 2005). We 
hypothesized that prp43 mutants that are defective in pre-mRNA splicing are unable to 
properly associate with the spliceosome due to a loss of interaction with Ntr1p. After 
growth at NPT for 3 hours, immunoprecipitations of each prp43 allele were performed, 
then Ntr1p-myc binding was assayed by western blotting. Interestingly, the prp43 alleles 
that lost Gno1p binding at NPT (Figure 4.12) also did not associate with Ntr1p at NPT. 
However, when we assayed Ntr1p binding in these mutants at 25˚C, we observed that 
Ntr1p association was also strongly reduced at PT. Therefore, prp43G395R, prp43L469R, 
prp43IRK, and prp43WLI mutants all have a constitutive defect in forming Prp43p/Ntr1p 
complexes. Though it might be expected that cells would not tolerate the loss of 
Ntr1p/Prp43p complexes, cells that lose Ntr1p/Prp43p association due to a L68A 
mutation in the G-patch domain of Ntr1p exhibit no growth defect at 30˚C. Only at 37˚C 
is the temperature sensitivity of the ntr1L68A allele revealed (Tanaka et al. 2007). In 
contrast, the WHD mutant prp43G473D E493K and the ratchet mutant prp43A565E still 
associated with Ntr1p.  
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Figure 4.12 prp43 mutants constitutively do not bind Ntr1p-myc.  
A). After growth at NPT for 3 hours, PRP43-TAP or prp43-TAP complexes were 
immunoprecipitated and analyzed for Ntr1-myc association by serial western blot (myc, 
top panels; TAP, bottom panels). Pfa1p-myc extract was utilized as negative control.  
B). Even at PT, prp43p-TAP mutants do not associate with Ntr1p-myc. 
1% input; 20% bound 
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4.3.11 prp43 mutants that do not associate with Gno1p also do not associate with 35S 
pre-rRNA 
Prp43p was previously shown to retain association with the 35S pre-rRNA in the 
absence of Gno1p; however, the extracts used for these immunoprecipitations were also 
deficient in Pfa1p (Lebaron et al. 2009). Since our results indicated that Pfa1p could 
inhibit Prp43p recruitment to the 35S pre-rRNA (Fig. 2.8), we reasoned Gno1p could still 
be partially responsible for bringing Prp43p into 90S pre-ribosomal particles. Since 
PRP43p/Gno1p interaction was affected in multiple prp43 alleles (Fig. 4.11), we 
analyzed prp43 mutant association with the 35S pre-rRNA. After shift to NPT for 3 
hours, the wild-type or mutant Prp43p-TAP was immunoprecipitated and the presence of 
the 35S pre-rRNA was determined by primer extension analysis (Fig. 4.13A). At NPT, 
35S association was reduced in prp43G395R, prp43L469R, prp43IRK and prp43WLI. In 
contrast, 35S association was unchanged in prp43E451D M492T, prp43G473D R493K, 
and prp43A565E. The relative levels of 35S pre-rRNA bound was normalized to the 
respective input and compared to wild-type (Fig. 4.13B). We note that the same prp43 
mutants that lost association with Gno1p also lost association with the 35S pre-rRNA. 
Since the CTD of Prp43p near the OB-fold has been shown to be necessary for RNA 
binding (Walbott et al. 2010), the triple alanine IRK and WLI mutations might disrupt the 
RNA binding capability of this domain. Additionally, neither of the WHD mutants lost 
association with the 35S pre-rRNA, which is consistent with their retention of Gno1p 
binding (Fig. 4.11).  
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Figure 4.13 prp43 mutants impact association with the 35S pre-rRNA. 
A). Primer extension analysis for the 35S pre-rRNA immunoprecipitated with each 
prp43p-TAP mutant indicated. 1% input; 50% bound; NEG, untagged control.  
B). Quantitation of averaged 35S pre-rRNA immunoprecipitated by each prp43p-TAP 
mutant. 35S pre-rRNA signals were normalized to input then fold change from wild-type 
determined. Dashed line represents wild-type level. Asterisks (*) indicate samples with 
significant p-values (p=<0.021) as determined by a two-tailed t-test. 
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4.3.12 prp43 mutants G359R and L469R mutants do not interact with snRNAs 
In addition to the role of the CTD of Prp43p in binding RNA (Walbott et al. 
2010), Ntr1p has been implicated in interacting with this region (Tanaka et al. 2007). We 
would expect that in the absence of Ntr1p binding, as we observed with the IRK and WLI 
mutants (Fig. 4.12), Prp43p would not be able to join the spliceosome and associate with 
snRNAs. Indeed, these two mutations reduced the association of all snRNAs with Prp43p 
(Fig. 4.14A, lanes 15 &18). Additionally, Ntr1p has been shown to bind a region that 
encompasses a portion of the RecA2 domain and almost all of the !-hairpin (He et al 
2010; Walbott et al. 2010), specifically between amino acids 390 and 411 (Tanaka et al. 
2007). We found that the G395R mutation also abrogates snRNA association (Fig. 4.14A, 
lane12), which is consistent with the loss of Ntr1p association. Likewise, we found that 
the L469R mutation reduced Prp43p association with the snRNAs within one hour after 
shift to NPT (Fig. 4.14B, lane 18). Since the L469R mutation affected Ntr1p binding at 
PT, we also analyzed the ability of the mutant to bind snRNA at PT. As expected, the 
L469R mutation resulted in the constitutive inability to bind snRNAs (Fig. 4.14B, lane 
15). In contrast to these mutants, prp43A565Ep, which still associates with Ntr1p-myc 
(Fig. 4.12B), still interacts with the snRNAs as expected (Fig. 4.14A, lane 9). We note 
that the association of the U5 snRNA in each mutant is the most affected compared to U2 
or U6.  
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Figure 4.14 prp43 mutants do not associate with snRNAs. 
A). Northern blot analysis for snRNAs immunoprecipitated with either wild-type Prp43p-
TAP or mutant prp43p-TAP at NPT. The quantitation for fold change in U2, U5a, and U6 
snRNAs associated with prp43p mutants is shown below the northern blot. Fold change 
was calculated as the percentage of each snRNA bound compared to wild-type. B). 
snRNAs associated with Prp43p-TAP and prp43L469Rp-TAP at 25° C or shifted to 37° 
C for 1 hour. U2, U6, and U5 snRNAs were visualized by northern blotting. Quantitation 
was preformed as described in (A). IN, 1% input; FT, 1% flow-through; B, 20% bound.  
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4.4 DISCUSSION  
In this work, we characterized novel and previously identified alleles of PRP43 
with mutations in the DEAH-C. For each allele, we determine the effect of the mutant on 
ribosome biogenesis and pre-mRNA splicing. Using these alleles, we have related RNA 
binding and G-patch protein binding to specific regions Prp43p, which sheds light on its 
regulation. Of the mutants we analyzed, they fell into four different categories (Table 
A2). First, alleles prp43G395R and prp43L469R do not impair spliceosome recycling to 
the point that pre-mRNA splicing is stalled (Figs. 4.4 & 4.5), but each drastically affects 
ribosome biogenesis (Figs. 4.6 & 4.7). Though we did not observe a first-step splicing 
defect in prp43G395R, a substitution of glutamic acid at this position was previously 
reported to accumulate pre-mRNAs (Arenas and Abelson 1997). Since G395 lies near the 
base of the 5' HP, perhaps the difference in phenotype for these two mutants is related to 
a difference in the effect of the substitution on the movement of that structure. L469 lies 
at the interface between the WHD and the RecA1 domain. It is quite possible that the 
arginine substitution at this position interferes with the movement of the WHD domain 
that is predicted to occur during catalysis. Since L469 does not lie on the surface of the 
protein this change in the internal mechanism of the enzyme is most likely. However, 
interestingly, the conformational changes affected by G359R or L469R impact the ability 
of Prp43p to interact with two of its cofactors. 
A second class of alleles with mutations in the CTD drastically affects both 
ribosome biogenesis and pre-mRNA splicing. Unlike the first class of mutants described, 
these CTD alleles have a strong defect in spliceosome recycling which results in a block 
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in the first step of splicing (Figs. 4.4 & 4.5). The triple alanine mutants 648IRK650 and 
717WLI719 lie at the interface between two ! helices distal to the OB-fold, and together 
line a small pocket (Fig. 2A right panel; Fig. 4.3B). The ! helix containing 717WLI719 also 
interfaces with the C-terminal ! helix that is truncated in the prp43Q732STOP allele. 
This C-terminal ! helix projects out into solution, but partially protects the surface it 
forms with L718 and I719. While mutations in L469 and G395 may directly impact 
conformational changes of Prp43p, mutations in the CTD are unlikely to directly affect 
catalysis. Though a portion of the CTD that encompasses part of the fourth ! strand of 
the OB-fold and the loop between it and the fifth ! sheet lies close to the 5' HP (amino 
acids 697-704), the other ! strands of the OB-fold lie between this region and  648IRK650 
and 717WLI719. This loop is modeled to make contact with the RNA, and mutation of the 
loops between the fourth and fifth ! sheets have been shown to reduce the RNA-
stimulated ATPase activity of Prp43p (Walbott et al. 2010). It is possible that movement 
of the three ! helices in which 648IRK650 and 717WLI719 lie and Q-STOP truncates 
indirectly affects the interaction between this loop and the RNA.  
Our third class of mutants contains two alleles with two mutations each. While we 
cannot be certain at this time whether one or both of the mutations are required for the 
phenotype, it is curious that a mutation in each allele lies adjacent to one another, M492 
and R493, implicating that region in the observed phenotype. Additionally, these two 
mutations lie along the interface between the WHD and the 5' HP. In particular, the 
mutation at R493 could impact 5' HP position; eleven of seventeen predicated rotamers 
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for this mutation clash with the tip of the 5' HP (R407). R493 lies one turn away on same 
! helix as E497, which is predicted to make a salt bridge with R407 (Walbott et al. 
2010). These alleles are constitutively partially deficient in ribosome biogenesis with 
little impact on pre-mRNA splicing. Perhaps minor perturbations of the movement of the 
5' HP are responsible for the phenotype observed. It is possible that ribosome biogenesis 
is more sensitive to the function of Prp43p. Association of none of the cofactors nor 35S 
rRNA were disrupted in these mutants, indicating these mutant proteins are being 
directed properly, but are partially incompetent mechanically.  
A final mutant, prp43A565E, belongs in a separate class since growth is mildly 
affected, but no change in pre-mRNA splicing or ribosome biogenesis was observed. 
A565 lies in the ratchet domain, though in one of the ! helices predicted to be part of the 
"motor" rather than the main ! helix predicted to be the ratchet. We believe 
prp43A565Ep is being targeted properly, but is deficient in its ability to translocate. 
Further in vitro analysis will be needed to further understand how A565 affects Prp43p 
mechanistically. 
Our data support a model in which more than one cofactor utilizes the same 
binding surface on Prp43p. It was previously reported that two mutations in the 5' HP of 
Prp43p cause temperature sensitivity, K398A and Y402A. The single mutation of Y402 
results in loss of Ntr1p binding in vitro, and, moreover, lariat introns partially accumulate 
in post-spliceosomal complexes. Ntr1p forms one binding interface with this 5' HP 
region, which would be consistent with the model for activation of Prp43p by cofactors 
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(Tanaka et al. 2007; Walbott et al. 2010). Our data further support this model since the 
mutation of G395 also loses association with Ntr1p in vivo. As in the case of Y402, the 
mutation of G395 to arginine does not completely abolish the ability of Prp43p to 
function in pre-mRNA splicing. Our data along with data for Y402 indicate that cells can 
survive without Ntr1p/Prp43p interaction. Furthermore, mutation of G395 or L469 results 
in loss of Gno1p binding. We propose that both Ntr1p and Gno1p interact with the same 
regions of the 5' HP, and most likely are acting in similar manner to stimulate of the 
activity of Prp43p.  
A single mutation in a conserved glycine of the G-patch domain of Ntr1p, L68A, 
results in its loss of interaction with Prp43p in vitro. While ntr1L68A is not a lethal allele, 
it is synthetically lethal with prp43Y402A. The ntr1L68A allele is also synthetically lethal 
in combination with a truncation of the CTD of Prp43p (aa 1-722) and triple alanine 
mutations of 717WLI719. However, the G-patch domain of Ntr1p makes contacts with 
Prp43p in the absence of the CTD (aa 1-712) in vitro (Tanaka et al.2007), proving that 
that region is not interacting with the CTD. These data were suggestive of a second 
function of the CTD of Prp43p, and more recent data have proven that the CTD is 
necessary for RNA binding in vitro (Walbott et al. 2010). Our data indicate that loss of 
RNA binding by the CTD is concomitant with loss of cofactor binding in vivo. Triple 
alanine mutants 648IRK650 and 717WLI719 lose interaction with Ntr1p and Gno1p, as well as 
snRNAs and the 35S pre-rRNA. While the Ntr1p/Prp43p interaction is dependent upon 
the G-patch domain of Ntr1p, it remains to be proven if Gno1p interacts in a similar 
manner. The mutation of a conserved tryptophan in the G-patch domain of Gno1p, 
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W38S, is sufficient to produce the rRNA processing defects observed in a gno1! 
(Guglielemi and Werner 2002). This single mutation does contribute to the interaction of 
Gno1p with Prp43p, but is not sufficient to completely disrupt their interaction in vivo 
(Fig. 3.6B). Perhaps other mutations in the G-patch domain will further elucidate the 
importance of the G-patch domain of Gno1p in relation to Prp43p. Nevertheless, we note 
that both Ntr1p and Gno1p require G-patch domains for their function in vivo, while the 
G-patch domain of Pfa1p is dispensable for growth and interaction with Prp43p (Tanaka 
et al. 2007; Guglielmi and Werner 2002; Pandit et al. 2009; Pertschy et al. 2009). Also, 
the G-patch domain of Pfa1p interacts with the C-terminus of Prp43p, not the ! hairpin 
(Walbott et al. 2010). Because of the nonessential nature of Pfa1p, our data indicate that 
the effect on RNA processing observed in each mutant is unlikely to be linked to Pfa1p. 
It is possible that the dominant nature of Pfa1p in its association with Prp43p over the 
other two cofactors exacerbates weakened Prp43p/Ntr1p or Prp43p/Gno1p associations 
(Hennigan and Stevens, unpublished). However, there was not an observable increase in 
the amount of Prp43p/Pfa1p complexes in our mutants. 
The dominant negative mutant prp43T123Ap retains the ability to bind the 
spliceosome, but is ATPase deficient and unable to unwind the intron lariat from post-
splicing lariat RNP complexes (Martin et al. 2002; Tanaka and Schwer 2006). 
Interestingly, if the triple alanine mutations, IRK or WLI, are also introduced into 
prp43T123A, the dominant negative phenotype is relieved (Tanaka and Schwer et al. 
2007). Therefore, these mutations in the CTD are affecting the targeting and binding of 
Prp43p to its substrates, which can relieve the dominance exhibited by the T123A 
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mutation. Since IRK and WLI both lose association with RNAs from both processes it is 
likely that this region in fact generally binds RNAs nonspecifically in vivo. Perhaps 
without the ability to bind RNA, the interaction between Prp43p and Ntr1p or Gno1p is 
not stabilized, which is why the loss of both RNA and cofactor binding is concomitant.  
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Chapter 5: Conclusions and Implications  
5.1 REGULATION OF PRP43P VIA ITS INTERACTIONS WITH G-PATCH PROTEINS IN YEAST 
In this work, we further define the previously suggested competition between the 
G-patch proteins (Pandit et al. 2009). We show that excess Pfa1p inhibits both the pre-
mRNA splicing (Fig. 2.12) and ribosome biogenesis (Fig. 2.7) pathways directly by 
outcompeting both Ntr1p and Gno1p for Prp43p binding (Figs. 2.9 & 2.13). Under 
conditions in which Pfa1p levels are increased, Prp43p is inhibited from associating with 
either the 35S rRNA for ribosome biogenesis or the U6 snRNA in pre-mRNA splicing 
(Fig. 2.8). Additionally, we show that Ntr1p and Gno1p can compete with one another for 
Prp43p occupancy (Figs. 3.5 & 3.8). The overexpression of both Gno1p-HA/ZZ and 
Ntr1p-HA/ZZ results in mild effects on pre-mRNA splicing (Fig. 3.2) or pre-rRNA 
processing (Fig. 3.8A), respectively. The competition between Gno1p and Ntr1p can be 
visualized through the change in Prp43p localization upon their overexpression (Fig. 3.4). 
We note that Pfa1p is thought to be both nucleolar and nucleoplasmic, and its association 
with Prp43p does not change upon Ntr1p or Gno1p overexpression (Fig. 3.9). These data 
support a model in which Pfa1p has a dominant interaction with Prp43p over the other 
two cofactors. Since we used an in vivo system, Prp43p associations with the G-patch 
proteins were determined in the context of native complexes. In vitro competition assays 
and kinetic data are necessary to further define and clarify the direct relationships 
between the Prp43p and its cofactors. However, to accomplish these experiments the 
reported difficulties in properly expressing Gno1p must be overcome (Lebaron et al. 
2009).  
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We believe that in response to stress, cells may use a regulatory mechanism that is 
dependent on Pfa1p (Fig. 2.14) to manipulate Prp43p distribution, thereby pausing both 
pre-rRNA and pre-mRNA processing pathways. This mechanism appears to be more 
complicated than simply increasing whole cell Pfa1p protein levels (Fig. 2.15), and will 
require further investigation. Our data also suggest that in response to heat shock, Pfa1p 
may be post-translationally modified (Fig. 2.15C). We are working to verify that such a 
modification exists and is functionally important. It will be interesting to determine if 
Pfa1p post-translational modification impacts Prp43p association.  
Furthermore, we found that the G-patch domain of Gno1p is necessary for its 
interaction with Prp43p (Fig 3.6B), similar to that of Ntr1p (Tanaka et al. 2007), but in 
contrast to Pfa1p (Pandit et al. 2009; Lebaron et al. 2009). This interaction between the 
G-patch domain of Gno1p and Prp43p is also important for the association of Prp43p 
with the 35S pre-rRNA (Fig. 3.6C). These data suggest that the rRNA defects observed in 
the absence of Gno1p are most likely due to the loss of a Prp43p-mediated event. More 
biochemical data will be necessary to prove whether Gno1p binds Prp43p prior to pre-
rRNA association or works to stabilize that association. Additionally, in vitro work with 
gno1W38Sp will be needed to demonstrate the loss of direct interaction and subsequent 
loss of Prp43p stimulation by Gno1p. Moreover, the exact function of Prp43p in pre-90S 
particles has not been determined. We note that there is an increase in the amount of 35S 
pre-rRNA in the gno1! strain, suggesting that 90S particles are stalled prior to 
Prp43p/Gno1p action. The characterization of the protein composition and rRNA 
structure of these stalled particles could help elucidate the role of Prp43p in the pre-90S.  
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The similarity of the interactions between Gno1p and Ntr1p with Prp43p suggests 
that they function with Prp43p in a similar manner. In contrast, Pfa1p appears to be 
unique in its interaction with Prp43p. Our analysis of prp43 mutants further demonstrates 
this difference since multiple mutants simultaneously lose interaction with Ntr1p and 
Gno1p, but not Pfa1p (Figs. 4.10, 4.11 & 4.12). Previous work has implicated the C-
terminus of Prp43p in pre-mRNA splicing (Tanaka et al. 2007), but not ribosome 
biogenesis. Our analysis of mutations in the DEAH-C of Prp43p has identified point 
mutants that strongly affect both pre-mRNA splicing and pre-rRNA processing. Both the 
prp43IRK and prp43WLI alleles lose snRNA and rRNA association (Figs. 4.13 & 4.14), 
which is consistent with the model that the OB-fold is needed for RNA binding (Walbott 
et al. 2010). Interestingly, these mutants lose interaction with Gno1p as well as with 
Ntr1p. (Figs. 4.11 & 4.12). This implies that the interaction surface of Prp43p is shared 
between Gno1p and Ntr1p. The loss of RNA interactions might contribute to the inability 
of Prp43p to incorporate into RNPs. Deletion of the OB-fold in the human ortholog of 
Prp43p (hPrp43p) resulted in a homogeneous localization of hPrp43p in the nucleus 
rather than in nuclear speckles or nucleoli (Fouraux et al. 2002). Our microscopy data 
demonstrating the delocalization of Prp43p when either Ntr1p/Prp43p or Gno1p/Prp43p 
interactions are disrupted (Fig. 3.4) supports the importance of the CTD in the subnuclear 
localization of Prp43p. Therefore, the ability of Prp43p to bind RNA, and therefore the 
basis for its specificity, is coupled to cofactor binding and stimulation. Once again, in 
vitro work with our prp43 mutants will be instructive in illuminating their effects. In 
particular, we hypothesize that the growth phenotype observed in prp43A565E (Fig. 
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4.2B), which is mutated in the ratchet domain (Fig. 4.2A & 4.3A), is a result of a defect 
in translocation. In vitro duplex unwinding assays with the A565E mutant and other 
ratchet mutants will be necessary to determine their affect on the translocation and 
processivity of Prp43p. Mutants that lose interaction with the cofactors in vivo would be 
predicted to lose the stimulation of their ATPase activity. To fully rule out an effect of 
intrinsic ATPase activity in each prp43 mutant, in vitro ATPase assays would be needed.  
5.2 HUMAN PRP43P AND ITS INTERACTIONS WITH COFACTORS ARE CONSERVED 
The human ortholog of Prp43p shares homology with the majority of the 
ScPrp43p, but contains a unique N-terminal region. Amino acids 25-60 consist of 
alternating positive and negative residues (Arg/Lys- Asp/Glu), and this region of hPrp43p 
is necessary for its proper localization. hPrp43p colocalizes to nuclear speckles with Sm 
proteins and U2B’’ as well as in nucleoli (Fouraux et al. 2002), suggesting the dual 
function of Prp43p is conserved. However, it has yet to be proven that hPrp43p has a role 
in ribosome biogenesis. Establishing the role of hPrp43p in both ribosome biogenesis 
would be key to translating our data from yeast into humans.  
In higher eukaryotes, nuclear speckles have been shown to be a storage site for 
splicing factors and the site of spliceosome assembly (Sleeman and Lamond 1999). In 
addition to the colocalization of hPrp43 with splicing factors, it associates with U1, U2, 
U4, U5 and U6 snRNAs. An N-terminal truncation of the first 62 amino acids of hPrp43p 
was shown to abrogate its localization to nucleoli, but not its localization to the nuclear 
speckles (Fouraux et al. 2002). Furthermore, an N-terminal truncation of the first 152 
amino acids resulted in the cytoplasmic distribution of hPrp43p, indicating its NLS signal 
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lies within this region (Fouraux et al. 2002). Since this region is not conserved from the 
yeast homolog, the NLS signal appears to be divergent in yeast.  
Additionally, hPrp43p does not share a twelve amino acid lysine rich C-terminal 
extension with ScPrp43p (Fouraux et al. 2002). A C-terminal truncation of 106 amino 
acids of hPrp43p also resulted in loss of its localization to nucleoli or nuclear speckles, 
but a homogeneous nuclear signal is observed. This C-terminal region is predicted to be 
necessary for targeting Prp43p to the subnuclear compartments accordingly (Fouraux et 
al. 2002). Interestingly, this C-terminal truncation of hPrp43p is upstream of the 
corresponding 648IRK650 in ScPrp43p. This truncation would be missing part of the OB-
fold and would be hypothesized to also lose interaction with RNA based on a similar 
truncation in ScPrp43p (Walbott et al. 2010). Our data demonstrates that prp43IRKp and 
prp43WLIp concomitantly lose interaction with RNAs (Fig. 4.13 & 4.14) and the pre-
mRNA splicing or pre-ribosomal processing machineries. Our data along with the human 
data suggest that the contribution of RNA binding to the proper localization of Prp43p is 
conserved. Investigations of the unique domains of hPrp43p described above will be most 
interesting in determining any new roles of hPrp43p and its regulation in humans.  
Interestingly, hPrp43p has been purified as a part of the 17S U2 snRNP, which is 
the species that joins the pre-mRNA (Hartmuth et al. 2002; Das et al. 2000). Our lab has 
been unable to demonstrate Prp43p is a component of the U2 snRNP in yeast (Hennigan 
and Stevens, unpublished). Two G-patch containing proteins are also found as part of 
purified human 17S U2 snRNPs, CHERP and SPF45 (Hartmuth et al. 2002). In 
Drosophila SPF45 (also termed RBM17) has been shown to play a role in the selection of 
  204 
the 3' SS in alternative splicing, which has important implications in alternative splicing 
(Lallena et al. 2002). CHERP has not been shown to have a role in pre-mRNA splicing, 
but has a role in calcium homeostasis (Laplante et al. 2000). Neither is known to have a 
functional connection to Prp43p or any other DExH/D helicase. However, several other 
G-patch proteins have been shown to function with hPrp43p. Two of the yeast cofactors, 
Gno1p and Ntr1p, have obvious homologs in humans (Tannukit et al. 2009; Zhou and Lu 
2001), and hPrp43p interacts with at least two other G-patch proteins, RBM5 and 
GPATCH2, not found in yeast (Lin et al. 2009; Niu et al. 2012).  
The human homolog of the spliceosome related protein Ntr1p is TFIP11, which 
possesses 30% amino acid conservation (Tannukit et al. 2008). TFIP11 localizes to 
nuclear puncta, distinct from the nuclear speckles that contain splicing factors, and is 
excluded from nucleoli (Wen et al. 2005). The G-patch domain of TFIP11 is dispensable 
for its localization (Wen et al. 2008), but the N-terminal region of TFIP11 containing the 
G-patch domain is necessary its interaction with hPrp43p (Yoshimoto et al. 2009). As in 
yeast, TFIP11/hPrp43p association is necessary to disassemble the post-splicing lariat 
RNP, indicating that they function together for the same role in pre-mRNA splicing in 
humans (Yoshimoto et al. 2009). Further investigations will be necessary to determine if 
TFIP11 acts differently in alternative splicing scenarios.  
hPINX1 is the human homolog of yeast protein Gno1p with approximately 50% 
amino acid similarity. However, though it localizes to the nucleolus, hPINX1 has yet to 
be proven to function in ribosome biogenesis (Zhou and Lu 2001). Despite this lack of 
data, hPINX1 rescues growth and ribosome biogenesis defects when expressed in a 
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gno1! strain, indicating that hPINX1 can support the role Gno1p plays in rRNA 
processing, at least in yeast (Guglielmi and Werner 2002). These data suggest that 
hPINX1 likely plays a role in human rRNA processing, but further work will be 
necessary to demonstrate a functional relationship between hPrp43p and hPINX1.  
hPINX1 has an additional function in maintaining telomeres by acting as an 
inhibitor of telomerase (Zhou and Lu 2001). hPinX1 binds directly to the telomerase 
catalytic component TERT (Zhou and Lu 2001), and recruits and mediates the 
localization of human telomerase to the telomere in a cell cycle-dependent manner 
(Cheung et al. 2012). In yeast, Gno1p competitively binds the same interface of TERT 
(Est2p) as the RNA component of telomerase (TLC1). While bound to Gno1p, TERT is 
sequestered from TLC1 and remains in an inactive state. While the G-patch domain of 
Gno1p is necessary for its role in ribosome biogenesis, it is dispensable for its function in 
telomere maintenance (Lin and Blackburn 2004; Guglielmi and Werner 2002). In vitro 
work will be needed to demonstrate the relationship between the G-patch domain of 
hPINX1 in rRNA processing and hPrp43p.  
The G-patch protein RBM5 has recently been shown to interact with hPrp43 in 
vivo in HeLa cells and directly in vitro. This interaction is mediated by the C-terminus of 
RBM5, which contains an essential G-patch domain (aa 742-815). It has already been 
shown that two or more point mutations of the glycines in this domain strongly reduce 
the binding of RBM5 to hPrp43, and, subsequently, the ATPase and helicase activity of 
hPrp43p is no longer stimulated by RBM5 (Niu et al. 2012). RBM5 was not detected in 
post-splicing lariat RNPs, so it is unlikely to be working in disassembly (Yoshimoto et al. 
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2009). Therefore, it is still unknown in which process RBM5 and hPrp43p are 
functioning together.  
RBM5 has also been shown to be a tumor suppressor that induces cell cycle arrest 
and apoptosis through cyclin A or Bax pathways, respectively, by regulating the splicing 
of pre-mRNA of target genes in those pathways (Oh et al. 2006). An Octamer Repeat 
(OCRE) domain in RBM5 contacts U5 and is necessary to modulate alternative splicing 
after assembly and exon definition (Bonnal et al. 2008). RBM5 is one of 35 genes related 
to tumor suppression in a 370 kB region on chromosome 3p21.3. The loss of this region 
is the most frequent and earliest event in the development of non-small cell lung cancer 
(Wei et al. 1996). In non-small cell lung cancers, RBM5 mRNA and protein levels were 
shown to be significantly reduced in patient tissue samples. Additionally, the decrease in 
RBM5 was positively correlated to lymph node metastasis and also seen in IIIA and IIIB 
stage cancers (Liang et al. 2012). Similarly, the mRNA and protein levels of RBM5 are 
downregulated in pancreatic cancer tissue compared to non-tumor tissue. This reduced 
level in RBM5 also correlates with in an increase in metastasis (Peng et al. 2013). These 
links between RBM5 and disease highlight the importance in understanding its 
relationship with hPrp43p.  
Finally, very little is known about the G-patch containing protein GPATCH2, 
which has been shown to interact with hPrp43p in beast carcinomas in a single report 
(Lin et al. 2009). This novel protein was identified as overexpressed by 3 fold in about 
40% of breast cancers tested. While, GPATCH2 has obvious murine and Xenopus 
homologues (Lin et al. 2009), there is no identified yeast homolog. hPrp43p 
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coimmunoprecipitates with GPATCH2 and colocalizes in both nuclear speckles and 
nucleoli. When protein levels of hPrp43p are decreased via siRNA treatment, breast 
cancer cells have reduced viability. Interestingly, the ATPase activity of recombinant 
hPrp43p was increased by 45-fold in the presence of GPATCH2, implicating it as a 
cofactor in an unknown pathway. The stimulation of hPrp43p by GPATCH2 could 
contribute to the transformation of normal beast cells, and further investigation into the 
nature and implications of this interaction is warranted for basis of further therapeutic 
study (Lin et al. 2009).  
In conclusion, potentially the regulation of hPrp43p by G-patch proteins is 
conserved in humans. Much work must be done with each of the four cofactors to 
understand their relationships with hPrp43p and roles in humans. Additionally, in 
humans, at least 22 G-patch domain-containing proteins are predicted, more than 4 times 
the number in yeast (The UniProt Consortium 2011). Likewise, the number of DEAH-
box helicases predicted in humans is 14, double the number identified in yeast (Umate et 
al. 2011). If the function of all of the human G-patch proteins is in regulating DEAH-box 
proteins, then the complexity of the regulation is even greater than that in yeast. It will be 
interesting to determine how other G-patch-containing proteins in metazoa are involved 
in regulating the activity of additional helicases by stimulation and/or recruitment.  
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Appendix 
 
Table A1. All prp43 alleles isolated from gap-repair mutagenesis in Chapter 4. 
 
Random prp43 alleles Phenotype 
L469R D567V ts 
E451D M492T ts 
F437L A502P ts 
G473D R493K ts 
L718P F656S ts 
Y440C ts 
R370G I619T ts 
A565E ts 
E10K, E16Q, L698P ts 
P127S, G434A, E497G, S702F ts 
E67K, E117K, P268S ts 
S59T, P73S, E11K, E134K, P454S, 
T559A, K745R 
ts 
H298Y, D386G, S621F, M658T, 
S665L 
ts 
H298Y, E443K, D592N, W717R ts 
N618I, H682R, Q732STOP  ts 
D638N cs 
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Table A2. Summary of characteristics for prp43 alleles. 
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